id	abstract_id	offset_start	offset_finish	type	mention	entity_ids
0	1711760	23	35	DiseaseOrPhenotypicFeature	hypertension	D006973
1	1711760	49	66	DiseaseOrPhenotypicFeature	cerebral ischemia	D002545
2	1711760	78	89	DiseaseOrPhenotypicFeature	brain edema	D001929
3	1711760	113	125	DiseaseOrPhenotypicFeature	hypertension	D006973
4	1711760	165	197	DiseaseOrPhenotypicFeature	middle cerebral artery occlusion	D020244
5	1711760	199	203	DiseaseOrPhenotypicFeature	MCAO	D020244
6	1711760	208	219	DiseaseOrPhenotypicFeature	brain edema	D001929
7	1711760	274	284	ChemicalEntity	isoflurane	D007530
8	1711760	325	337	DiseaseOrPhenotypicFeature	hypertensive	D006973
9	1711760	338	342	OrganismTaxon	rats	10116
10	1711760	448	460	DiseaseOrPhenotypicFeature	hypertensive	D006973
11	1711760	532	536	DiseaseOrPhenotypicFeature	MCAO	D020244
12	1711760	555	559	DiseaseOrPhenotypicFeature	MCAO	D020244
13	1711760	565	569	OrganismTaxon	rats	10116
14	1711760	684	692	DiseaseOrPhenotypicFeature	ischemia	D007511
15	1711760	705	709	DiseaseOrPhenotypicFeature	MCAO	D020244
16	1711760	823	831	DiseaseOrPhenotypicFeature	ischemic	D007511
17	1711760	858	873	DiseaseOrPhenotypicFeature	neuronal injury	D009410
18	1711760	892	918	ChemicalEntity	2,3,5-triphenyltetrazolium	C009591
19	1711760	936	944	DiseaseOrPhenotypicFeature	ischemic	D007511
20	1711760	1052	1060	DiseaseOrPhenotypicFeature	ischemic	D007511
21	1711760	1107	1112	DiseaseOrPhenotypicFeature	edema	D004487
22	1711760	1134	1146	DiseaseOrPhenotypicFeature	hypertensive	D006973
23	1711760	1319	1331	DiseaseOrPhenotypicFeature	hypertensive	D006973
24	1711760	1405	1418	ChemicalEntity	phenylephrine	D010656
25	1711760	1427	1439	DiseaseOrPhenotypicFeature	hypertension	D006973
26	1711760	1461	1465	DiseaseOrPhenotypicFeature	MCAO	D020244
27	1711760	1485	1490	DiseaseOrPhenotypicFeature	edema	D004487
28	1711760	1498	1506	DiseaseOrPhenotypicFeature	ischemic	D007511
29	1711760	1530	1535	DiseaseOrPhenotypicFeature	edema	D004487
30	1711760	1560	1568	DiseaseOrPhenotypicFeature	ischemic	D007511
31	1711760	1626	1646	DiseaseOrPhenotypicFeature	neuronal dysfunction	D009410
32	6086495	20	50	GeneOrGeneProduct	Becker muscular dystrophy gene	1756
33	6086495	146	171	DiseaseOrPhenotypicFeature	Becker muscular dystrophy	D020388
34	6086495	173	176	DiseaseOrPhenotypicFeature	BMD	D020388
35	6086495	329	332	GeneOrGeneProduct	BMD	1756
36	6086495	420	451	DiseaseOrPhenotypicFeature	Becker and Duchenne dystrophies	D020388
37	7018927	22	59	GeneOrGeneProduct	luteinizing hormone-releasing hormone	2796
38	7018927	67	78	ChemicalEntity	haloperidol	D006220
39	7018927	87	105	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
40	7018927	145	156	ChemicalEntity	haloperidol	D006220
41	7018927	166	175	GeneOrGeneProduct	prolactin	5617
42	7018927	180	199	GeneOrGeneProduct	luteinizing hormone	1081
43	7018927	201	203	GeneOrGeneProduct	LH	1081
44	7018927	332	352	GeneOrGeneProduct	LH-releasing hormone	2796
45	7018927	354	359	GeneOrGeneProduct	LH-RH	2796
46	7018927	386	394	OrganismTaxon	patients	9606
47	7018927	422	426	ChemicalEntity	NaCl	D012965
48	7018927	458	469	ChemicalEntity	haloperidol	D006220
49	7018927	493	511	DiseaseOrPhenotypicFeature	hyperprolactinemia	D006966
50	7018927	572	577	GeneOrGeneProduct	LH-RH	2796
51	7811247	0	29	DiseaseOrPhenotypicFeature	X-linked adrenoleukodystrophy	D000326
52	7811247	31	34	DiseaseOrPhenotypicFeature	ALD	D000326
53	7811247	61	64	GeneOrGeneProduct	ALD	215
54	7811247	152	172	DiseaseOrPhenotypicFeature	adrenoleukodystrophy	D000326
55	7811247	174	177	DiseaseOrPhenotypicFeature	ALD	D000326
56	7811247	191	198	OrganismTaxon	patient	9606
57	7811247	215	218	DiseaseOrPhenotypicFeature	ALD	D000326
58	7811247	324	327	GeneOrGeneProduct	ALD	215
59	7811247	345	396	SequenceVariant	cytosine to guanine transversion at nucleotide 1451	rs128624214
60	7811247	440	463	SequenceVariant	proline 484 by arginine	rs128624214
61	7811247	494	501	OrganismTaxon	patient	9606
62	7811247	527	530	DiseaseOrPhenotypicFeature	ALD	D000326
63	7811247	536	557	DiseaseOrPhenotypicFeature	adrenomyeloneuropathy	D000326
64	7811247	563	570	DiseaseOrPhenotypicFeature	Addison	D000224
65	7811247	633	655	ChemicalEntity	long chain fatty acids	D005227
66	7811247	745	748	DiseaseOrPhenotypicFeature	ALD	D000326
67	7811247	749	757	OrganismTaxon	patients	9606
68	8944024	39	44	GeneOrGeneProduct	BRCA1	672
69	8944024	241	248	OrganismTaxon	patient	9606
70	8944024	520	550	GeneOrGeneProduct	breast and ovarian cancer gene	672
71	8944024	551	556	GeneOrGeneProduct	BRCA1	672
72	8944024	718	725	OrganismTaxon	patient	9606
73	14510914	0	25	DiseaseOrPhenotypicFeature	Congenital hypothyroidism	D003409
74	14510914	55	78	GeneOrGeneProduct	sodium/iodide symporter	6528
75	14510914	99	122	DiseaseOrPhenotypicFeature	Iodide transport defect	C564766
76	14510914	124	127	DiseaseOrPhenotypicFeature	ITD	C564766
77	14510914	168	192	DiseaseOrPhenotypicFeature	inability of the thyroid	D050033
78	14510914	208	214	ChemicalEntity	iodide	D007454
79	14510914	307	332	DiseaseOrPhenotypicFeature	congenital hypothyroidism	D003409
80	14510914	471	494	GeneOrGeneProduct	sodium/iodide symporter	6528
81	14510914	496	499	GeneOrGeneProduct	NIS	6528
82	14510914	502	509	OrganismTaxon	PATIENT	9606
83	14510914	525	530	OrganismTaxon	woman	9606
84	14510914	536	550	DiseaseOrPhenotypicFeature	hypothyroidism	D007037
85	14510914	605	608	DiseaseOrPhenotypicFeature	ITD	C564766
86	14510914	634	648	DiseaseOrPhenotypicFeature	nodular goitre	D020518
87	14510914	668	674	ChemicalEntity	iodide	D007454
88	14510914	733	739	ChemicalEntity	iodide	D007454
89	14510914	764	778	DiseaseOrPhenotypicFeature	hypothyroidism	D007037
90	14510914	825	836	ChemicalEntity	L-thyroxine	D013974
91	14510914	872	883	ChemicalEntity	radioiodide	D007454
92	14510914	968	973	OrganismTaxon	human	9606
93	14510914	974	977	GeneOrGeneProduct	TSH	7200
94	14510914	1000	1002	ChemicalEntity	I-	D007454
95	14510914	1083	1085	ChemicalEntity	I-	D007454
96	14510914	1152	1159	OrganismTaxon	patient	9606
97	14510914	1162	1165	GeneOrGeneProduct	NIS	6528
98	14510914	1201	1258	SequenceVariant	deletion of the coding sequence (nt 1314 through nt 1328)	c|DEL|1314_1328|
99	14510914	1267	1310	SequenceVariant	insertion of 15 nt duplicating the first 15	c|DUP||15
100	14510914	1342	1349	OrganismTaxon	patient	9606
101	14510914	1498	1556	SequenceVariant	lacking the five terminal amino acids of exon XI (439-443)	p|DEL|439_443|
102	14510914	1606	1611	CellLine	COS-7	9606
103	14510914	1666	1679	SequenceVariant	del-(439-443)	p|DEL|439_443|
104	14510914	1680	1683	GeneOrGeneProduct	NIS	6528
105	14510914	1706	1712	ChemicalEntity	iodide	D007454
106	14510914	1771	1774	DiseaseOrPhenotypicFeature	ITD	C564766
107	14510914	1783	1790	OrganismTaxon	patient	9606
108	14510914	1856	1881	DiseaseOrPhenotypicFeature	congenital hypothyroidism	D003409
109	14510914	1911	1914	GeneOrGeneProduct	NIS	6528
110	15041272	36	66	DiseaseOrPhenotypicFeature	type 2B von Willebrand disease	D056728
111	15041272	72	78	SequenceVariant	R1306W	rs61749384
112	15041272	114	128	DiseaseOrPhenotypicFeature	genetic defect	D030342
113	15041272	156	186	DiseaseOrPhenotypicFeature	type 2B von Willebrand disease	D056728
114	15041272	188	191	DiseaseOrPhenotypicFeature	VWD	D014842
115	15041272	237	242	OrganismTaxon	woman	9606
116	15041272	352	361	DiseaseOrPhenotypicFeature	bleedings	D006470
117	15041272	446	454	DiseaseOrPhenotypicFeature	bleeding	D006470
118	15041272	472	476	GeneOrGeneProduct	VIII	2157
119	15041272	488	509	GeneOrGeneProduct	von Willebrand factor	7450
120	15041272	519	522	GeneOrGeneProduct	VWF	7450
121	15041272	536	556	GeneOrGeneProduct	von Willerand factor	7450
122	15041272	557	567	ChemicalEntity	ristocetin	D012310
123	15041272	578	581	GeneOrGeneProduct	VWF	7450
124	15041272	593	632	DiseaseOrPhenotypicFeature	ristocetin-induced platelet aggregation	D001791
125	15041272	634	638	DiseaseOrPhenotypicFeature	RIPA	D001791
126	15041272	664	674	ChemicalEntity	ristocetin	D012310
127	15041272	731	741	ChemicalEntity	ristocetin	D012310
128	15041272	829	850	GeneOrGeneProduct	von Willebrand factor	7450
129	15041272	852	855	GeneOrGeneProduct	VWF	7450
130	15041272	1016	1019	GeneOrGeneProduct	VWF	7450
131	15041272	1161	1197	SequenceVariant	C to T transition at nucleotide 3916	rs61749384
132	15041272	1211	1223	SequenceVariant	Arg 1306 Trp	rs61749384
133	15041272	1225	1231	SequenceVariant	R1306W	rs61749384
134	15041272	1268	1283	GeneOrGeneProduct	glycoprotein Ib	2811
135	15041272	1285	1289	GeneOrGeneProduct	GPIb	2811
136	15041272	1354	1357	GeneOrGeneProduct	VWF	7450
137	15041272	1420	1436	DiseaseOrPhenotypicFeature	thrombocytopenia	D013921
138	15041272	1471	1482	DiseaseOrPhenotypicFeature	type 2B VWD	D056728
139	15041272	1522	1528	SequenceVariant	R1306W	rs61749384
140	15041272	1541	1544	GeneOrGeneProduct	VWF	7450
141	15096016	107	126	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
142	15096016	128	130	DiseaseOrPhenotypicFeature	PD	D010300
143	15096016	271	273	DiseaseOrPhenotypicFeature	PD	D010300
144	15096016	666	668	DiseaseOrPhenotypicFeature	PD	D010300
145	15096016	678	689	DiseaseOrPhenotypicFeature	dyskinesias	D004409
146	15096016	730	738	DiseaseOrPhenotypicFeature	rigidity	D009127
147	15096016	740	752	DiseaseOrPhenotypicFeature	bradykinesia	D018476
148	15096016	809	821	DiseaseOrPhenotypicFeature	bradykinesia	D018476
149	15096016	826	834	DiseaseOrPhenotypicFeature	rigidity	D009127
150	15096016	901	909	ChemicalEntity	levodopa	D007980
151	15096016	918	929	DiseaseOrPhenotypicFeature	dyskinesias	D004409
152	15096016	980	1000	DiseaseOrPhenotypicFeature	hyper- or dyskinetic	D004409,D006948
153	15096016	1129	1136	OrganismTaxon	patient	9606
154	15096016	1215	1223	OrganismTaxon	patients	9606
155	15099351	17	22	GeneOrGeneProduct	PCSK9	255738
156	15099351	55	94	DiseaseOrPhenotypicFeature	autosomal dominant hypercholesterolemia	D006938
157	15099351	96	141	GeneOrGeneProduct	Proprotein convertase subtilisin/kexin type 9	255738
158	15099351	143	148	GeneOrGeneProduct	PCSK9	255738
159	15099351	168	207	DiseaseOrPhenotypicFeature	autosomal dominant hypercholesterolemia	D006938
160	15099351	243	248	GeneOrGeneProduct	PCSK9	255738
161	15099351	269	280	ChemicalEntity	cholesterol	D002784
162	15099351	367	387	DiseaseOrPhenotypicFeature	hypercholesterolemia	D006937
163	15099351	442	447	GeneOrGeneProduct	PCSK9	255738
164	15099351	526	555	DiseaseOrPhenotypicFeature	familial hypercholesterolemia	D006937
165	15099351	579	611	GeneOrGeneProduct	low-density lipoprotein receptor	3949
166	15099351	630	636	SequenceVariant	R3500Q	rs5742904
167	15099351	644	664	GeneOrGeneProduct	apolipoprotein B-100	338
168	15099351	766	771	GeneOrGeneProduct	PCSK9	255738
169	15099351	782	790	OrganismTaxon	patients	9606
170	15099351	814	819	SequenceVariant	D374Y	rs137852912
171	15099351	829	836	OrganismTaxon	patient	9606
172	15099351	867	872	SequenceVariant	D374Y	rs137852912
173	15099351	877	882	SequenceVariant	N157K	rs143117125
174	15099351	884	889	SequenceVariant	D374Y	rs137852912
175	15099351	906	926	DiseaseOrPhenotypicFeature	hypercholesterolemia	D006937
176	15099351	1055	1060	GeneOrGeneProduct	PCSK9	255738
177	15099351	1072	1111	DiseaseOrPhenotypicFeature	autosomal dominant hypercholesterolemia	D006938
178	15122708	0	23	DiseaseOrPhenotypicFeature	Desmin-related myopathy	C563319
179	15122708	88	103	GeneOrGeneProduct	selenoprotein N	57190
180	15122708	110	135	DiseaseOrPhenotypicFeature	Desmin-related myopathies	C563319
181	15122708	137	141	DiseaseOrPhenotypicFeature	DRMs	C563319
182	15122708	172	188	DiseaseOrPhenotypicFeature	muscle disorders	D009135
183	15122708	249	255	GeneOrGeneProduct	desmin	1674
184	15122708	274	280	GeneOrGeneProduct	desmin	1674
185	15122708	289	307	GeneOrGeneProduct	alpha-B crystallin	1410
186	15122708	357	360	DiseaseOrPhenotypicFeature	DRM	C563319
187	15122708	501	505	DiseaseOrPhenotypicFeature	DRMs	C563319
188	15122708	547	555	OrganismTaxon	patients	9606
189	15122708	585	600	GeneOrGeneProduct	selenoprotein N	57190
190	15122708	607	612	GeneOrGeneProduct	SEPN1	57190
191	15122708	633	654	DiseaseOrPhenotypicFeature	SEPN-related myopathy	D009135
192	15122708	656	663	DiseaseOrPhenotypicFeature	SEPN-RM	D009135
193	15122708	687	695	DiseaseOrPhenotypicFeature	myopathy	D009135
194	15122708	754	784	DiseaseOrPhenotypicFeature	rigid spine muscular dystrophy	C535683
195	15122708	818	839	DiseaseOrPhenotypicFeature	multiminicore disease	C564969
196	15122708	924	931	DiseaseOrPhenotypicFeature	SEPN-RM	D009135
197	15122708	976	979	DiseaseOrPhenotypicFeature	DRM	C563319
198	15122708	984	989	GeneOrGeneProduct	SEPN1	57190
199	15122708	1010	1013	DiseaseOrPhenotypicFeature	DRM	C563319
200	15122708	1077	1082	GeneOrGeneProduct	SEPN1	57190
201	15122708	1127	1132	GeneOrGeneProduct	SEPN1	57190
202	15122708	1143	1168	SequenceVariant	del 92 nucleotide -19/+73	c|DEL|-19_+73|92
203	15122708	1186	1194	OrganismTaxon	patients	9606
204	15122708	1238	1241	DiseaseOrPhenotypicFeature	DRM	C563319
205	15122708	1246	1253	DiseaseOrPhenotypicFeature	SEPN-RM	D009135
206	15122708	1319	1322	DiseaseOrPhenotypicFeature	DRM	C563319
207	15122708	1348	1355	DiseaseOrPhenotypicFeature	SEPN-RM	D009135
208	15122708	1416	1419	DiseaseOrPhenotypicFeature	DRM	C563319
209	15122708	1458	1465	DiseaseOrPhenotypicFeature	SEPN-RM	D009135
210	15122708	1551	1561	DiseaseOrPhenotypicFeature	myopathies	D009135
211	15188772	18	69	DiseaseOrPhenotypicFeature	left ventricular systolic and diastolic dysfunction	D018487
212	15188772	99	110	ChemicalEntity	epinephrine	D004837
213	15188772	121	134	ChemicalEntity	Catecholamine	D002395
214	15188772	143	157	DiseaseOrPhenotypicFeature	cardiomyopathy	D009202
215	15188772	194	208	ChemicalEntity	catecholamines	D002395
216	15188772	291	313	DiseaseOrPhenotypicFeature	myocardial dysfunction	D009202
217	15188772	371	376	OrganismTaxon	woman	9606
218	15188772	436	447	ChemicalEntity	epinephrine	D004837
219	15188772	458	477	DiseaseOrPhenotypicFeature	myocardial stunning	D017682
220	15188772	563	614	DiseaseOrPhenotypicFeature	left ventricular systolic and diastolic dysfunction	D018487
221	15188772	666	685	DiseaseOrPhenotypicFeature	myocardial necrosis	D009202
222	15614572	30	39	ChemicalEntity	trazodone	D014196
223	15614572	43	62	GeneOrGeneProduct	5-HT 2A/2C receptor	25187,29595
224	15614572	78	86	ChemicalEntity	dopamine	D004298
225	15614572	110	114	OrganismTaxon	rats	10116
226	15614572	127	146	ChemicalEntity	5-Hydroxytryptamine	D012701
227	15614572	167	184	GeneOrGeneProduct	5-HT 2C receptors	25187
228	15614572	279	296	GeneOrGeneProduct	5-HT 2A receptors	29595
229	15614572	363	372	ChemicalEntity	trazodone	D014196
230	15614572	378	397	GeneOrGeneProduct	5-HT 2A/2C receptor	25187,29595
231	15614572	448	457	ChemicalEntity	trazodone	D014196
232	15614572	594	603	ChemicalEntity	trazodone	D014196
233	15614572	607	621	ChemicalEntity	dexamphetamine	D003913
234	15614572	627	638	ChemicalEntity	apomorphine	D001058
235	15614572	647	664	DiseaseOrPhenotypicFeature	oral stereotypies	D009062
236	15614572	669	678	DiseaseOrPhenotypicFeature	catalepsy	D002375
237	15614572	690	701	ChemicalEntity	haloperidol	D006220
238	15614572	706	717	ChemicalEntity	apomorphine	D001058
239	15614572	741	752	ChemicalEntity	ergometrine	D004874
240	15614572	794	804	ChemicalEntity	fluoxetine	D005473
241	15614572	845	849	OrganismTaxon	rats	10116
242	15614572	880	889	ChemicalEntity	trazodone	D014196
243	15614572	898	907	DiseaseOrPhenotypicFeature	catalepsy	D002375
244	15614572	911	915	OrganismTaxon	rats	10116
245	15614572	926	935	ChemicalEntity	Trazodone	D014196
246	15614572	972	981	DiseaseOrPhenotypicFeature	catalepsy	D002375
247	15614572	1006	1017	ChemicalEntity	apomorphine	D001058
248	15614572	1051	1062	ChemicalEntity	apomorphine	D001058
249	15614572	1084	1093	DiseaseOrPhenotypicFeature	catalepsy	D002375
250	15614572	1146	1155	ChemicalEntity	trazodone	D014196
251	15614572	1165	1179	ChemicalEntity	dexamphetamine	D003913
252	15614572	1208	1219	ChemicalEntity	haloperidol	D006220
253	15614572	1220	1229	DiseaseOrPhenotypicFeature	catalepsy	D002375
254	15614572	1231	1242	ChemicalEntity	ergometrine	D004874
255	15614572	1268	1278	ChemicalEntity	fluoxetine	D005473
256	15614572	1305	1314	ChemicalEntity	Trazodone	D014196
257	15614572	1351	1360	DiseaseOrPhenotypicFeature	catalepsy	D002375
258	15614572	1377	1388	ChemicalEntity	apomorphine	D001058
259	15614572	1393	1407	ChemicalEntity	dexamphetamine	D003913
260	15614572	1461	1470	ChemicalEntity	trazodone	D014196
261	15614572	1533	1548	GeneOrGeneProduct	D2 DA receptors	24318
262	15614572	1611	1626	GeneOrGeneProduct	D2 DA receptors	24318
263	15614572	1664	1673	ChemicalEntity	trazodone	D014196
264	15614572	1681	1710	GeneOrGeneProduct	5-HT 2A and 5-HT 2C receptors	25187,29595
265	15614572	1728	1737	ChemicalEntity	trazodone	D014196
266	15614572	1776	1793	GeneOrGeneProduct	5-HT 2C receptors	25187
267	15614572	1870	1874	ChemicalEntity	5-HT	D012701
268	15614572	1900	1914	ChemicalEntity	dexamphetamine	D003913
269	15614572	1942	1953	ChemicalEntity	haloperidol	D006220
270	15614572	1954	1963	DiseaseOrPhenotypicFeature	catalepsy	D002375
271	15623763	0	5	GeneOrGeneProduct	TGFBI	7045
272	15623763	29	69	DiseaseOrPhenotypicFeature	lattice and granular corneal dystrophies	C537881,D003317
273	15623763	80	88	OrganismTaxon	patients	9606
274	15623763	128	133	GeneOrGeneProduct	TGFBI	7045
275	15623763	149	157	OrganismTaxon	patients	9606
276	15623763	163	188	DiseaseOrPhenotypicFeature	lattice corneal dystrophy	C537881
277	15623763	190	193	DiseaseOrPhenotypicFeature	LCD	C537881
278	15623763	198	224	DiseaseOrPhenotypicFeature	granular corneal dystrophy	D003317
279	15623763	226	229	DiseaseOrPhenotypicFeature	GCD	D003317
280	15623763	312	320	OrganismTaxon	patients	9606
281	15623763	343	346	DiseaseOrPhenotypicFeature	LCD	C537881
282	15623763	359	362	DiseaseOrPhenotypicFeature	GCD	D003317
283	15623763	381	384	DiseaseOrPhenotypicFeature	LCD	C537881
284	15623763	388	391	DiseaseOrPhenotypicFeature	GCD	D003317
285	15623763	506	511	GeneOrGeneProduct	TGFBI	7045
286	15623763	803	811	OrganismTaxon	patients	9606
287	15623763	817	820	DiseaseOrPhenotypicFeature	LCD	C537881
288	15623763	835	843	OrganismTaxon	patients	9606
289	15623763	849	852	DiseaseOrPhenotypicFeature	GCD	D003317
290	15623763	857	860	DiseaseOrPhenotypicFeature	LCD	C537881
291	15623763	908	926	SequenceVariant	glycine-594-valine	p|SUB|G|594|V
292	15623763	928	937	SequenceVariant	Gly594Val	p|SUB|G|594|V
293	15623763	950	958	OrganismTaxon	patients	9606
294	15623763	960	984	SequenceVariant	valine-539-aspartic acid	p|SUB|V|539|D
295	15623763	986	995	SequenceVariant	Val539Asp	p|SUB|V|539|D
296	15623763	1002	1009	OrganismTaxon	patient	9606
297	15623763	1015	1049	SequenceVariant	deletion of valine 624, valine 625	p|DEL|624_625|VV
298	15623763	1051	1067	SequenceVariant	Val624-Val625del	p|DEL|624_625|VV
299	15623763	1074	1081	OrganismTaxon	patient	9606
300	15623763	1108	1132	SequenceVariant	arginine 124-to-cysteine	rs121909210
301	15623763	1134	1143	SequenceVariant	Arg124Cys	rs121909210
302	15623763	1166	1174	OrganismTaxon	patients	9606
303	15623763	1179	1204	SequenceVariant	histidine 626-to-arginine	p|SUB|H|626|R
304	15623763	1206	1215	SequenceVariant	His626Arg	p|SUB|H|626|R
305	15623763	1228	1236	OrganismTaxon	patients	9606
306	15623763	1269	1272	DiseaseOrPhenotypicFeature	LCD	C537881
307	15623763	1287	1295	OrganismTaxon	patients	9606
308	15623763	1305	1314	SequenceVariant	Gly594Val	p|SUB|G|594|V
309	15623763	1319	1335	SequenceVariant	Val624-Val625del	p|DEL|624_625|VV
310	15623763	1350	1353	DiseaseOrPhenotypicFeature	GCD	D003317
311	15623763	1358	1366	OrganismTaxon	patients	9606
312	15623763	1372	1382	DiseaseOrPhenotypicFeature	GCD type I	C537304
313	15623763	1401	1427	SequenceVariant	arginine 555-to-tryptophan	rs121909208
314	15623763	1429	1438	SequenceVariant	Arg555Trp	rs121909208
315	15623763	1446	1453	OrganismTaxon	patient	9606
316	15623763	1459	1471	DiseaseOrPhenotypicFeature	GCD type III	C535476
317	15623763	1473	1496	DiseaseOrPhenotypicFeature	Reis-Bucklers dystrophy	C535476
318	15623763	1507	1516	SequenceVariant	Arg124Leu	rs121909211
319	15623763	1616	1644	SequenceVariant	leucine 269 to phenylalanine	rs199852470
320	15623763	1646	1655	SequenceVariant	Leu269Phe	rs199852470
321	15623763	1679	1687	OrganismTaxon	patients	9606
322	15623763	1697	1706	SequenceVariant	Arg555Trp	rs121909208
323	15623763	1730	1739	SequenceVariant	Arg124Cys	rs121909210
324	15623763	1744	1753	SequenceVariant	Arg555Trp	rs121909208
325	15623763	1801	1804	DiseaseOrPhenotypicFeature	LCD	C537881
326	15623763	1809	1812	DiseaseOrPhenotypicFeature	GCD	D003317
327	15818664	15	41	DiseaseOrPhenotypicFeature	sporadic chondrocalcinosis	D002805
328	15818664	49	67	SequenceVariant	-4-basepair G-to-A	c|SUB|G|-4|A
329	15818664	112	116	GeneOrGeneProduct	ANKH	56172
330	15818664	154	158	GeneOrGeneProduct	ANKH	56172
331	15818664	206	229	ChemicalEntity	inorganic pyrophosphate	D043564
332	15818664	263	267	GeneOrGeneProduct	ANKH	56172
333	15818664	336	359	ChemicalEntity	inorganic pyrophosphate	D043564
334	15818664	361	364	ChemicalEntity	PPi	D043564
335	15818664	391	436	DiseaseOrPhenotypicFeature	autosomal-dominant familial chondrocalcinosis	D002805
336	15818664	480	484	GeneOrGeneProduct	ANKH	56172
337	15818664	523	540	DiseaseOrPhenotypicFeature	chondrocalcinosis	D002805
338	15818664	551	555	GeneOrGeneProduct	ANKH	56172
339	15818664	633	650	DiseaseOrPhenotypicFeature	chondrocalcinosis	D002805
340	15818664	658	666	OrganismTaxon	patients	9606
341	15818664	688	705	DiseaseOrPhenotypicFeature	chondrocalcinosis	D002805
342	15818664	709	719	DiseaseOrPhenotypicFeature	pseudogout	D002805
343	15818664	941	946	OrganismTaxon	human	9606
344	15818664	960	964	CellLine	CH-8	9606
345	15818664	998	1024	DiseaseOrPhenotypicFeature	Sporadic chondrocalcinosis	D002805
346	15818664	1047	1053	SequenceVariant	G-to-A	c|SUB|G||A
347	15818664	1072	1076	GeneOrGeneProduct	ANKH	56172
348	15818664	1331	1370	DiseaseOrPhenotypicFeature	familial and sporadic chondrocalcinosis	D002805
349	15818664	1372	1385	SequenceVariant	+14 bp C-to-T	c|SUB|C|14|T
350	15818664	1401	1413	SequenceVariant	GAG deletion	c|DEL||GAG
351	15818664	1449	1475	DiseaseOrPhenotypicFeature	familial chondrocalcinosis	D002805
352	15818664	1484	1497	SequenceVariant	143-bp T-to-C	c|SUB|T|143|C
353	15818664	1531	1535	GeneOrGeneProduct	ANKH	56172
354	15818664	1550	1554	GeneOrGeneProduct	ANKH	56172
355	15818664	1634	1638	GeneOrGeneProduct	ANKH	56172
356	15818664	1653	1657	GeneOrGeneProduct	ANKH	56172
357	15818664	1707	1710	ChemicalEntity	PPi	D043564
358	15818664	1714	1718	CellLine	CH-8	9606
359	15818664	1750	1754	GeneOrGeneProduct	ANKH	56172
360	15818664	1820	1823	ChemicalEntity	PPi	D043564
361	15818664	1844	1855	DiseaseOrPhenotypicFeature	hypertrophy	D006984
362	15818664	1864	1879	GeneOrGeneProduct	type X collagen	1300
363	15818664	1905	1931	DiseaseOrPhenotypicFeature	sporadic chondrocalcinosis	D002805
364	15818664	1962	1974	SequenceVariant	-4-bp G-to-A	c|SUB|G|-4|A
365	15818664	1975	1979	GeneOrGeneProduct	ANKH	56172
366	15818664	2030	2034	GeneOrGeneProduct	ANKH	56172
367	15818664	2053	2056	ChemicalEntity	PPi	D043564
368	15818664	2088	2092	GeneOrGeneProduct	ANKH	56172
369	15818664	2129	2146	DiseaseOrPhenotypicFeature	chondrocalcinosis	D002805
370	15818664	2205	2208	ChemicalEntity	PPi	D043564
371	15818664	2225	2236	DiseaseOrPhenotypicFeature	hypertrophy	D006984
372	15824163	16	20	GeneOrGeneProduct	BRAF	673
373	15824163	26	34	DiseaseOrPhenotypicFeature	melanoma	D008545
374	15824163	35	40	DiseaseOrPhenotypicFeature	nevus	D009506
375	15824163	83	87	GeneOrGeneProduct	BRAF	673
376	15824163	117	132	DiseaseOrPhenotypicFeature	melanoma tumors	D008545
377	15824163	144	148	DiseaseOrPhenotypicFeature	nevi	D009506
378	15824163	173	177	GeneOrGeneProduct	BRAF	673
379	15824163	240	248	DiseaseOrPhenotypicFeature	melanoma	D008545
380	15824163	291	295	GeneOrGeneProduct	BRAF	673
381	15824163	334	351	DiseaseOrPhenotypicFeature	sporadic melanoma	D008545
382	15824163	355	358	OrganismTaxon	men	9606
383	15824163	399	403	GeneOrGeneProduct	BRAF	673
384	15824163	465	470	DiseaseOrPhenotypicFeature	nevus	D009506
385	15824163	471	479	DiseaseOrPhenotypicFeature	melanoma	D008545
386	15824163	708	725	DiseaseOrPhenotypicFeature	familial melanoma	D008545
387	15824163	736	740	GeneOrGeneProduct	BRAF	673
388	15824163	860	864	GeneOrGeneProduct	BRAF	673
389	15824163	892	901	SequenceVariant	rs1639679	rs1639679
390	15824163	934	942	DiseaseOrPhenotypicFeature	melanoma	D008545
391	15824163	1019	1023	GeneOrGeneProduct	BRAF	673
392	15824163	1040	1048	DiseaseOrPhenotypicFeature	melanoma	D008545
393	15824163	1394	1398	GeneOrGeneProduct	BRAF	673
394	15824163	1484	1488	GeneOrGeneProduct	BRAF	673
395	15824163	1539	1547	DiseaseOrPhenotypicFeature	melanoma	D008545
396	15824163	1702	1706	GeneOrGeneProduct	BRAF	673
397	15824163	1759	1763	DiseaseOrPhenotypicFeature	nevi	D009506
398	15970799	31	38	GeneOrGeneProduct	SLCO1B1	10599
399	15970799	40	46	GeneOrGeneProduct	OATP-C	10599
400	15970799	58	65	GeneOrGeneProduct	SLCO1B1	10599
401	15970799	69	76	GeneOrGeneProduct	SLCO1B1	10599
402	15970799	84	91	GeneOrGeneProduct	SLCO1B1	10599
403	15970799	95	101	SequenceVariant	C1007G	rs72559747
404	15970799	144	148	CellLine	HeLa	9606
405	15970799	153	159	CellLine	HEK293	9606
406	15970799	179	186	GeneOrGeneProduct	SLCO1B1	10599
407	15970799	193	200	GeneOrGeneProduct	SLCO1B1	10599
408	15970799	250	261	ChemicalEntity	pravastatin	D017035
409	15970799	338	345	GeneOrGeneProduct	SLCO1B1	10599
410	15970799	367	374	GeneOrGeneProduct	OATP1B1	10599
411	15970799	412	419	GeneOrGeneProduct	SLCO1B1	10599
412	15970799	442	449	GeneOrGeneProduct	OATP1B1	10599
413	15970799	560	567	GeneOrGeneProduct	SLCO1B1	10599
414	15970799	583	589	SequenceVariant	C1007G	rs72559747
415	15970799	620	627	OrganismTaxon	patient	9606
416	15970799	633	644	ChemicalEntity	pravastatin	D017035
417	15970799	653	661	DiseaseOrPhenotypicFeature	myopathy	D009135
418	15970799	695	702	GeneOrGeneProduct	OATP1B1	10599
419	15970799	738	744	CellLine	HEK293	9606
420	15970799	749	753	CellLine	HeLa	9606
421	15970799	891	898	ChemicalEntity	tritium	D014316
422	15970799	907	937	ChemicalEntity	estradiol-17beta-D-glucuronide	C025483
423	15970799	942	959	ChemicalEntity	estrone-3-sulfate	C017296
424	15970799	977	988	ChemicalEntity	pravastatin	D017035
425	15970799	990	1002	ChemicalEntity	atorvastatin	D000069059
426	15970799	1004	1016	ChemicalEntity	cerivastatin	C086276
427	15970799	1021	1032	ChemicalEntity	simvastatin	D019821
428	15970799	1144	1151	GeneOrGeneProduct	SLCO1B1	10599
429	15970799	1167	1173	SequenceVariant	C1007G	rs72559747
430	15970799	1211	1218	GeneOrGeneProduct	SLCO1B1	10599
431	15970799	1227	1233	SequenceVariant	C1007G	rs72559747
432	15970799	1242	1248	SequenceVariant	C1007G	rs72559747
433	15970799	1310	1321	ChemicalEntity	simvastatin	D019821
434	15970799	1343	1354	ChemicalEntity	pravastatin	D017035
435	15970799	1359	1371	ChemicalEntity	atorvastatin	D000069059
436	15970799	1471	1478	GeneOrGeneProduct	SLCO1B1	10599
437	15970799	1494	1500	SequenceVariant	C1007G	rs72559747
438	15970799	1539	1546	GeneOrGeneProduct	SLCO1B1	10599
439	15970799	1562	1568	SequenceVariant	C1007G	rs72559747
440	15970799	1702	1708	SequenceVariant	521T>C	c|SUB|T|521|C
441	15970799	1731	1738	GeneOrGeneProduct	SLCO1B1	10599
442	15970799	1754	1760	SequenceVariant	C1007G	rs72559747
443	15970799	1855	1862	GeneOrGeneProduct	SLCO1B1	10599
444	15970799	1878	1884	SequenceVariant	C1007G	rs72559747
445	16001362	3	39	DiseaseOrPhenotypicFeature	autosomal dominant cerebellar ataxia	OMIM:604121
446	16001362	207	245	GeneOrGeneProduct	Rho guanine-nucleotide exchange-factor	9138
447	16001362	255	291	DiseaseOrPhenotypicFeature	Autosomal dominant cerebellar ataxia	OMIM:604121
448	16001362	293	297	DiseaseOrPhenotypicFeature	ADCA	OMIM:604121
449	16001362	327	354	DiseaseOrPhenotypicFeature	neurodegenerative disorders	D019636
450	16001362	442	461	DiseaseOrPhenotypicFeature	degenerative ataxia	D001259
451	16001362	489	493	DiseaseOrPhenotypicFeature	ADCA	OMIM:604121
452	16001362	534	551	DiseaseOrPhenotypicFeature	cerebellar ataxia	D002524
453	16001362	609	641	DiseaseOrPhenotypicFeature	sensorineural hearing impairment	D034381
454	16001362	665	671	DiseaseOrPhenotypicFeature	ataxia	D001259
455	16001362	791	799	OrganismTaxon	patients	9606
456	16001362	858	863	SequenceVariant	C-->T	c|SUB|C||T
457	16001362	994	1006	GeneOrGeneProduct	DKFZP434I216	25894
458	16001362	1030	1043	GeneOrGeneProduct	puratrophin-1	25894
459	16001362	1046	1088	GeneOrGeneProduct	Purkinje cell atrophy associated protein-1	25894
460	16001362	1107	1120	GeneOrGeneProduct	puratrophin-1	25894
461	16001362	1243	1277	GeneOrGeneProduct	guanine-nucleotide exchange factor	9138
462	16001362	1279	1282	GeneOrGeneProduct	GEF	9138
463	16001362	1288	1299	GeneOrGeneProduct	Rho GTPases	387
464	16001362	1368	1381	GeneOrGeneProduct	puratrophin-1	25894
465	16001362	1413	1418	GeneOrGeneProduct	actin	60
466	16001362	1452	1465	GeneOrGeneProduct	Puratrophin-1	25894
467	16001362	1626	1630	DiseaseOrPhenotypicFeature	ADCA	OMIM:604121
468	16001362	1686	1699	GeneOrGeneProduct	puratrophin-1	25894
469	16001362	1903	1908	OrganismTaxon	human	9606
470	16001362	2048	2051	GeneOrGeneProduct	GEF	9138
471	16001362	2079	2102	DiseaseOrPhenotypicFeature	cerebellar degeneration	D013132
472	16001362	2106	2112	OrganismTaxon	humans	9606
473	16321363	0	39	DiseaseOrPhenotypicFeature	Congenital disorder of glycosylation Ic	C535741
474	16321363	73	79	GeneOrGeneProduct	hALG-6	29929
475	16321363	117	156	DiseaseOrPhenotypicFeature	congenital disorder of glycosylation-Ic	C535741
476	16321363	158	164	DiseaseOrPhenotypicFeature	CDG-Ic	C535741
477	16321363	201	204	DiseaseOrPhenotypicFeature	CDG	D018981
478	16321363	238	267	ChemicalEntity	lipid-linked oligosaccharides	C023023
479	16321363	282	289	ChemicalEntity	glucose	D005947
480	16321363	322	326	GeneOrGeneProduct	ALG6	29929
481	16321363	404	410	SequenceVariant	338G>A	rs768372697
482	16321363	457	464	OrganismTaxon	patient	9606
483	16321363	556	560	GeneOrGeneProduct	ALG6	29929
484	16321363	694	712	SequenceVariant	deletion (10-12Mb)	c|DEL||10-12MB
485	16321363	714	732	SequenceVariant	del(1)(p31.2p32.3)	c|DEL|p31.2_p32.3|
486	16321363	849	852	DiseaseOrPhenotypicFeature	CDG	D018981
487	16321363	909	915	DiseaseOrPhenotypicFeature	CDG-Ic	C535741
488	16330669	126	165	DiseaseOrPhenotypicFeature	primary cutaneous large B-cell lymphoma	D016403
489	16330669	237	276	DiseaseOrPhenotypicFeature	primary cutaneous large B-cell lymphoma	D016403
490	16330669	278	284	DiseaseOrPhenotypicFeature	PCLBCL	D016403
491	16330669	287	295	OrganismTaxon	PATIENTS	9606
492	16330669	335	343	OrganismTaxon	patients	9606
493	16330669	351	357	DiseaseOrPhenotypicFeature	PCLBCL	D016403
494	16330669	379	421	DiseaseOrPhenotypicFeature	primary cutaneous follicle center lymphoma	D008224
495	16330669	423	428	DiseaseOrPhenotypicFeature	PCFCL	D008224
496	16330669	441	447	DiseaseOrPhenotypicFeature	PCLBCL	D016403
497	16330669	541	547	DiseaseOrPhenotypicFeature	Cancer	D009369
498	16330669	775	780	DiseaseOrPhenotypicFeature	PCFCL	D008224
499	16330669	899	904	GeneOrGeneProduct	c-REL	5966
500	16330669	922	930	OrganismTaxon	patients	9606
501	16330669	956	962	DiseaseOrPhenotypicFeature	PCLBCL	D016403
502	16330669	1077	1082	GeneOrGeneProduct	BCL-2	596
503	16330669	1087	1092	GeneOrGeneProduct	MALT1	10892
504	16330669	1182	1188	GeneOrGeneProduct	CDKN2A	1029
505	16330669	1190	1196	GeneOrGeneProduct	CDKN2B	1030
506	16330669	1202	1207	GeneOrGeneProduct	NSG-x	27099
507	16330669	1272	1280	OrganismTaxon	patients	9606
508	16330669	1286	1292	DiseaseOrPhenotypicFeature	PCLBCL	D016403
509	16330669	1322	1330	OrganismTaxon	patients	9606
510	16330669	1336	1341	DiseaseOrPhenotypicFeature	PCFCL	D008224
511	16330669	1394	1400	GeneOrGeneProduct	CDKN2A	1029
512	16330669	1430	1436	DiseaseOrPhenotypicFeature	PCLBCL	D016403
513	16330669	1448	1455	OrganismTaxon	patient	9606
514	16330669	1489	1496	OrganismTaxon	patient	9606
515	16330669	1533	1541	OrganismTaxon	patients	9606
516	16330669	1547	1552	DiseaseOrPhenotypicFeature	PCFCL	D008224
517	16330669	1569	1575	DiseaseOrPhenotypicFeature	PCLBCL	D016403
518	16330669	1587	1595	OrganismTaxon	patients	9606
519	16330669	1651	1657	GeneOrGeneProduct	CDKN2A	1029
520	16330669	1684	1692	DiseaseOrPhenotypicFeature	lymphoma	D008223
521	16330669	1787	1792	DiseaseOrPhenotypicFeature	PCFCL	D008224
522	16330669	1797	1803	DiseaseOrPhenotypicFeature	PCLBCL	D016403
523	16330669	1915	1921	GeneOrGeneProduct	CDKN2A	1029
524	16330669	2032	2038	DiseaseOrPhenotypicFeature	PCLBCL	D016403
525	16419642	27	32	SequenceVariant	F826Y	rs13306592
526	16419642	41	67	GeneOrGeneProduct	mineralocorticoid receptor	4306
527	16419642	85	98	DiseaseOrPhenotypicFeature	hypertensives	D006973
528	16419642	187	192	SequenceVariant	S810L	rs41511344
529	16419642	254	280	GeneOrGeneProduct	mineralocorticoid receptor	4306
530	16419642	282	284	GeneOrGeneProduct	MR	4306
531	16419642	299	304	GeneOrGeneProduct	NR3C2	4306
532	16419642	337	349	DiseaseOrPhenotypicFeature	hypertension	D006973
533	16419642	519	531	DiseaseOrPhenotypicFeature	hypertension	D006973
534	16419642	576	584	OrganismTaxon	patients	9606
535	16419642	590	602	DiseaseOrPhenotypicFeature	hypertension	D006973
536	16419642	611	616	SequenceVariant	S810L	rs41511344
537	16419642	643	645	GeneOrGeneProduct	MR	4306
538	16419642	671	676	SequenceVariant	S810L	rs41511344
539	16419642	693	705	DiseaseOrPhenotypicFeature	hypertensive	D006973
540	16419642	734	739	SequenceVariant	S810L	rs41511344
541	16419642	786	808	DiseaseOrPhenotypicFeature	essential hypertension	D000075222
542	16419642	872	877	SequenceVariant	F826Y	rs13306592
543	16419642	888	896	OrganismTaxon	patients	9606
544	16419642	1010	1015	SequenceVariant	L809L	rs145670736
545	16419642	1022	1027	SequenceVariant	F826Y	rs13306592
546	16419642	1055	1057	GeneOrGeneProduct	MR	4306
547	16419642	1123	1128	SequenceVariant	F826Y	rs13306592
548	16419642	1179	1192	DiseaseOrPhenotypicFeature	hypertensives	D006973
549	16419642	1315	1320	SequenceVariant	F826Y	rs13306592
550	16419642	1337	1349	DiseaseOrPhenotypicFeature	hypertensive	D006973
551	16419642	1380	1392	DiseaseOrPhenotypicFeature	hypertensive	D006973
552	16419642	1561	1573	DiseaseOrPhenotypicFeature	hypertension	D006973
553	16419642	1628	1633	SequenceVariant	F826Y	rs13306592
554	16419642	1683	1709	GeneOrGeneProduct	mineralocorticoid receptor	4306
555	16419642	1821	1823	GeneOrGeneProduct	MR	4306
556	16629641	29	35	DiseaseOrPhenotypicFeature	anemia	D000740
557	16629641	39	47	OrganismTaxon	patients	9606
558	16629641	48	79	DiseaseOrPhenotypicFeature	infected with hepatitis C virus	D006526
559	16629641	81	121	DiseaseOrPhenotypicFeature	Chronic infection with hepatitis C virus	D019698
560	16629641	123	126	OrganismTaxon	HCV	11103
561	16629641	144	153	DiseaseOrPhenotypicFeature	cirrhosis	D005355
562	16629641	155	179	DiseaseOrPhenotypicFeature	hepatocellular carcinoma	D006528
563	16629641	185	208	DiseaseOrPhenotypicFeature	end-stage liver disease	D058625
564	16629641	241	254	DiseaseOrPhenotypicFeature	HCV infection	D006526
565	16629641	283	303	GeneOrGeneProduct	pegylated interferon	3439
566	16629641	308	317	ChemicalEntity	ribavirin	D012254
567	16629641	411	419	OrganismTaxon	patients	9606
568	16629641	475	491	DiseaseOrPhenotypicFeature	hemolytic anemia	D000743
569	16629641	493	503	GeneOrGeneProduct	Hemoglobin	3039
570	16629641	550	559	ChemicalEntity	ribavirin	D012254
571	16629641	568	577	DiseaseOrPhenotypicFeature	hemolysis	D006461
572	16629641	588	594	DiseaseOrPhenotypicFeature	anemia	D000740
573	16629641	617	625	OrganismTaxon	patients	9606
574	16629641	631	644	DiseaseOrPhenotypicFeature	HCV infection	D006526
575	16629641	681	714	DiseaseOrPhenotypicFeature	renal or cardiovascular disorders	D002318,D007674
576	16629641	728	734	DiseaseOrPhenotypicFeature	anemia	D000740
577	16629641	866	875	ChemicalEntity	ribavirin	D012254
578	16629641	887	893	DiseaseOrPhenotypicFeature	anemia	D000740
579	16629641	1034	1039	OrganismTaxon	human	9606
580	16629641	1040	1054	GeneOrGeneProduct	erythropoietin	2056
581	16629641	1079	1088	ChemicalEntity	ribavirin	D012254
582	16629641	1100	1106	DiseaseOrPhenotypicFeature	anemia	D000740
583	16629641	1146	1156	ChemicalEntity	Viramidine	C026956
584	16629641	1187	1196	ChemicalEntity	ribavirin	D012254
585	16629641	1254	1263	ChemicalEntity	ribavirin	D012254
586	16629641	1293	1309	DiseaseOrPhenotypicFeature	hemolytic anemia	D000743
587	16629641	1313	1321	OrganismTaxon	patients	9606
588	16629641	1327	1346	DiseaseOrPhenotypicFeature	chronic hepatitis C	D019698
589	16731636	9	22	ChemicalEntity	isoproterenol	D007545
590	16731636	31	50	DiseaseOrPhenotypicFeature	cardiac hypertrophy	D006332
591	16731636	65	69	OrganismTaxon	rats	10116
592	16731636	85	100	GeneOrGeneProduct	angiotensinogen	24179
593	16731636	168	173	GeneOrGeneProduct	renin	24715
594	16731636	174	185	GeneOrGeneProduct	angiotensin	24179
595	16731636	370	387	GeneOrGeneProduct	beta-adrenoceptor	24925
596	16731636	389	396	GeneOrGeneProduct	beta-AR	24925
597	16731636	406	419	ChemicalEntity	isoproterenol	D007545
598	16731636	421	424	ChemicalEntity	Iso	D007545
599	16731636	438	442	OrganismTaxon	rats	10116
600	16731636	458	473	GeneOrGeneProduct	angiotensinogen	24179
601	16731636	511	514	ChemicalEntity	Iso	D007545
602	16731636	671	675	OrganismTaxon	rats	10116
603	16731636	677	691	DiseaseOrPhenotypicFeature	LV hypertrophy	D006332
604	16731636	703	706	ChemicalEntity	Iso	D007545
605	16731636	760	764	OrganismTaxon	rats	10116
606	16731636	854	868	DiseaseOrPhenotypicFeature	LV hypertrophy	D006332
607	16731636	876	880	OrganismTaxon	rats	10116
608	16731636	935	942	GeneOrGeneProduct	beta-AR	24925
609	16731636	966	982	GeneOrGeneProduct	beta-AR kinase-1	25238
610	16731636	1021	1025	OrganismTaxon	rats	10116
611	16731636	1078	1085	GeneOrGeneProduct	beta-AR	24925
612	16731636	1097	1107	ChemicalEntity	metoprolol	D008790
613	16731636	1121	1125	OrganismTaxon	rats	10116
614	16731636	1179	1183	OrganismTaxon	rats	10116
615	16731636	1270	1278	ChemicalEntity	atropine	D001285
616	16731636	1368	1375	GeneOrGeneProduct	beta-AR	24925
617	16731636	1423	1434	DiseaseOrPhenotypicFeature	hypertrophy	D006984
618	16737910	56	60	GeneOrGeneProduct	ETV6	2120
619	16737910	62	65	GeneOrGeneProduct	TEL	2120
620	16737910	76	80	GeneOrGeneProduct	ETV6	2120
621	16737910	85	111	GeneOrGeneProduct	Translocation-Ets-Leukemia	2120
622	16737910	113	116	GeneOrGeneProduct	TEL	2120
623	16737910	296	301	OrganismTaxon	human	9606
624	16737910	302	308	DiseaseOrPhenotypicFeature	cancer	D009369
625	16737910	310	314	GeneOrGeneProduct	ETV6	2120
626	16737910	478	482	GeneOrGeneProduct	ETV6	2120
627	16737910	629	633	GeneOrGeneProduct	ETV6	2120
628	16737910	635	639	GeneOrGeneProduct	ETV6	2120
629	16737910	836	840	GeneOrGeneProduct	ETV6	2120
630	16737910	899	917	GeneOrGeneProduct	beta-galactosidase	2720
631	16737910	1063	1067	GeneOrGeneProduct	ETV6	2120
632	16755009	46	59	OrganismTaxon	Daucus carota	4039
633	16755009	81	103	DiseaseOrPhenotypicFeature	cognitive dysfunctions	D003072
634	16755009	165	178	OrganismTaxon	Daucus carota	4039
635	16755009	221	232	ChemicalEntity	cholesterol	D002784
636	16755009	250	264	GeneOrGeneProduct	cholinesterase	12038
637	16755009	277	281	OrganismTaxon	mice	10090
638	16755009	297	327	ChemicalEntity	extract of Daucus carota seeds	D010936
639	16755009	329	332	ChemicalEntity	DCE	D010936
640	16755009	459	463	OrganismTaxon	mice	10090
641	16755009	582	590	ChemicalEntity	Diazepam	D003975
642	16755009	593	604	ChemicalEntity	scopolamine	D012601
643	16755009	625	632	DiseaseOrPhenotypicFeature	amnesia	D000647
644	16755009	680	683	ChemicalEntity	DCE	D010936
645	16755009	773	777	OrganismTaxon	mice	10090
646	16755009	822	825	ChemicalEntity	DCE	D010936
647	16755009	901	905	OrganismTaxon	mice	10090
648	16755009	1042	1046	OrganismTaxon	mice	10090
649	16755009	1061	1064	ChemicalEntity	DCE	D010936
650	16755009	1078	1085	DiseaseOrPhenotypicFeature	amnesia	D000647
651	16755009	1097	1108	ChemicalEntity	scopolamine	D012601
652	16755009	1131	1139	ChemicalEntity	diazepam	D003975
653	16755009	1157	1178	ChemicalEntity	Daucus carota extract	D010936
654	16755009	1234	1254	GeneOrGeneProduct	acetylcholinesterase	11423
655	16755009	1268	1279	ChemicalEntity	cholesterol	D002784
656	16755009	1305	1309	OrganismTaxon	mice	10090
657	16755009	1345	1359	GeneOrGeneProduct	cholinesterase	12038
658	16755009	1379	1382	ChemicalEntity	DCE	D010936
659	16755009	1441	1445	OrganismTaxon	mice	10090
660	16755009	1489	1500	ChemicalEntity	cholesterol	D002784
661	16755009	1588	1591	ChemicalEntity	DCE	D010936
662	16755009	1604	1607	ChemicalEntity	DCE	D010936
663	16755009	1662	1684	DiseaseOrPhenotypicFeature	cognitive dysfunctions	D003072
664	16755009	1771	1782	ChemicalEntity	cholesterol	D002784
665	16822828	27	35	OrganismTaxon	patients	9606
666	16822828	41	71	DiseaseOrPhenotypicFeature	17alpha-hydroxylase deficiency	C538237
667	16822828	180	185	GeneOrGeneProduct	CYP17	1586
668	16822828	206	236	DiseaseOrPhenotypicFeature	17alpha-Hydroxylase deficiency	C538237
669	16822828	255	285	DiseaseOrPhenotypicFeature	congenital adrenal hyperplasia	D000312
670	16822828	296	301	GeneOrGeneProduct	CYP17	1586
671	16822828	342	350	OrganismTaxon	patients	9606
672	16822828	356	386	DiseaseOrPhenotypicFeature	17alpha-hydroxylase deficiency	C538237
673	16822828	403	411	OrganismTaxon	PATIENTS	9606
674	16822828	422	430	OrganismTaxon	patients	9606
675	16822828	511	541	DiseaseOrPhenotypicFeature	17alpha-hydroxylase deficiency	C538237
676	16822828	660	665	GeneOrGeneProduct	CYP17	1586
677	16822828	708	716	OrganismTaxon	patients	9606
678	16822828	730	736	SequenceVariant	V311fs	p|FS|V|311||
679	16822828	741	747	SequenceVariant	Y329fs	p|FS|Y|329||
680	16822828	788	794	SequenceVariant	V311fs	p|FS|V|311||
681	16822828	801	836	SequenceVariant	8-bp nucleotide (TTAAATGG) deletion	c|DEL||TTAAATGG
682	16822828	848	854	SequenceVariant	Y329fs	p|FS|Y|329||
683	16822828	897	920	SequenceVariant	(TAC-->AA) at codon 329	c|SUB|TAC|CODON329|AA
684	16822828	952	958	SequenceVariant	Y329fs	p|FS|Y|329||
685	16822828	993	999	SequenceVariant	Y329fs	p|FS|Y|329||
686	16822828	1004	1010	SequenceVariant	V311fs	p|FS|V|311||
687	16822828	1089	1112	SequenceVariant	D487_S488_F489 deletion	p|DEL|487_489|DSF
688	16822828	1223	1253	DiseaseOrPhenotypicFeature	17alpha-hydroxylase deficiency	C538237
689	16822828	1259	1282	SequenceVariant	D487_S488_F489 deletion	p|DEL|487_489|DSF
690	16822828	1474	1479	GeneOrGeneProduct	CYP17	1586
691	16822828	1538	1544	SequenceVariant	Y329fs	p|FS|Y|329||
692	16822828	1672	1677	GeneOrGeneProduct	CYP17	1586
693	16822828	1723	1731	OrganismTaxon	patients	9606
694	16822828	1779	1785	SequenceVariant	Y329fs	p|FS|Y|329||
695	16822828	1859	1889	DiseaseOrPhenotypicFeature	17alpha-hydroxylase deficiency	C538237
696	16904497	0	21	DiseaseOrPhenotypicFeature	Cauda equina syndrome	D011128
697	16904497	37	44	ChemicalEntity	steroid	D013256
698	16904497	128	141	DiseaseOrPhenotypicFeature	radiculopathy	D011843
699	16904497	173	180	ChemicalEntity	steroid	D013256
700	16904497	244	265	DiseaseOrPhenotypicFeature	Cauda equina syndrome	D011128
701	16904497	347	368	DiseaseOrPhenotypicFeature	cauda equina syndrome	D011128
702	16904497	410	423	ChemicalEntity	triamcinolone	D014221
703	16904497	428	439	ChemicalEntity	bupivacaine	D002045
704	16904497	474	479	OrganismTaxon	woman	9606
705	16904497	485	512	DiseaseOrPhenotypicFeature	low back and right leg pain	D010146,D017116
706	16904497	540	547	ChemicalEntity	steroid	D013256
707	16904497	808	819	ChemicalEntity	bupivacaine	D002045
708	16904497	824	847	ChemicalEntity	triamcinolone diacetate	C030262
709	16904497	975	983	DiseaseOrPhenotypicFeature	numbness	D006987
710	16904497	988	1012	DiseaseOrPhenotypicFeature	lower extremity weakness	D020335
711	16904497	1049	1066	DiseaseOrPhenotypicFeature	loss of sensation	D006987
712	16904497	1275	1282	OrganismTaxon	patient	9606
713	16904497	1538	1545	ChemicalEntity	steroid	D013256
714	16904497	1616	1640	DiseaseOrPhenotypicFeature	neurologic deterioration	D009422
715	16904497	1656	1663	ChemicalEntity	steroid	D013256
716	16970763	17	20	GeneOrGeneProduct	NDP	4693
717	16970763	43	57	DiseaseOrPhenotypicFeature	Norrie disease	C537849
718	16970763	59	95	DiseaseOrPhenotypicFeature	familial exudative vitreoretinopathy	D000080345
719	16970763	100	126	DiseaseOrPhenotypicFeature	retinopathy of prematurity	D012178
720	16970763	192	206	DiseaseOrPhenotypicFeature	Norrie disease	C537849
721	16970763	208	211	GeneOrGeneProduct	NDP	4693
722	16970763	244	275	DiseaseOrPhenotypicFeature	retinal diseases Norrie disease	C537849
723	16970763	277	322	DiseaseOrPhenotypicFeature	X-linked familial exudative vitreoretinopathy	D000080345
724	16970763	324	328	DiseaseOrPhenotypicFeature	FEVR	D000080345
725	16970763	331	345	DiseaseOrPhenotypicFeature	Coat's disease	D058456
726	16970763	350	376	DiseaseOrPhenotypicFeature	retinopathy of prematurity	D012178
727	16970763	378	381	DiseaseOrPhenotypicFeature	ROP	D012178
728	16970763	417	428	DiseaseOrPhenotypicFeature	Norrie-FEVR	C537849
729	16970763	434	448	DiseaseOrPhenotypicFeature	Coat's disease	D058456
730	16970763	453	456	DiseaseOrPhenotypicFeature	ROP	D012178
731	16970763	457	465	OrganismTaxon	patients	9606
732	16970763	600	603	GeneOrGeneProduct	NDP	4693
733	16970763	936	939	GeneOrGeneProduct	NDP	4693
734	16970763	960	969	SequenceVariant	Leu103Val	p|SUB|L|103|V
735	16970763	977	981	DiseaseOrPhenotypicFeature	FEVR	D000080345
736	16970763	982	989	OrganismTaxon	patient	9606
737	16970763	994	1002	SequenceVariant	His43Arg	p|SUB|H|43|R
738	16970763	1023	1037	DiseaseOrPhenotypicFeature	Norrie disease	C537849
739	16970763	1038	1046	OrganismTaxon	patients	9606
740	16970763	1084	1098	SequenceVariant	14-bp deletion	c|DEL||14
741	16970763	1145	1148	GeneOrGeneProduct	NDP	4693
742	16970763	1195	1198	DiseaseOrPhenotypicFeature	ROP	D012178
743	16970763	1223	1237	SequenceVariant	14-bp deletion	c|DEL||14
744	16970763	1306	1317	DiseaseOrPhenotypicFeature	Norrie-FEVR	C537849
745	16970763	1355	1369	DiseaseOrPhenotypicFeature	Norrie disease	C537849
746	16970763	1375	1383	DiseaseOrPhenotypicFeature	deafness	D003638
747	16970763	1388	1406	DiseaseOrPhenotypicFeature	mental retardation	D008607
748	16970763	1472	1475	GeneOrGeneProduct	NDP	4693
749	16970763	1544	1558	DiseaseOrPhenotypicFeature	Norrie disease	C537849
750	16970763	1578	1582	DiseaseOrPhenotypicFeature	FEVR	D000080345
751	16970763	1664	1667	DiseaseOrPhenotypicFeature	ROP	D012178
752	16970763	1710	1721	DiseaseOrPhenotypicFeature	prematurity	D007235
753	16970763	1738	1744	ChemicalEntity	oxygen	D010100
754	16970763	1773	1791	DiseaseOrPhenotypicFeature	retinal detachment	D012163
755	16970763	1837	1851	DiseaseOrPhenotypicFeature	Norrie disease	C537849
756	17000021	27	36	SequenceVariant	-1123 G>C	rs2488457
757	17000021	40	49	SequenceVariant	+2740 A>G	rs1217412
758	17000021	81	87	GeneOrGeneProduct	PTPN22	26191
759	17000021	93	108	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
760	17000021	113	142	DiseaseOrPhenotypicFeature	juvenile idiopathic arthritis	D001171
761	17000021	191	197	GeneOrGeneProduct	PTPN22	26191
762	17000021	250	258	SequenceVariant	+1858C>T	rs2476601
763	17000021	260	265	SequenceVariant	R620W	rs2476601
764	17000021	333	352	DiseaseOrPhenotypicFeature	autoimmune diseases	D001327
765	17000021	364	379	DiseaseOrPhenotypicFeature	type 1 diabetes	D003922
766	17000021	381	384	DiseaseOrPhenotypicFeature	T1D	D003922
767	17000021	390	419	DiseaseOrPhenotypicFeature	juvenile idiopathic arthritis	D001171
768	17000021	421	424	DiseaseOrPhenotypicFeature	JIA	D001171
769	17000021	712	718	GeneOrGeneProduct	PTPN22	26191
770	17000021	789	792	DiseaseOrPhenotypicFeature	T1D	D003922
771	17000021	802	805	DiseaseOrPhenotypicFeature	JIA	D001171
772	17000021	823	826	DiseaseOrPhenotypicFeature	T1D	D003922
773	17000021	900	909	SequenceVariant	rs2488457	rs2488457
774	17000021	919	928	SequenceVariant	rs2476601	rs2476601
775	17000021	934	939	SequenceVariant	R620W	rs2476601
776	17000021	966	975	SequenceVariant	rs1217412	rs1217412
777	17000021	1049	1052	DiseaseOrPhenotypicFeature	T1D	D003922
778	17000021	1072	1075	DiseaseOrPhenotypicFeature	JIA	D001171
779	17000021	1144	1147	DiseaseOrPhenotypicFeature	T1D	D003922
780	17000021	1549	1572	SequenceVariant	(W) allele at codon 620	rs2476601
781	17000021	1593	1596	DiseaseOrPhenotypicFeature	T1D	D003922
782	17000021	1672	1675	DiseaseOrPhenotypicFeature	JIA	D001171
783	17000021	1751	1774	SequenceVariant	(R) allele at codon 620	rs2476601
784	17000021	1846	1867	DiseaseOrPhenotypicFeature	autoimmune conditions	D001327
785	17000021	2099	2105	GeneOrGeneProduct	PTPN22	26191
786	17033974	26	33	ChemicalEntity	calcium	D002118
787	17033974	50	58	GeneOrGeneProduct	CACNA2D4	93589
788	17033974	86	100	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
789	17033974	183	190	ChemicalEntity	calcium	D002118
790	17033974	297	305	GeneOrGeneProduct	Cacna2d4	319734
791	17033974	328	333	OrganismTaxon	mouse	10090
792	17033974	450	458	GeneOrGeneProduct	Cacna2d4	319734
793	17033974	475	543	GeneOrGeneProduct	l-type calcium-channel auxiliary subunit of the alpha (2) delta type	781
794	17033974	562	567	OrganismTaxon	human	9606
795	17033974	580	588	GeneOrGeneProduct	CACNA2D4	93589
796	17033974	679	687	OrganismTaxon	patients	9606
797	17033974	725	740	DiseaseOrPhenotypicFeature	night blindness	D009755
798	17033974	823	834	SequenceVariant	c.2406C-->A	rs71454844
799	17033974	839	847	GeneOrGeneProduct	CACNA2D4	93589
800	17033974	967	975	OrganismTaxon	patients	9606
801	17033974	1013	1027	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
802	17033974	1092	1097	OrganismTaxon	human	9606
803	17033974	1098	1106	GeneOrGeneProduct	CACNA2D4	93589
804	17033974	1175	1189	DiseaseOrPhenotypicFeature	cone dystrophy	D000077765
805	17273972	0	5	OrganismTaxon	Human	9606
806	17273972	6	10	GeneOrGeneProduct	TBX1	6899
807	17273972	88	105	DiseaseOrPhenotypicFeature	22q11.2 deletions	D004062
808	17273972	107	132	DiseaseOrPhenotypicFeature	Deletion 22q11.2 syndrome	D004062
809	17273972	245	297	DiseaseOrPhenotypicFeature	DiGeorge and Shprintzen (velocardiofacial) syndromes	D004062
810	17273972	334	360	GeneOrGeneProduct	T-box transcription factor	6899
811	17273972	366	370	GeneOrGeneProduct	TBX1	6899
812	17273972	454	458	GeneOrGeneProduct	TBX1	6899
813	17273972	527	552	DiseaseOrPhenotypicFeature	22q11.2 deletion syndrome	D004062
814	17273972	749	754	SequenceVariant	H194Q	rs74315522
815	17273972	778	797	DiseaseOrPhenotypicFeature	Shprintzen syndrome	D004062
816	17273972	988	992	GeneOrGeneProduct	TBX1	6899
817	17286451	0	14	DiseaseOrPhenotypicFeature	Retinoblastoma	D012175
818	17286451	230	233	GeneOrGeneProduct	RB1	5925
819	17286451	278	284	DiseaseOrPhenotypicFeature	tumors	D009369
820	17286451	288	296	OrganismTaxon	patients	9606
821	17286451	344	347	GeneOrGeneProduct	RB1	5925
822	17286451	474	488	DiseaseOrPhenotypicFeature	retinoblastoma	D012175
823	17286451	490	492	DiseaseOrPhenotypicFeature	RB	D012175
824	17286451	548	554	DiseaseOrPhenotypicFeature	tumors	D009369
825	17286451	561	563	DiseaseOrPhenotypicFeature	RB	D012175
826	17286451	564	572	OrganismTaxon	patients	9606
827	17286451	669	672	GeneOrGeneProduct	RB1	5925
828	17286451	867	872	DiseaseOrPhenotypicFeature	tumor	D009369
829	17286451	895	897	DiseaseOrPhenotypicFeature	RB	D012175
830	17286451	898	906	OrganismTaxon	patients	9606
831	17286451	914	922	OrganismTaxon	patients	9606
832	17286451	1026	1028	DiseaseOrPhenotypicFeature	RB	D012175
833	17286451	1029	1037	OrganismTaxon	patients	9606
834	17286451	1070	1073	GeneOrGeneProduct	RB1	5925
835	17286451	1112	1114	DiseaseOrPhenotypicFeature	RB	D012175
836	17286451	1115	1123	OrganismTaxon	patients	9606
837	17286451	1316	1319	GeneOrGeneProduct	RB1	5925
838	17286451	1357	1362	DiseaseOrPhenotypicFeature	tumor	D009369
839	17286451	1400	1403	GeneOrGeneProduct	RB1	5925
840	17286451	1578	1580	DiseaseOrPhenotypicFeature	RB	D012175
841	17318851	0	30	GeneOrGeneProduct	Interferon regulatory factor 6	3664
842	17318851	32	36	GeneOrGeneProduct	IRF6	3664
843	17318851	42	77	GeneOrGeneProduct	fibroblast growth factor receptor 1	2260
844	17318851	79	84	GeneOrGeneProduct	FGFR1	2260
845	17318851	100	105	OrganismTaxon	human	9606
846	17318851	106	120	DiseaseOrPhenotypicFeature	tooth agenesis	D000848
847	17318851	301	323	DiseaseOrPhenotypicFeature	craniofacial syndromes	D019465
848	17318851	325	330	GeneOrGeneProduct	FGFR1	2260
849	17318851	335	339	GeneOrGeneProduct	IRF6	3664
850	17318851	383	397	DiseaseOrPhenotypicFeature	tooth agenesis	D000848
851	17318851	856	860	GeneOrGeneProduct	IRF6	3664
852	17318851	900	916	DiseaseOrPhenotypicFeature	orofacial clefts	C566121
853	17318851	942	947	OrganismTaxon	human	9606
854	17318851	948	962	DiseaseOrPhenotypicFeature	tooth agenesis	D000848
855	17318851	964	972	SequenceVariant	rs861019	rs861019
856	17318851	985	995	SequenceVariant	rs17015215	rs17015215
857	17318851	996	1001	SequenceVariant	V274I	rs2235371
858	17318851	1015	1021	SequenceVariant	rs7802	rs7802
859	17318851	1048	1052	GeneOrGeneProduct	IRF6	3664
860	17318851	1059	1106	DiseaseOrPhenotypicFeature	Van der Woude and popliteal pterygium syndromes	C536528,C562509
861	17318851	1179	1190	DiseaseOrPhenotypicFeature	oral clefts	D002972
862	17318851	1208	1222	DiseaseOrPhenotypicFeature	tooth agenesis	D000848
863	17318851	1258	1280	DiseaseOrPhenotypicFeature	pits on the lower lips	C536528,C562509
864	17318851	1353	1358	GeneOrGeneProduct	FGFR1	2260
865	17318851	1375	1379	GeneOrGeneProduct	IRF6	3664
866	17318851	1459	1463	GeneOrGeneProduct	IRF6	3664
867	17318851	1488	1492	GeneOrGeneProduct	MSX1	4487
868	17318851	1520	1524	GeneOrGeneProduct	TGFA	7039
869	17327131	26	32	GeneOrGeneProduct	CYP2F1	1572
870	17327131	104	110	GeneOrGeneProduct	CYP2F1	1572
871	17327131	116	121	OrganismTaxon	human	9606
872	17327131	122	137	GeneOrGeneProduct	cytochrome P450	1572
873	17327131	256	268	DiseaseOrPhenotypicFeature	carcinogenic	D009369
874	17327131	433	439	GeneOrGeneProduct	CYP2F1	1572
875	17327131	503	511	OrganismTaxon	patients	9606
876	17327131	517	528	DiseaseOrPhenotypicFeature	lung cancer	D008175
877	17327131	822	828	GeneOrGeneProduct	CYP2F1	1572
878	17327131	862	868	GeneOrGeneProduct	CYP2F1	1572
879	17327131	958	964	GeneOrGeneProduct	CYP2F1	1572
880	17327131	1047	1056	SequenceVariant	Asp218Asn	rs305974
881	17327131	1061	1070	SequenceVariant	Gln266His	rs75405062
882	17327131	1078	1092	SequenceVariant	1-bp insertion	rs11399890
883	17327131	1094	1105	SequenceVariant	c.14_15insC	rs11399890
884	17327131	1413	1419	GeneOrGeneProduct	CYP2F1	1572
885	17327131	1675	1681	GeneOrGeneProduct	CYP2F1	1572
886	17327131	1743	1754	DiseaseOrPhenotypicFeature	lung cancer	D008175
887	17384765	0	8	ChemicalEntity	Succimer	D004113
888	17384765	75	79	ChemicalEntity	lead	D007854
889	17384765	88	92	OrganismTaxon	rats	10116
890	17384765	114	134	DiseaseOrPhenotypicFeature	cognitive impairment	D003072
891	17384765	153	157	ChemicalEntity	lead	D007854
892	17384765	284	288	ChemicalEntity	lead	D007854
893	17384765	387	389	ChemicalEntity	Pb	D007854
894	17384765	505	507	ChemicalEntity	Pb	D007854
895	17384765	628	630	ChemicalEntity	Pb	D007854
896	17384765	659	667	ChemicalEntity	succimer	D004113
897	17384765	720	732	DiseaseOrPhenotypicFeature	Pb poisoning	D007855
898	17384765	743	745	ChemicalEntity	Pb	D007854
899	17384765	772	850	DiseaseOrPhenotypicFeature	impairments in learning, attention, inhibitory control, and arousal regulation	D007859,D019958
900	17384765	897	899	ChemicalEntity	Pb	D007854
901	17384765	918	926	ChemicalEntity	Succimer	D004113
902	17384765	944	946	ChemicalEntity	Pb	D007854
903	17384765	955	959	OrganismTaxon	rats	10116
904	17384765	1095	1097	ChemicalEntity	Pb	D007854
905	17384765	1163	1171	ChemicalEntity	succimer	D004113
906	17384765	1185	1189	OrganismTaxon	rats	10116
907	17384765	1216	1218	ChemicalEntity	Pb	D007854
908	17384765	1250	1285	DiseaseOrPhenotypicFeature	cognitive and affective dysfunction	D003072,D019964
909	17384765	1341	1343	ChemicalEntity	Pb	D007854
910	17384765	1481	1499	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
911	17384765	1507	1509	ChemicalEntity	Pb	D007854
912	17384765	1581	1589	ChemicalEntity	succimer	D004113
913	17384765	1645	1647	ChemicalEntity	Pb	D007854
914	17384765	1698	1706	ChemicalEntity	succimer	D004113
915	17384765	1803	1805	ChemicalEntity	Pb	D007854
916	17391797	4	48	GeneOrGeneProduct	phosphatidylethanolamine N-methyltransferase	10400
917	17391797	54	59	SequenceVariant	V175M	rs7946
918	17391797	121	125	DiseaseOrPhenotypicFeature	NASH	D065626
919	17391797	216	244	DiseaseOrPhenotypicFeature	nonalcoholic steatohepatitis	D065626
920	17391797	246	250	DiseaseOrPhenotypicFeature	NASH	D065626
921	17391797	306	315	SequenceVariant	Val175Met	rs7946
922	17391797	332	376	GeneOrGeneProduct	phosphatidylethanolamine N-methyltransferase	10400
923	17391797	378	382	GeneOrGeneProduct	PEMT	10400
924	17391797	417	441	ChemicalEntity	phosphatidylethanolamine	D010714
925	17391797	445	464	ChemicalEntity	phosphatidylcholine	D010713
926	17391797	531	540	SequenceVariant	Val175Met	rs7946
927	17391797	561	565	GeneOrGeneProduct	PEMT	10400
928	17391797	599	603	DiseaseOrPhenotypicFeature	NASH	D065626
929	17391797	635	643	OrganismTaxon	patients	9606
930	17391797	663	667	DiseaseOrPhenotypicFeature	NASH	D065626
931	17391797	806	815	SequenceVariant	Val175Met	rs7946
932	17391797	838	842	GeneOrGeneProduct	PEMT	10400
933	17391797	883	887	DiseaseOrPhenotypicFeature	NASH	D065626
934	17391797	888	896	OrganismTaxon	patients	9606
935	17391797	951	960	SequenceVariant	Val175Met	rs7946
936	17391797	1005	1009	DiseaseOrPhenotypicFeature	NASH	D065626
937	17391797	1010	1018	OrganismTaxon	patients	9606
938	17391797	1062	1066	DiseaseOrPhenotypicFeature	NASH	D065626
939	17391797	1067	1075	OrganismTaxon	patients	9606
940	17391797	1135	1140	DiseaseOrPhenotypicFeature	obese	D009765
941	17391797	1141	1149	OrganismTaxon	patients	9606
942	17391797	1208	1217	SequenceVariant	Val175Met	rs7946
943	17391797	1259	1263	GeneOrGeneProduct	PEMT	10400
944	17391797	1278	1287	SequenceVariant	Val175Met	rs7946
945	17391797	1299	1303	GeneOrGeneProduct	PEMT	10400
946	17391797	1372	1376	DiseaseOrPhenotypicFeature	NASH	D065626
947	17391797	1420	1424	DiseaseOrPhenotypicFeature	NASH	D065626
948	17391797	1425	1433	OrganismTaxon	patients	9606
949	17391797	1442	1447	DiseaseOrPhenotypicFeature	obese	D009765
950	17391797	1461	1470	SequenceVariant	Val175Met	rs7946
951	17391797	1482	1486	GeneOrGeneProduct	PEMT	10400
952	17391797	1514	1518	DiseaseOrPhenotypicFeature	NASH	D065626
953	17495183	0	11	GeneOrGeneProduct	Tenomodulin	64102
954	17495183	31	38	DiseaseOrPhenotypicFeature	obesity	D009765
955	17495183	43	51	DiseaseOrPhenotypicFeature	diabetes	D003920
956	17495183	70	78	DiseaseOrPhenotypicFeature	diabetes	D003920
957	17495183	205	215	DiseaseOrPhenotypicFeature	overweight	D050177
958	17495183	233	259	DiseaseOrPhenotypicFeature	impaired glucose tolerance	D018149
959	17495183	261	264	DiseaseOrPhenotypicFeature	IGT	D018149
960	17495183	313	324	GeneOrGeneProduct	tenomodulin	64102
961	17495183	326	330	GeneOrGeneProduct	TNMD	64102
962	17495183	472	481	DiseaseOrPhenotypicFeature	adiposity	D009765
963	17495183	483	490	ChemicalEntity	glucose	D005947
964	17495183	519	534	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
965	17495183	536	539	DiseaseOrPhenotypicFeature	T2D	D003924
966	17495183	663	671	DiseaseOrPhenotypicFeature	Diabetes	D003920
967	17495183	804	813	DiseaseOrPhenotypicFeature	adiposity	D009765
968	17495183	817	822	OrganismTaxon	women	9606
969	17495183	824	833	SequenceVariant	rs5966709	rs5966709
970	17495183	835	844	SequenceVariant	rs4828037	rs4828037
971	17495183	850	853	OrganismTaxon	men	9606
972	17495183	855	865	SequenceVariant	rs11798018	rs11798018
973	17495183	876	885	SequenceVariant	rs2073163	rs2073163
974	17495183	890	899	SequenceVariant	rs1155794	rs1155794
975	17495183	953	960	ChemicalEntity	glucose	D005947
976	17495183	971	974	OrganismTaxon	men	9606
977	17495183	1039	1048	SequenceVariant	rs2073162	rs2073162
978	17495183	1083	1086	DiseaseOrPhenotypicFeature	IGT	D018149
979	17495183	1090	1093	DiseaseOrPhenotypicFeature	T2D	D003924
980	17495183	1097	1100	OrganismTaxon	men	9606
981	17495183	1125	1128	DiseaseOrPhenotypicFeature	T2D	D003924
982	17495183	1221	1228	ChemicalEntity	glucose	D005947
983	17495183	1282	1291	SequenceVariant	rs2073162	rs2073162
984	17495183	1317	1326	SequenceVariant	rs2073163	rs2073163
985	17495183	1356	1365	SequenceVariant	rs1155974	rs1155974
986	17495183	1396	1400	GeneOrGeneProduct	TNMD	64102
987	17495183	1435	1444	DiseaseOrPhenotypicFeature	adiposity	D009765
988	17495183	1459	1466	ChemicalEntity	glucose	D005947
989	17495183	1498	1501	DiseaseOrPhenotypicFeature	IGT	D018149
990	17495183	1505	1508	DiseaseOrPhenotypicFeature	T2D	D003924
991	17495183	1512	1515	OrganismTaxon	men	9606
992	17572393	27	36	ChemicalEntity	melatonin	D008550
993	17572393	81	84	OrganismTaxon	rat	10116
994	17572393	94	98	ChemicalEntity	BCNU	D002330
995	17572393	107	125	DiseaseOrPhenotypicFeature	cortical dysplasia	D054220
996	17572393	127	145	DiseaseOrPhenotypicFeature	Cortical dysplasia	D054220
997	17572393	298	301	OrganismTaxon	rat	10116
998	17572393	345	355	ChemicalEntity	carmustine	D002330
999	17572393	357	393	ChemicalEntity	1,3-bis (2-chloroethyl)-1-nitrosoure	D002330
1000	17572393	396	400	ChemicalEntity	BCNU	D002330
1001	17572393	446	455	ChemicalEntity	melatonin	D008550
1002	17572393	472	476	ChemicalEntity	BCNU	D002330
1003	17572393	485	503	DiseaseOrPhenotypicFeature	cortical dysplasia	D054220
1004	17572393	566	570	OrganismTaxon	rats	10116
1005	17572393	633	642	ChemicalEntity	melatonin	D008550
1006	17572393	652	656	ChemicalEntity	BCNU	D002330
1007	17572393	669	673	ChemicalEntity	BCNU	D002330
1008	17572393	687	696	ChemicalEntity	melatonin	D008550
1009	17572393	698	702	OrganismTaxon	Rats	10116
1010	17572393	719	723	ChemicalEntity	BCNU	D002330
1011	17572393	748	757	ChemicalEntity	melatonin	D008550
1012	17572393	890	905	ChemicalEntity	malondialdehyde	D008315
1013	17572393	910	920	ChemicalEntity	superoxide	D013481
1014	17572393	1117	1121	ChemicalEntity	BCNU	D002330
1015	17572393	1130	1148	DiseaseOrPhenotypicFeature	cortical dysplasia	D054220
1016	17572393	1251	1255	ChemicalEntity	BCNU	D002330
1017	17572393	1307	1338	GeneOrGeneProduct	glial fibrillary acidic protein	24387
1018	17572393	1340	1353	GeneOrGeneProduct	synaptophysin	24804
1019	17572393	1358	1390	GeneOrGeneProduct	transforming growth factor beta1	59086
1020	17572393	1442	1451	ChemicalEntity	melatonin	D008550
1021	17572393	1490	1505	ChemicalEntity	Malondialdehyde	D008315
1022	17572393	1515	1519	ChemicalEntity	BCNU	D002330
1023	17572393	1578	1587	ChemicalEntity	melatonin	D008550
1024	17572393	1598	1613	ChemicalEntity	malondialdehyde	D008315
1025	17572393	1624	1628	ChemicalEntity	BCNU	D002330
1026	17572393	1696	1716	GeneOrGeneProduct	superoxide dismutase	24786
1027	17572393	1793	1797	ChemicalEntity	BCNU	D002330
1028	17572393	1871	1880	ChemicalEntity	melatonin	D008550
1029	17572393	1928	1932	ChemicalEntity	BCNU	D002330
1030	17935240	33	62	DiseaseOrPhenotypicFeature	X-linked retinitis pigmentosa	D012174
1031	17935240	68	90	SequenceVariant	g.ORF15 + 652-653delAG	g|DEL|ORF15+652_653|AG
1032	17935240	107	111	GeneOrGeneProduct	RPGR	6103
1033	17935240	150	179	DiseaseOrPhenotypicFeature	X-linked retinitis pigmentosa	D012174
1034	17935240	181	185	DiseaseOrPhenotypicFeature	XLRP	D012174
1035	17935240	270	274	DiseaseOrPhenotypicFeature	XLRP	D012174
1036	17935240	305	307	DiseaseOrPhenotypicFeature	RP	D012174
1037	17935240	431	435	GeneOrGeneProduct	RPGR	6103
1038	17935240	740	762	SequenceVariant	g.ORF15 + 652-653delAG	g|DEL|ORF15+652_653|AG
1039	17935240	819	827	OrganismTaxon	patients	9606
1040	17935240	1050	1087	SequenceVariant	AG-deletion at nucleotide 652 and 653	g|DEL|652_653|AG
1041	17935240	1276	1281	OrganismTaxon	woman	9606
1042	17935240	1319	1323	GeneOrGeneProduct	RPGR	6103
1043	17935240	1409	1413	DiseaseOrPhenotypicFeature	XLRP	D012174
1044	17935240	1493	1495	DiseaseOrPhenotypicFeature	RP	D012174
1045	17935240	1545	1547	DiseaseOrPhenotypicFeature	RP	D012174
1046	17962394	28	46	DiseaseOrPhenotypicFeature	X linked nystagmus	C580539
1047	17962394	77	84	SequenceVariant	p.R229G	rs137852212
1048	17962394	111	116	GeneOrGeneProduct	FRMD7	90167
1049	17962394	173	187	DiseaseOrPhenotypicFeature	genetic defect	D030342
1050	17962394	207	225	DiseaseOrPhenotypicFeature	X linked nystagmus	C580539
1051	17962394	227	230	DiseaseOrPhenotypicFeature	NYS	C580539
1052	17962394	352	357	GeneOrGeneProduct	FRMD7	90167
1053	17962394	553	563	SequenceVariant	CAG repeat	c|DUP||CAG|
1054	17962394	571	588	GeneOrGeneProduct	androgen receptor	367
1055	17962394	660	663	DiseaseOrPhenotypicFeature	NYS	C580539
1056	17962394	725	733	SequenceVariant	c.686C>G	rs137852212
1057	17962394	789	835	SequenceVariant	arginine at amino acid position 229 by glycine	rs137852212
1058	17962394	837	844	SequenceVariant	p.R229G	rs137852212
1059	17962394	863	868	GeneOrGeneProduct	FRMD7	90167
1060	17962394	1179	1186	SequenceVariant	p.R229G	rs137852212
1061	17962394	1203	1208	GeneOrGeneProduct	FRMD7	90167
1062	17962394	1225	1228	DiseaseOrPhenotypicFeature	NYS	C580539
1063	17962394	1313	1325	DiseaseOrPhenotypicFeature	X linked NYS	C580539
1064	18235024	0	44	DiseaseOrPhenotypicFeature	Cone dystrophy with supernormal rod response	C563678
1065	18235024	86	91	GeneOrGeneProduct	KCNV2	169522
1066	18235024	102	146	DiseaseOrPhenotypicFeature	Cone dystrophy with supernormal rod response	C563678
1067	18235024	148	153	DiseaseOrPhenotypicFeature	CDSRR	C563678
1068	18235024	160	176	DiseaseOrPhenotypicFeature	retinal disorder	D012164
1069	18235024	217	237	DiseaseOrPhenotypicFeature	color vision defects	D003117
1070	18235024	374	379	GeneOrGeneProduct	PDE6H	5149
1071	18235024	387	392	GeneOrGeneProduct	KCNV2	169522
1072	18235024	416	421	DiseaseOrPhenotypicFeature	CDSRR	C563678
1073	18235024	490	498	OrganismTaxon	patients	9606
1074	18235024	504	509	DiseaseOrPhenotypicFeature	CDSRR	C563678
1075	18235024	558	566	OrganismTaxon	patients	9606
1076	18235024	826	831	GeneOrGeneProduct	PDE6C	5146
1077	18235024	836	841	GeneOrGeneProduct	KCNV2	169522
1078	18235024	995	1000	GeneOrGeneProduct	PDE6H	5149
1079	18235024	1020	1025	GeneOrGeneProduct	KCNV2	169522
1080	18235024	1049	1057	OrganismTaxon	patients	9606
1081	18235024	1351	1356	DiseaseOrPhenotypicFeature	CDSRR	C563678
1082	18235024	1432	1452	DiseaseOrPhenotypicFeature	color vision defects	D003117
1083	18235024	1526	1533	DiseaseOrPhenotypicFeature	atrophy	D001284
1084	18235024	1555	1563	OrganismTaxon	patients	9606
1085	18235024	1628	1636	OrganismTaxon	patients	9606
1086	18235024	1688	1732	DiseaseOrPhenotypicFeature	cone dystrophy with supernormal rod response	C563678
1087	18235024	1769	1774	GeneOrGeneProduct	KCNV2	169522
1088	18408250	40	44	GeneOrGeneProduct	IRF5	3663
1089	18408250	98	118	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
1090	18408250	159	189	GeneOrGeneProduct	Interferon regulatory factor 5	3663
1091	18408250	191	195	GeneOrGeneProduct	IRF5	3663
1092	18408250	216	219	GeneOrGeneProduct	IRF	3663
1093	18408250	286	311	GeneOrGeneProduct	proinflammatory cytokines	3553
1094	18408250	334	338	GeneOrGeneProduct	IRF5	3663
1095	18408250	388	417	DiseaseOrPhenotypicFeature	systemic lupus erythaematosus	D008180
1096	18408250	419	422	DiseaseOrPhenotypicFeature	SLE	D008180
1097	18408250	491	510	DiseaseOrPhenotypicFeature	autoimmune diseases	D001327
1098	18408250	569	573	GeneOrGeneProduct	IRF5	3663
1099	18408250	595	615	DiseaseOrPhenotypicFeature	rheumatoid arthritis	D001172
1100	18408250	617	619	DiseaseOrPhenotypicFeature	RA	D001172
1101	18408250	757	761	GeneOrGeneProduct	IRF5	3663
1102	18408250	856	864	OrganismTaxon	patients	9606
1103	18408250	870	872	DiseaseOrPhenotypicFeature	RA	D001172
1104	18408250	908	916	OrganismTaxon	patients	9606
1105	18408250	922	924	DiseaseOrPhenotypicFeature	RA	D001172
1106	18408250	991	996	OrganismTaxon	human	9606
1107	18408250	997	1025	GeneOrGeneProduct	leukocyte antigen (HLA)-DRB1	3123
1108	18408250	1139	1147	SequenceVariant	rs729302	rs729302
1109	18408250	1162	1164	DiseaseOrPhenotypicFeature	RA	D001172
1110	18408250	1291	1299	OrganismTaxon	patients	9606
1111	18408250	1331	1339	SequenceVariant	rs729302	rs729302
1112	18408250	1387	1389	DiseaseOrPhenotypicFeature	RA	D001172
1113	18408250	1393	1401	OrganismTaxon	patients	9606
1114	18408250	1483	1491	OrganismTaxon	patients	9606
1115	18408250	1626	1628	DiseaseOrPhenotypicFeature	RA	D001172
1116	18408250	1649	1657	SequenceVariant	rs729302	rs729302
1117	18408250	1759	1763	GeneOrGeneProduct	IRF5	3663
1118	18408250	1813	1815	DiseaseOrPhenotypicFeature	RA	D001172
1119	18408250	1881	1889	OrganismTaxon	patients	9606
1120	18487244	59	67	OrganismTaxon	patients	9606
1121	18487244	73	78	GeneOrGeneProduct	POLG1	5428
1122	18487244	249	291	GeneOrGeneProduct	mitochondrial DNA (mtDNA) gamma polymerase	5428
1123	18487244	293	298	GeneOrGeneProduct	POLG1	5428
1124	18487244	316	331	DiseaseOrPhenotypicFeature	Alpers syndrome	D002549
1125	18487244	354	359	GeneOrGeneProduct	POLG1	5428
1126	18487244	402	422	DiseaseOrPhenotypicFeature	hepatoencephalopathy	C563797
1127	18487244	541	549	OrganismTaxon	Patients	9606
1128	18487244	702	710	OrganismTaxon	patients	9606
1129	18487244	805	813	OrganismTaxon	patients	9606
1130	18487244	858	863	GeneOrGeneProduct	POLG1	5428
1131	18487244	957	965	OrganismTaxon	patients	9606
1132	18487244	1041	1049	DiseaseOrPhenotypicFeature	Epilepsy	D004827
1133	18487244	1057	1074	DiseaseOrPhenotypicFeature	movement disorder	D009069
1134	18487244	1328	1335	OrganismTaxon	patient	9606
1135	18487244	1415	1420	GeneOrGeneProduct	POLG1	5428
1136	18487244	1500	1505	GeneOrGeneProduct	POLG1	5428
1137	18631865	0	15	ChemicalEntity	mToR inhibitors	-
1138	18631865	24	35	DiseaseOrPhenotypicFeature	proteinuria	D011507
1139	18631865	153	175	ChemicalEntity	calcineurin inhibitors	D065095
1140	18631865	179	226	ChemicalEntity	mammalian target of rapamycin (mToR) inhibitors	-
1141	18631865	239	248	ChemicalEntity	sirolimus	D020123
1142	18631865	286	315	DiseaseOrPhenotypicFeature	chronic allograft nephropathy	D051436
1143	18631865	325	336	DiseaseOrPhenotypicFeature	proteinuria	D011507
1144	18631865	473	484	DiseaseOrPhenotypicFeature	proteinuria	D011507
1145	18631865	496	505	ChemicalEntity	sirolimus	D020123
1146	18631865	531	553	ChemicalEntity	calcineurin inhibitors	D065095
1147	18631865	600	611	DiseaseOrPhenotypicFeature	proteinuria	D011507
1148	18631865	637	646	ChemicalEntity	sirolimus	D020123
1149	18631865	687	695	OrganismTaxon	patients	9606
1150	18631865	709	718	ChemicalEntity	sirolimus	D020123
1151	18631865	764	782	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
1152	18631865	804	808	GeneOrGeneProduct	mToR	2475
1153	18631865	828	836	OrganismTaxon	patients	9606
1154	18631865	965	969	GeneOrGeneProduct	mToR	2475
1155	18631865	987	998	DiseaseOrPhenotypicFeature	proteinuria	D011507
1156	18768591	0	44	GeneOrGeneProduct	Serum- and glucocorticoid-inducible kinase 1	20393
1157	18768591	48	59	ChemicalEntity	doxorubicin	D004317
1158	18768591	68	86	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1159	18768591	88	99	ChemicalEntity	Doxorubicin	D004317
1160	18768591	108	119	DiseaseOrPhenotypicFeature	nephropathy	D007674
1161	18768591	140	146	ChemicalEntity	sodium	D012964
1162	18768591	172	188	DiseaseOrPhenotypicFeature	volume retention	D016055
1163	18768591	193	207	DiseaseOrPhenotypicFeature	renal fibrosis	D007674
1164	18768591	213	224	ChemicalEntity	aldosterone	D000450
1165	18768591	235	277	GeneOrGeneProduct	serum- and glucocorticoid-inducible kinase	20393
1166	18768591	278	282	GeneOrGeneProduct	SGK1	20393
1167	18768591	355	369	DiseaseOrPhenotypicFeature	renal fibrosis	D007674
1168	18768591	380	397	ChemicalEntity	mineralocorticoid	D008901
1169	18768591	402	406	ChemicalEntity	salt	D012492
1170	18768591	472	476	GeneOrGeneProduct	SGK1	20393
1171	18768591	484	500	DiseaseOrPhenotypicFeature	volume retention	D016055
1172	18768591	505	513	DiseaseOrPhenotypicFeature	fibrosis	D005355
1173	18768591	521	539	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1174	18768591	554	565	ChemicalEntity	doxorubicin	D004317
1175	18768591	631	635	OrganismTaxon	mice	10090
1176	18768591	644	648	GeneOrGeneProduct	SGK1	20393
1177	18768591	650	654	GeneOrGeneProduct	sgk1	20393
1178	18768591	694	698	GeneOrGeneProduct	sgk1	20393
1179	18768591	706	717	ChemicalEntity	Doxorubicin	D004317
1180	18768591	746	757	DiseaseOrPhenotypicFeature	proteinuria	D011507
1181	18768591	778	782	ChemicalEntity	crea	D003404
1182	18768591	796	800	GeneOrGeneProduct	sgk1	20393
1183	18768591	819	823	GeneOrGeneProduct	sgk1	20393
1184	18768591	829	833	OrganismTaxon	mice	10090
1185	18768591	852	870	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1186	18768591	876	883	DiseaseOrPhenotypicFeature	ascites	D001201
1187	18768591	885	894	DiseaseOrPhenotypicFeature	lipidemia	D006949
1188	18768591	900	915	DiseaseOrPhenotypicFeature	hypoalbuminemia	D034141
1189	18768591	942	953	ChemicalEntity	aldosterone	D000450
1190	18768591	974	983	DiseaseOrPhenotypicFeature	nephrotic	D009404
1191	18768591	984	988	OrganismTaxon	mice	10090
1192	18768591	1037	1041	GeneOrGeneProduct	SGK1	20393
1193	18768591	1064	1068	GeneOrGeneProduct	sgk1	20393
1194	18768591	1074	1078	OrganismTaxon	mice	10090
1195	18768591	1088	1094	ChemicalEntity	sodium	D012964
1196	18768591	1142	1146	GeneOrGeneProduct	sgk1	20393
1197	18768591	1152	1156	OrganismTaxon	mice	10090
1198	18768591	1176	1180	ChemicalEntity	crea	D003404
1199	18768591	1190	1194	GeneOrGeneProduct	sgk1	20393
1200	18768591	1200	1204	OrganismTaxon	mice	10090
1201	18768591	1224	1228	ChemicalEntity	crea	D003404
1202	18768591	1282	1293	DiseaseOrPhenotypicFeature	weight gain	D015430
1203	18768591	1297	1301	GeneOrGeneProduct	sgk1	20393
1204	18768591	1321	1325	GeneOrGeneProduct	sgk1	20393
1205	18768591	1331	1335	OrganismTaxon	mice	10090
1206	18768591	1392	1410	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1207	18768591	1418	1422	ChemicalEntity	urea	D014508
1208	18768591	1472	1476	GeneOrGeneProduct	sgk1	20393
1209	18768591	1482	1486	OrganismTaxon	mice	10090
1210	18768591	1495	1499	GeneOrGeneProduct	sgk1	20393
1211	18768591	1505	1509	OrganismTaxon	mice	10090
1212	18768591	1521	1527	DiseaseOrPhenotypicFeature	uremia	D014511
1213	18768591	1561	1565	GeneOrGeneProduct	sgk1	20393
1214	18768591	1571	1575	OrganismTaxon	mice	10090
1215	18768591	1595	1599	GeneOrGeneProduct	sgk1	20393
1216	18768591	1605	1609	OrganismTaxon	mice	10090
1217	18768591	1641	1645	OrganismTaxon	mice	10090
1218	18768591	1654	1658	GeneOrGeneProduct	SGK1	20393
1219	18768591	1674	1690	DiseaseOrPhenotypicFeature	volume retention	D016055
1220	18768591	1723	1737	DiseaseOrPhenotypicFeature	renal fibrosis	D007674
1221	18768591	1758	1776	DiseaseOrPhenotypicFeature	nephrotic syndrome	D009404
1222	18991055	37	44	GeneOrGeneProduct	SLC30A8	169026
1223	18991055	46	50	GeneOrGeneProduct	HHEX	3087
1224	18991055	52	60	GeneOrGeneProduct	CDKN2A/B	1029,1030
1225	18991055	62	69	GeneOrGeneProduct	IGF2BP2	10644
1226	18991055	71	74	GeneOrGeneProduct	FTO	79068
1227	18991055	76	80	GeneOrGeneProduct	WFS1	7466
1228	18991055	82	88	GeneOrGeneProduct	CDKAL1	54901
1229	18991055	90	95	GeneOrGeneProduct	KCNQ1	3784
1230	18991055	100	115	DiseaseOrPhenotypicFeature	type 2 diabetes	D003924
1231	18991055	281	305	DiseaseOrPhenotypicFeature	type 2 diabetes mellitus	D003924
1232	18991055	307	311	DiseaseOrPhenotypicFeature	T2DM	D003924
1233	18991055	405	412	GeneOrGeneProduct	SLC30A8	169026
1234	18991055	414	418	GeneOrGeneProduct	HHEX	3087
1235	18991055	420	428	GeneOrGeneProduct	CDKN2A/B	1029,1030
1236	18991055	430	437	GeneOrGeneProduct	IGF2BP2	10644
1237	18991055	439	442	GeneOrGeneProduct	FTO	79068
1238	18991055	444	448	GeneOrGeneProduct	WFS1	7466
1239	18991055	450	456	GeneOrGeneProduct	CDKAL1	54901
1240	18991055	461	466	GeneOrGeneProduct	KCNQ1	3784
1241	18991055	483	487	DiseaseOrPhenotypicFeature	T2DM	D003924
1242	18991055	586	594	OrganismTaxon	patients	9606
1243	18991055	600	604	DiseaseOrPhenotypicFeature	T2DM	D003924
1244	18991055	617	625	DiseaseOrPhenotypicFeature	diabetic	D003920
1245	18991055	649	659	SequenceVariant	rs13266634	rs13266634
1246	18991055	661	670	SequenceVariant	rs1111875	rs1111875
1247	18991055	672	682	SequenceVariant	rs10811661	rs10811661
1248	18991055	684	693	SequenceVariant	rs4402960	rs4402960
1249	18991055	695	704	SequenceVariant	rs8050136	rs8050136
1250	18991055	706	714	SequenceVariant	rs734312	rs734312
1251	18991055	716	725	SequenceVariant	rs7754840	rs7754840
1252	18991055	730	739	SequenceVariant	rs2237892	rs2237892
1253	18991055	805	812	ChemicalEntity	glucose	D005947
1254	18991055	820	828	OrganismTaxon	patients	9606
1255	18991055	895	901	GeneOrGeneProduct	CDKAL1	54901
1256	18991055	903	912	SequenceVariant	rs7754840	rs7754840
1257	18991055	994	1003	SequenceVariant	rs1111875	rs1111875
1258	18991055	1057	1061	GeneOrGeneProduct	HHEX	3087
1259	18991055	1080	1090	SequenceVariant	rs10811661	rs10811661
1260	18991055	1144	1152	GeneOrGeneProduct	CDKN2A/B	1029,1030
1261	18991055	1174	1183	SequenceVariant	rs2237892	rs2237892
1262	18991055	1230	1235	GeneOrGeneProduct	KCNQ1	3784
1263	18991055	1273	1277	DiseaseOrPhenotypicFeature	T2DM	D003924
1264	18991055	1279	1289	SequenceVariant	Rs13266634	rs13266634
1265	18991055	1336	1343	GeneOrGeneProduct	SLC30A8	169026
1266	18991055	1390	1394	DiseaseOrPhenotypicFeature	T2DM	D003924
1267	18991055	1412	1419	GeneOrGeneProduct	IGF2BP2	10644
1268	18991055	1421	1424	GeneOrGeneProduct	FTO	79068
1269	18991055	1429	1433	GeneOrGeneProduct	WFS1	7466
1270	18991055	1497	1501	GeneOrGeneProduct	HHEX	3087
1271	18991055	1503	1511	GeneOrGeneProduct	CDKN2A/B	1029,1030
1272	18991055	1513	1519	GeneOrGeneProduct	CDKAL1	54901
1273	18991055	1521	1526	GeneOrGeneProduct	KCNQ1	3784
1274	18991055	1531	1538	GeneOrGeneProduct	SLC30A8	169026
1275	18991055	1556	1560	DiseaseOrPhenotypicFeature	T2DM	D003924
1276	19058010	10	19	ChemicalEntity	green tea	D010936
1277	19058010	24	33	ChemicalEntity	vitamin E	D014810
1278	19058010	49	62	ChemicalEntity	isoproterenol	D007545
1279	19058010	71	92	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
1280	19058010	96	100	OrganismTaxon	rats	10116
1281	19058010	169	178	ChemicalEntity	green tea	D010936
1282	19058010	183	192	ChemicalEntity	vitamin E	D014810
1283	19058010	245	250	ChemicalEntity	lipid	D008055
1284	19058010	276	288	ChemicalEntity	antioxidants	D000975
1285	19058010	319	332	ChemicalEntity	isoproterenol	D007545
1286	19058010	334	337	ChemicalEntity	ISO	D007545
1287	19058010	347	368	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
1288	19058010	372	376	OrganismTaxon	rats	10116
1289	19058010	396	400	OrganismTaxon	rats	10116
1290	19058010	415	418	ChemicalEntity	ISO	D007545
1291	19058010	550	555	ChemicalEntity	lipid	D008055
1292	19058010	573	584	ChemicalEntity	Ca+2 ATPase	D000252
1293	19058010	668	680	ChemicalEntity	antioxidants	D000975
1294	19058010	682	696	ChemicalEntity	Na+/ K+ ATPase	D000254
1295	19058010	701	712	ChemicalEntity	Mg+2 ATPase	D017301
1296	19058010	739	748	ChemicalEntity	green tea	D010936
1297	19058010	775	784	ChemicalEntity	vitamin E	D014810
1298	19058010	860	863	ChemicalEntity	ISO	D007545
1299	19058010	968	973	ChemicalEntity	lipid	D008055
1300	19058010	988	999	ChemicalEntity	Ca+2 ATPase	D000252
1301	19058010	1058	1070	ChemicalEntity	antioxidants	D000975
1302	19058010	1072	1085	ChemicalEntity	Na+/K+ ATPase	D000254
1303	19058010	1090	1101	ChemicalEntity	Mg+2 ATPase	D017301
1304	19058010	1121	1124	ChemicalEntity	ISO	D007545
1305	19058010	1143	1152	ChemicalEntity	green tea	D010936
1306	19058010	1156	1165	ChemicalEntity	vitamin E	D014810
1307	19058010	1249	1258	ChemicalEntity	green tea	D010936
1308	19058010	1263	1272	ChemicalEntity	vitamin E	D014810
1309	19058010	1280	1283	ChemicalEntity	ISO	D007545
1310	19058010	1292	1313	DiseaseOrPhenotypicFeature	myocardial infarction	D009203
1311	19058010	1317	1321	OrganismTaxon	rats	10116
1312	19218574	0	29	GeneOrGeneProduct	Phosphatidylinositol 3-kinase	5295
1313	19218574	30	38	GeneOrGeneProduct	p85alpha	5295
1314	19218574	63	72	SequenceVariant	Met326Ile	rs3730089
1315	19218574	89	94	OrganismTaxon	women	9606
1316	19218574	100	125	DiseaseOrPhenotypicFeature	polycystic ovary syndrome	D011085
1317	19218574	139	157	DiseaseOrPhenotypicFeature	Insulin resistance	D007333
1318	19218574	179	204	DiseaseOrPhenotypicFeature	polycystic ovary syndrome	D011085
1319	19218574	206	210	DiseaseOrPhenotypicFeature	PCOS	D011085
1320	19218574	213	247	GeneOrGeneProduct	Phosphatidylinositol (PI) 3-kinase	5295
1321	19218574	284	291	GeneOrGeneProduct	insulin	3630
1322	19218574	334	341	GeneOrGeneProduct	insulin	3630
1323	19218574	351	358	ChemicalEntity	glucose	D005947
1324	19218574	397	405	GeneOrGeneProduct	p85alpha	5295
1325	19218574	454	463	SequenceVariant	Met326Ile	rs3730089
1326	19218574	538	546	GeneOrGeneProduct	p85alpha	5295
1327	19218574	570	580	GeneOrGeneProduct	PI3-kinase	5295
1328	19218574	607	616	SequenceVariant	Met326Ile	rs3730089
1329	19218574	670	674	DiseaseOrPhenotypicFeature	PCOS	D011085
1330	19218574	675	683	OrganismTaxon	patients	9606
1331	19218574	814	823	SequenceVariant	Met326Ile	rs3730089
1332	19218574	844	848	DiseaseOrPhenotypicFeature	PCOS	D011085
1333	19218574	900	909	SequenceVariant	Met326Met	rs3730089
1334	19218574	910	919	SequenceVariant	Met326Ile	rs3730089
1335	19218574	920	929	SequenceVariant	Ile326Ile	rs3730089
1336	19218574	987	991	DiseaseOrPhenotypicFeature	PCOS	D011085
1337	19218574	1041	1045	DiseaseOrPhenotypicFeature	PCOS	D011085
1338	19218574	1124	1130	SequenceVariant	326Ile	rs3730089
1339	19218574	1189	1195	SequenceVariant	326Ile	rs3730089
1340	19218574	1222	1231	SequenceVariant	Met326Met	rs3730089
1341	19218574	1258	1280	ChemicalEntity	17-hydroxyprogesterone	D019326
1342	19218574	1282	1288	ChemicalEntity	17-OHP	D019326
1343	19218574	1358	1367	SequenceVariant	Met326Met	rs3730089
1344	19218574	1425	1434	SequenceVariant	Ile326Ile	rs3730089
1345	19218574	1439	1448	SequenceVariant	Met326Ile	rs3730089
1346	19218574	1481	1493	ChemicalEntity	testosterone	D013739
1347	19218574	1533	1542	SequenceVariant	Met326Met	rs3730089
1348	19218574	1590	1599	SequenceVariant	Ile326Ile	rs3730089
1349	19218574	1604	1613	SequenceVariant	Met326Ile	rs3730089
1350	19218574	1679	1689	GeneOrGeneProduct	PI3-kinase	5295
1351	19218574	1695	1704	SequenceVariant	Met326Ile	rs3730089
1352	19218574	1772	1776	DiseaseOrPhenotypicFeature	PCOS	D011085
1353	19218574	1826	1832	ChemicalEntity	17-OHP	D019326
1354	19218574	1841	1853	ChemicalEntity	testosterone	D013739
1355	19218574	1857	1861	DiseaseOrPhenotypicFeature	PCOS	D011085
1356	19218574	1862	1870	OrganismTaxon	patients	9606
1357	19353688	112	117	GeneOrGeneProduct	PCDH9	5101
1358	19353688	146	184	DiseaseOrPhenotypicFeature	autosomal dominant auditory neuropathy	C563790
1359	19353688	186	191	DiseaseOrPhenotypicFeature	AUNA1	C563790
1360	19353688	716	724	DiseaseOrPhenotypicFeature	deafness	D003638
1361	19353688	726	743	DiseaseOrPhenotypicFeature	duodenal stenosis	C535720
1362	19353688	745	775	DiseaseOrPhenotypicFeature	developmental and growth delay	D002658
1363	19353688	777	796	DiseaseOrPhenotypicFeature	vertebral anomalies	C535781
1364	19353688	802	821	DiseaseOrPhenotypicFeature	facial dysmorphisms	D019465
1365	19353688	864	876	DiseaseOrPhenotypicFeature	dysmorphisms	D019465
1366	19353688	885	890	DiseaseOrPhenotypicFeature	AUNA1	C563790
1367	19353688	891	899	DiseaseOrPhenotypicFeature	deafness	D003638
1368	19353688	941	946	GeneOrGeneProduct	PCDH9	5101
1369	19353688	948	963	GeneOrGeneProduct	protocadherin-9	5101
1370	19353688	978	983	GeneOrGeneProduct	PCDH9	5101
1371	19353688	1025	1033	DiseaseOrPhenotypicFeature	deafness	D003638
1372	19353688	1119	1124	DiseaseOrPhenotypicFeature	AUNA1	C563790
1373	19353688	1151	1156	GeneOrGeneProduct	PCDH9	5101
1374	19353688	1241	1246	DiseaseOrPhenotypicFeature	AUNA1	C563790
1375	19353688	1312	1319	OrganismTaxon	patient	9606
1376	19353688	1360	1365	DiseaseOrPhenotypicFeature	AUNA1	C563790
1377	19353688	1366	1374	DiseaseOrPhenotypicFeature	deafness	D003638
1378	19353688	1413	1421	DiseaseOrPhenotypicFeature	deafness	D003638
1379	19353688	1462	1470	DiseaseOrPhenotypicFeature	deafness	D003638
1380	19353688	1499	1504	GeneOrGeneProduct	PCHD9	5101
1381	19521089	0	21	GeneOrGeneProduct	Serotonin transporter	6532
1382	19521089	47	55	GeneOrGeneProduct	5-HTTLPR	6532
1383	19521089	87	106	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
1384	19521089	117	136	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
1385	19521089	138	140	DiseaseOrPhenotypicFeature	PD	D010300
1386	19521089	147	173	DiseaseOrPhenotypicFeature	neurodegenerative disorder	D019636
1387	19521089	182	199	DiseaseOrPhenotypicFeature	muscular rigidity	D009127
1388	19521089	201	215	DiseaseOrPhenotypicFeature	resting tremor	D014202
1389	19521089	220	232	DiseaseOrPhenotypicFeature	bradykinesia	D018476
1390	19521089	282	284	DiseaseOrPhenotypicFeature	PD	D010300
1391	19521089	321	342	GeneOrGeneProduct	serotonin transporter	6532
1392	19521089	349	355	GeneOrGeneProduct	SLC6A4	6532
1393	19521089	376	384	GeneOrGeneProduct	5-HTTLPR	6532
1394	19521089	403	461	SequenceVariant	insertion/deletion (long allele-L/short allele-S) of 43 bp	c|INDEL||43
1395	19521089	469	475	GeneOrGeneProduct	SLC6A4	6532
1396	19521089	497	503	GeneOrGeneProduct	SLC6A4	6532
1397	19521089	544	551	SequenceVariant	rs25531	rs25531
1398	19521089	552	557	SequenceVariant	A-->G	rs25531
1399	19521089	621	623	DiseaseOrPhenotypicFeature	PD	D010300
1400	19521089	667	675	GeneOrGeneProduct	5-HTTLPR	6532
1401	19521089	701	703	DiseaseOrPhenotypicFeature	PD	D010300
1402	19521089	771	778	SequenceVariant	rs25531	rs25531
1403	19521089	797	805	GeneOrGeneProduct	5-HTTLPR	6532
1404	19521089	806	813	SequenceVariant	rs25531	rs25531
1405	19521089	845	847	DiseaseOrPhenotypicFeature	PD	D010300
1406	19521089	876	884	GeneOrGeneProduct	5-HTTLPR	6532
1407	19521089	916	922	GeneOrGeneProduct	SLC6A4	6532
1408	19521089	963	965	DiseaseOrPhenotypicFeature	PD	D010300
1409	19592582	0	12	GeneOrGeneProduct	Matriptase-2	164656
1410	19592582	26	30	ChemicalEntity	iron	D007501
1411	19592582	42	64	DiseaseOrPhenotypicFeature	iron deficiency anemia	D018798
1412	19592582	65	73	OrganismTaxon	patients	9606
1413	19592582	167	179	GeneOrGeneProduct	matriptase-2	164656
1414	19592582	204	210	OrganismTaxon	humans	9606
1415	19592582	234	272	DiseaseOrPhenotypicFeature	iron-refractory iron deficiency anemia	C562385
1416	19592582	274	279	DiseaseOrPhenotypicFeature	IRIDA	C562385
1417	19592582	297	305	GeneOrGeneProduct	hepcidin	57817
1418	19592582	375	387	GeneOrGeneProduct	matriptase-2	164656
1419	19592582	389	396	GeneOrGeneProduct	TMPRSS6	164656
1420	19592582	443	448	DiseaseOrPhenotypicFeature	IRIDA	C562385
1421	19592582	498	504	SequenceVariant	P686fs	p|FS|P|686||
1422	19592582	520	558	SequenceVariant	insertion of the four nucleotides CCCC	c|INS||CCCC
1423	19592582	571	587	SequenceVariant	2172_2173insCCCC	c|INS|2172_2173|CCCC
1424	19592582	715	723	SequenceVariant	c.467C>A	c|SUB|C|467|A
1425	19592582	728	736	SequenceVariant	c.468C>T	c|SUB|C|468|T
1426	19592582	781	786	SequenceVariant	A118D	p|SUB|A|118|D
1427	19592582	841	853	GeneOrGeneProduct	matriptase-2	164656
1428	19592582	891	903	GeneOrGeneProduct	matriptase-2	164656
1429	19592582	972	980	GeneOrGeneProduct	hepcidin	57817
1430	19592582	1025	1030	SequenceVariant	A118D	p|SUB|A|118|D
1431	19592582	1111	1123	GeneOrGeneProduct	matriptase-2	164656
1432	19592582	1186	1193	GeneOrGeneProduct	TMPRSS6	164656
1433	19592582	1220	1225	DiseaseOrPhenotypicFeature	IRIDA	C562385
1434	19592582	1382	1394	GeneOrGeneProduct	matriptase-2	164656
1435	19592582	1402	1417	DiseaseOrPhenotypicFeature	iron deficiency	D018798
1436	19642243	0	19	DiseaseOrPhenotypicFeature	Acute renal failure	D058186
1437	19642243	23	31	OrganismTaxon	patients	9606
1438	19642243	37	41	DiseaseOrPhenotypicFeature	AIDS	D000163
1439	19642243	45	54	ChemicalEntity	tenofovir	D000068698
1440	19642243	81	91	ChemicalEntity	vancomycin	D014640
1441	19642243	103	116	DiseaseOrPhenotypicFeature	osteomyelitis	D010019
1442	19642243	118	131	DiseaseOrPhenotypicFeature	Renal failure	D051437
1443	19642243	170	180	ChemicalEntity	vancomycin	D014640
1444	19642243	194	202	OrganismTaxon	patients	9606
1445	19642243	222	251	ChemicalEntity	tenofovir disoproxil fumarate	D000068698
1446	19642243	290	299	ChemicalEntity	Tenofovir	D000068698
1447	19642243	342	358	DiseaseOrPhenotypicFeature	Fanconi syndrome	D005198
1448	19642243	363	382	DiseaseOrPhenotypicFeature	renal insufficiency	D051437
1449	19642243	436	446	ChemicalEntity	Vancomycin	D014640
1450	19642243	447	461	DiseaseOrPhenotypicFeature	nephrotoxicity	D007674
1451	19642243	520	531	DiseaseOrPhenotypicFeature	nephrotoxic	D007674
1452	19642243	571	580	ChemicalEntity	tenofovir	D000068698
1453	19642243	603	616	DiseaseOrPhenotypicFeature	renal failure	D051437
1454	19642243	652	662	ChemicalEntity	vancomycin	D014640
1455	19696792	34	39	GeneOrGeneProduct	ABCG2	9429
1456	19696792	59	69	ChemicalEntity	irinotecan	D000077146
1457	19696792	85	101	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1458	19696792	103	113	ChemicalEntity	Irinotecan	D000077146
1459	19696792	175	202	DiseaseOrPhenotypicFeature	colorectal and lung cancers	D008175,D015179
1460	19696792	221	231	DiseaseOrPhenotypicFeature	toxicities	D064420
1461	19696792	247	263	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1462	19696792	268	276	DiseaseOrPhenotypicFeature	diarrhea	D003967
1463	19696792	353	363	ChemicalEntity	irinotecan	D000077146
1464	19696792	379	395	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1465	19696792	437	445	OrganismTaxon	patients	9606
1466	19696792	467	483	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1467	19696792	491	499	OrganismTaxon	patients	9606
1468	19696792	524	532	DiseaseOrPhenotypicFeature	toxicity	D064420
1469	19696792	650	660	ChemicalEntity	irinotecan	D000077146
1470	19696792	744	760	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1471	19696792	882	891	SequenceVariant	rs2622604	rs2622604
1472	19696792	896	901	GeneOrGeneProduct	ABCG2	9429
1473	19696792	998	1014	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1474	19696792	1182	1187	GeneOrGeneProduct	ABCG2	9429
1475	19696792	1282	1292	ChemicalEntity	irinotecan	D000077146
1476	19696792	1312	1328	DiseaseOrPhenotypicFeature	myelosuppression	D001855
1477	19728177	10	21	DiseaseOrPhenotypicFeature	hypothermia	D007036
1478	19728177	50	64	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1479	19728177	69	94	DiseaseOrPhenotypicFeature	intracranial hypertension	D019586
1480	19728177	111	136	DiseaseOrPhenotypicFeature	fulminant hepatic failure	D017114
1481	19728177	196	204	OrganismTaxon	patients	9606
1482	19728177	210	224	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1483	19728177	238	263	DiseaseOrPhenotypicFeature	fulminant hepatic failure	D017114
1484	19728177	265	268	DiseaseOrPhenotypicFeature	FHF	D017114
1485	19728177	312	323	DiseaseOrPhenotypicFeature	hypothermia	D007036
1486	19728177	456	459	DiseaseOrPhenotypicFeature	FHF	D017114
1487	19728177	465	478	ChemicalEntity	acetaminophen	D000082
1488	19728177	493	507	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1489	19728177	522	529	OrganismTaxon	patient	9606
1490	19728177	600	608	DiseaseOrPhenotypicFeature	toxicity	D064420
1491	19728177	614	627	ChemicalEntity	acetaminophen	D000082
1492	19728177	672	679	OrganismTaxon	patient	9606
1493	19728177	684	693	DiseaseOrPhenotypicFeature	depressed	D003866
1494	19728177	782	785	DiseaseOrPhenotypicFeature	FHF	D017114
1495	19728177	791	804	ChemicalEntity	acetaminophen	D000082
1496	19728177	809	823	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1497	19728177	829	836	OrganismTaxon	patient	9606
1498	19728177	876	892	DiseaseOrPhenotypicFeature	hyperventilation	D006985
1499	19728177	917	926	DiseaseOrPhenotypicFeature	paralysis	D010243
1500	19728177	1035	1046	DiseaseOrPhenotypicFeature	hypothermia	D007036
1501	19728177	1094	1101	OrganismTaxon	patient	9606
1502	19728177	1124	1138	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1503	19728177	1143	1168	DiseaseOrPhenotypicFeature	intracranial hypertension	D019586
1504	19728177	1264	1272	OrganismTaxon	patients	9606
1505	19728177	1278	1281	DiseaseOrPhenotypicFeature	FHF	D017114
1506	19728177	1286	1300	DiseaseOrPhenotypicFeature	cerebral edema	D001929
1507	19728177	1306	1319	ChemicalEntity	acetaminophen	D000082
1508	19728177	1352	1363	DiseaseOrPhenotypicFeature	hypothermia	D007036
1509	19728177	1486	1497	DiseaseOrPhenotypicFeature	hypothermia	D007036
1510	19728177	1501	1509	OrganismTaxon	patients	9606
1511	19811499	37	64	GeneOrGeneProduct	tumor necrosis factor-alpha	21926,7124
1512	19811499	66	87	GeneOrGeneProduct	nuclear factor-kappaB	18033,4790
1513	19811499	93	121	GeneOrGeneProduct	bone morphogenetic protein-2	12156,650
1514	19811499	139	149	DiseaseOrPhenotypicFeature	metastasis	D009362
1515	19811499	170	185	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1516	19811499	234	242	CellLine	MC3T3-E1	10090
1517	19811499	303	334	DiseaseOrPhenotypicFeature	prostate cancer (PC) metastasis	D009362,D011471
1518	19811499	404	453	GeneOrGeneProduct	phosphoinositide 3-kinase (PI3K)/protein kinase B	207
1519	19811499	455	458	GeneOrGeneProduct	Akt	207
1520	19811499	514	548	GeneOrGeneProduct	bone morphogenetic protein (BMP)-2	650
1521	19811499	562	588	GeneOrGeneProduct	nuclear factor (NF)-kappaB	4790
1522	19811499	608	623	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1523	19811499	673	682	GeneOrGeneProduct	NF-kappaB	4790
1524	19811499	717	722	OrganismTaxon	human	9606
1525	19811499	723	756	GeneOrGeneProduct	tumor necrosis factor (TNF)-alpha	7124
1526	19811499	789	792	GeneOrGeneProduct	p65	5970
1527	19811499	875	879	CellLine	PC-3	9606
1528	19811499	884	889	CellLine	C4-2B	9606
1529	19811499	899	904	CellLine	LNCaP	9606
1530	19811499	999	1010	GeneOrGeneProduct	osteopontin	6696
1531	19811499	1012	1023	GeneOrGeneProduct	osteocalcin	632
1532	19811499	1029	1041	GeneOrGeneProduct	collagen IA1	1277
1533	19811499	1057	1059	DiseaseOrPhenotypicFeature	PC	D011471
1534	19811499	1108	1110	DiseaseOrPhenotypicFeature	PC	D011471
1535	19811499	1125	1130	GeneOrGeneProduct	BMP-4	652
1536	19811499	1132	1137	GeneOrGeneProduct	BMP-2	650
1537	19811499	1182	1187	CellLine	C4-2B	9606
1538	19811499	1206	1211	CellLine	LNCaP	9606
1539	19811499	1254	1260	GeneOrGeneProduct	Noggin	9241
1540	19811499	1275	1280	GeneOrGeneProduct	BMP-2	650
1541	19811499	1290	1299	GeneOrGeneProduct	TNF-alpha	7124
1542	19811499	1320	1325	CellLine	C4-2B	9606
1543	19811499	1337	1346	GeneOrGeneProduct	NF-kappaB	4790
1544	19811499	1366	1375	GeneOrGeneProduct	TNF-alpha	7124
1545	19811499	1405	1414	GeneOrGeneProduct	TNF-alpha	7124
1546	19811499	1426	1431	CellLine	C4-2B	9606
1547	19811499	1450	1455	GeneOrGeneProduct	BMP-2	12156
1548	19811499	1460	1463	GeneOrGeneProduct	BMP	12156
1549	19811499	1474	1478	GeneOrGeneProduct	Smad	17127
1550	19811499	1505	1543	GeneOrGeneProduct	receptor activator of NF-kappaB ligand	21943
1551	19811499	1559	1568	CellLine	RAW 264.7	10090
1552	19811499	1738	1747	GeneOrGeneProduct	TNF-alpha	7124
1553	19811499	1761	1765	GeneOrGeneProduct	BMP2	650
1554	19811499	1777	1782	CellLine	C4-2B	9606
1555	19811499	1824	1832	CellLine	MC3T3-E1	10090
1556	19811499	1855	1860	GeneOrGeneProduct	BMP-2	12156
1557	19811499	1875	1884	GeneOrGeneProduct	NF-kappaB	4790
1558	19811499	2082	2084	DiseaseOrPhenotypicFeature	PC	D011471
1559	19918264	0	5	GeneOrGeneProduct	FGFR4	2264
1560	19918264	6	15	SequenceVariant	Gly388Arg	rs351855
1561	19918264	33	48	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1562	19918264	66	69	OrganismTaxon	men	9606
1563	19918264	71	106	GeneOrGeneProduct	Fibroblast growth factor receptor 4	2264
1564	19918264	108	113	GeneOrGeneProduct	FGFR4	2264
1565	19918264	132	158	GeneOrGeneProduct	fibroblast growth receptor	2264
1566	19918264	318	323	GeneOrGeneProduct	FGFR4	2264
1567	19918264	375	408	SequenceVariant	glycine (Gly) with arginine (Arg)	rs351855
1568	19918264	477	492	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1569	19918264	493	501	OrganismTaxon	patients	9606
1570	19918264	551	566	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1571	19918264	567	575	OrganismTaxon	patients	9606
1572	19918264	581	584	DiseaseOrPhenotypicFeature	BPH	D011470
1573	19918264	585	593	OrganismTaxon	patients	9606
1574	19918264	711	716	GeneOrGeneProduct	FGFR4	2264
1575	19918264	840	855	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1576	19918264	944	950	DiseaseOrPhenotypicFeature	cancer	D009369
1577	19918264	987	990	DiseaseOrPhenotypicFeature	BPH	D011470
1578	19918264	1067	1073	DiseaseOrPhenotypicFeature	cancer	D009369
1579	19918264	1078	1081	DiseaseOrPhenotypicFeature	BPH	D011470
1580	19918264	1082	1090	OrganismTaxon	patients	9606
1581	19918264	1107	1113	DiseaseOrPhenotypicFeature	cancer	D009369
1582	19918264	1179	1190	SequenceVariant	Gly(388)Arg	rs351855
1583	19918264	1194	1199	GeneOrGeneProduct	FGFR4	2264
1584	19918264	1241	1256	DiseaseOrPhenotypicFeature	prostate cancer	D011471
1585	19918264	1269	1272	OrganismTaxon	men	9606
1586	19923525	0	10	ChemicalEntity	Nimodipine	D009553
1587	19923525	20	37	DiseaseOrPhenotypicFeature	memory impairment	D008569
1588	19923525	48	61	ChemicalEntity	nitroglycerin	D005996
1589	19923525	70	81	DiseaseOrPhenotypicFeature	hypotension	D007022
1590	19923525	91	95	OrganismTaxon	mice	10090
1591	19923525	109	120	DiseaseOrPhenotypicFeature	Hypotension	D007022
1592	19923525	212	233	DiseaseOrPhenotypicFeature	cognitive dysfunction	D003072
1593	19923525	265	275	ChemicalEntity	nimodipine	D009553
1594	19923525	277	281	ChemicalEntity	NIMO	D009553
1595	19923525	312	325	ChemicalEntity	nitroglycerin	D005996
1596	19923525	327	330	ChemicalEntity	NTG	D005996
1597	19923525	340	351	DiseaseOrPhenotypicFeature	hypotension	D007022
1598	19923525	712	716	OrganismTaxon	mice	10090
1599	19923525	790	793	ChemicalEntity	NTG	D005996
1600	19923525	825	828	ChemicalEntity	NTG	D005996
1601	19923525	852	855	ChemicalEntity	NTG	D005996
1602	19923525	860	864	ChemicalEntity	NIMO	D009553
1603	19923525	885	889	ChemicalEntity	NIMO	D009553
1604	19923525	911	922	DiseaseOrPhenotypicFeature	hypotension	D007022
1605	19923525	1120	1124	OrganismTaxon	Mice	10090
1606	19923525	1138	1149	DiseaseOrPhenotypicFeature	hypotensive	D007022
1607	19923525	1263	1266	ChemicalEntity	NTG	D005996
1608	19923525	1269	1273	ChemicalEntity	NIMO	D009553
1609	19923525	1286	1289	ChemicalEntity	NTG	D005996
1610	19923525	1508	1512	OrganismTaxon	mice	10090
1611	19923525	1567	1570	ChemicalEntity	NTG	D005996
1612	19923525	1583	1586	ChemicalEntity	NTG	D005996
1613	19923525	1589	1593	ChemicalEntity	NIMO	D009553
1614	19923525	1809	1813	OrganismTaxon	mice	10090
1615	19923525	1827	1831	ChemicalEntity	NIMO	D009553
1616	19923525	2042	2045	ChemicalEntity	NTG	D005996
1617	19923525	2117	2120	ChemicalEntity	NTG	D005996
1618	19923525	2123	2127	ChemicalEntity	NIMO	D009553
1619	19923525	2259	2262	ChemicalEntity	NTG	D005996
1620	19923525	2359	2363	OrganismTaxon	mice	10090
1621	19923525	2389	2400	DiseaseOrPhenotypicFeature	hypotension	D007022
1622	19923525	2416	2420	ChemicalEntity	NIMO	D009553
1623	19923525	2494	2497	ChemicalEntity	NTG	D005996
1624	19923525	2544	2555	DiseaseOrPhenotypicFeature	hypotension	D007022
1625	19923525	2580	2584	ChemicalEntity	NIMO	D009553
1626	19923525	2635	2642	ChemicalEntity	calcium	D002118
1627	19923525	2662	2673	DiseaseOrPhenotypicFeature	hypotension	D007022
1628	20105280	10	13	GeneOrGeneProduct	Ras	3265
1629	20105280	122	125	GeneOrGeneProduct	Ras	3265
1630	20105280	242	247	OrganismTaxon	human	9606
1631	20105280	248	255	DiseaseOrPhenotypicFeature	cancers	D009369
1632	20105280	257	262	DiseaseOrPhenotypicFeature	Tumor	D009369
1633	20105280	290	293	GeneOrGeneProduct	Ras	3265
1634	20105280	410	416	OrganismTaxon	murine	10090
1635	20105280	539	563	GeneOrGeneProduct	fibroblast growth factor	64654
1636	20105280	565	568	GeneOrGeneProduct	FGF	64654
1637	20105280	841	845	OrganismTaxon	mice	10090
1638	20105280	894	899	OrganismTaxon	human	9606
1639	20105280	900	905	GeneOrGeneProduct	H-Ras	3265
1640	20105280	944	947	GeneOrGeneProduct	Ras	3265
1641	20105280	1056	1072	GeneOrGeneProduct	cyclin D1 and D2	12443,12444
1642	20105280	1205	1208	GeneOrGeneProduct	cdk	12575
1643	20105280	1220	1227	GeneOrGeneProduct	p27Kip1	12576
1644	20105280	1232	1239	GeneOrGeneProduct	p57Kip2	12577
1645	20105280	1264	1267	GeneOrGeneProduct	Ras	3265
1646	20105280	1318	1322	GeneOrGeneProduct	Erk1	26417
1647	20105280	1327	1331	GeneOrGeneProduct	Erk2	26413
1648	20105280	1391	1397	GeneOrGeneProduct	Spry 1	24063
1649	20105280	1402	1408	GeneOrGeneProduct	Spry 2	24064
1650	20105280	1433	1436	GeneOrGeneProduct	Ras	3265
1651	20105280	1437	1440	GeneOrGeneProduct	Raf	109880
1652	20105280	1441	1444	GeneOrGeneProduct	Erk	26413,26417
1653	20105280	1593	1596	GeneOrGeneProduct	Ras	3265
1654	20105280	1609	1612	GeneOrGeneProduct	Ras	3265
1655	20105280	1701	1704	GeneOrGeneProduct	Ras	3265
1656	20105280	1755	1760	GeneOrGeneProduct	Prox1	19130
1657	20105280	1936	1946	GeneOrGeneProduct	Keratin 12	268482
1658	20105280	2015	2018	GeneOrGeneProduct	Ras	3265
1659	20105280	2093	2096	GeneOrGeneProduct	Ras	3265
1660	20195852	8	19	DiseaseOrPhenotypicFeature	nephropathy	D007674
1661	20195852	50	64	ChemicalEntity	contrast media	D003287
1662	20195852	169	183	ChemicalEntity	contrast media	D003287
1663	20195852	192	203	DiseaseOrPhenotypicFeature	nephropathy	D007674
1664	20195852	205	208	DiseaseOrPhenotypicFeature	CIN	D007674
1665	20195852	481	484	DiseaseOrPhenotypicFeature	CIN	D007674
1666	20195852	502	516	ChemicalEntity	contrast media	D003287
1667	20195852	518	520	ChemicalEntity	CM	D003287
1668	20195852	523	532	ChemicalEntity	iopromide	C038192
1669	20195852	537	544	ChemicalEntity	iohexol	D007472
1670	20195852	669	671	ChemicalEntity	CM	D003287
1671	20195852	692	700	DiseaseOrPhenotypicFeature	cyanosis	D003490
1672	20195852	761	770	ChemicalEntity	iopromide	C038192
1673	20195852	792	799	ChemicalEntity	iohexol	D007472
1674	20195852	825	831	ChemicalEntity	sodium	D012964
1675	20195852	833	835	ChemicalEntity	Na	D012964
1676	20195852	838	847	ChemicalEntity	potassium	D011188
1677	20195852	849	850	ChemicalEntity	K	D011188
1678	20195852	857	867	ChemicalEntity	creatinine	D003404
1679	20195852	869	871	ChemicalEntity	Cr	D003404
1680	20195852	989	991	ChemicalEntity	CM	D003287
1681	20195852	1015	1017	ChemicalEntity	Na	D012964
1682	20195852	1022	1024	ChemicalEntity	Cr	D003404
1683	20195852	1074	1087	DiseaseOrPhenotypicFeature	renal failure	D051437
1684	20195852	1089	1109	DiseaseOrPhenotypicFeature	Injury to the kidney	D058186
1685	20195852	1111	1137	DiseaseOrPhenotypicFeature	Failure of kidney function	D051437
1686	20195852	1139	1162	DiseaseOrPhenotypicFeature	Loss of kidney function	D051437
1687	20195852	1178	1190	DiseaseOrPhenotypicFeature	renal damage	D007674
1688	20195852	1228	1231	DiseaseOrPhenotypicFeature	CIN	D007674
1689	20195852	1301	1304	DiseaseOrPhenotypicFeature	CIN	D007674
1690	20195852	1389	1401	DiseaseOrPhenotypicFeature	renal injury	D058186
1691	20195852	1457	1469	DiseaseOrPhenotypicFeature	renal injury	D058186
1692	20195852	1506	1509	DiseaseOrPhenotypicFeature	CIN	D007674
1693	20195852	1561	1563	ChemicalEntity	CM	D003287
1694	20195852	1688	1691	DiseaseOrPhenotypicFeature	CIN	D007674
1695	20195852	1728	1730	ChemicalEntity	CM	D003287
1696	20195852	1771	1774	DiseaseOrPhenotypicFeature	CIN	D007674
1697	20195852	1791	1816	DiseaseOrPhenotypicFeature	congenital heart diseases	D006331
1698	20195852	1945	1948	DiseaseOrPhenotypicFeature	CIN	D007674
1699	20195852	2049	2051	ChemicalEntity	CM	D003287
1700	20195852	2076	2084	DiseaseOrPhenotypicFeature	cyanosis	D003490
1701	20195852	2099	2102	DiseaseOrPhenotypicFeature	CIN	D007674
1702	20520283	23	32	ChemicalEntity	asenapine	C522667
1703	20520283	51	62	ChemicalEntity	haloperidol	D006220
1704	20520283	119	132	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1705	20520283	134	143	ChemicalEntity	Asenapine	C522667
1706	20520283	226	239	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1707	20520283	246	251	DiseaseOrPhenotypicFeature	manic	D001714
1708	20520283	286	304	DiseaseOrPhenotypicFeature	bipolar I disorder	D001714
1709	20520283	321	330	DiseaseOrPhenotypicFeature	psychotic	D011618
1710	20520283	397	410	DiseaseOrPhenotypicFeature	schizophrenia	D012559
1711	20520283	463	472	ChemicalEntity	asenapine	C522667
1712	20520283	500	509	ChemicalEntity	asenapine	C522667
1713	20520283	536	547	ChemicalEntity	haloperidol	D006220
1714	20520283	761	770	ChemicalEntity	asenapine	C522667
1715	20520283	795	806	ChemicalEntity	haloperidol	D006220
1716	20520283	950	959	ChemicalEntity	asenapine	C522667
1717	20520283	1015	1026	ChemicalEntity	haloperidol	D006220
1718	20520283	1194	1203	ChemicalEntity	asenapine	C522667
1719	20520283	1423	1432	ChemicalEntity	asenapine	C522667
1720	20520283	1453	1464	ChemicalEntity	haloperidol	D006220
1721	20520283	1500	1523	DiseaseOrPhenotypicFeature	Extrapyramidal symptoms	D001480
1722	20520283	1585	1594	ChemicalEntity	asenapine	C522667
1723	20520283	1615	1626	ChemicalEntity	haloperidol	D006220
1724	20520283	1810	1819	ChemicalEntity	asenapine	C522667
1725	20520283	1824	1835	ChemicalEntity	haloperidol	D006220
1726	20520283	1884	1907	DiseaseOrPhenotypicFeature	extrapyramidal symptoms	D001480
1727	20528871	21	31	ChemicalEntity	nelarabine	C104457
1728	20528871	33	42	ChemicalEntity	etoposide	D005047
1729	20528871	48	64	ChemicalEntity	cyclophosphamide	D003520
1730	20528871	99	142	DiseaseOrPhenotypicFeature	T-cell lymphoblastic leukaemia and lymphoma	D015458|D016399
1731	20528871	168	178	ChemicalEntity	nelarabine	C104457
1732	20528871	180	184	ChemicalEntity	AraG	C104457
1733	20528871	198	207	ChemicalEntity	etoposide	D005047
1734	20528871	209	211	ChemicalEntity	VP	D005047
1735	20528871	217	233	ChemicalEntity	cyclophosphamide	D003520
1736	20528871	235	238	ChemicalEntity	CPM	D003520
1737	20528871	356	384	DiseaseOrPhenotypicFeature	T-cell leukaemia or lymphoma	D015458|D016399
1738	20528871	435	439	ChemicalEntity	AraG	C104457
1739	20528871	481	491	DiseaseOrPhenotypicFeature	neuropathy	D009422
1740	20528871	496	516	DiseaseOrPhenotypicFeature	musculoskeletal pain	D059352
1741	20528871	518	541	DiseaseOrPhenotypicFeature	Haematological toxicity	D006402
1742	20528871	579	583	ChemicalEntity	AraG	C104457
1743	20528871	827	831	ChemicalEntity	AraG	C104457
1744	20528871	832	834	ChemicalEntity	VP	D005047
1745	20528871	835	838	ChemicalEntity	CPM	D003520
1746	20528871	885	889	ChemicalEntity	AraG	C104457
1747	20528871	927	936	ChemicalEntity	etoposide	D005047
1748	20528871	941	957	ChemicalEntity	cyclophosphamide	D003520
1749	20528871	968	989	DiseaseOrPhenotypicFeature	neurological toxicity	D009422
1750	20648600	18	28	ChemicalEntity	lamivudine	D019259
1751	20648600	63	71	OrganismTaxon	patients	9606
1752	20648600	72	108	DiseaseOrPhenotypicFeature	co-infected with HIV and hepatitis B	D006509,D015658
1753	20648600	173	183	ChemicalEntity	lamivudine	D019259
1754	20648600	185	188	ChemicalEntity	LAM	D019259
1755	20648600	194	203	ChemicalEntity	tenofovir	D000068698
1756	20648600	205	208	ChemicalEntity	TDF	D000068698
1757	20648600	245	253	OrganismTaxon	patients	9606
1758	20648600	254	296	DiseaseOrPhenotypicFeature	co-infected with HIV and hepatitis B virus	D006509,D015658
1759	20648600	298	301	OrganismTaxon	HBV	10407
1760	20648600	335	343	OrganismTaxon	patients	9606
1761	20648600	349	352	OrganismTaxon	HIV	11676
1762	20648600	368	376	OrganismTaxon	Patients	9606
1763	20648600	404	409	ChemicalEntity	HBsAg	D006514
1764	20648600	433	436	OrganismTaxon	HBV	10407
1765	20648600	509	512	OrganismTaxon	HBV	10407
1766	20648600	590	597	GeneOrGeneProduct	precore	944568
1767	20648600	654	662	OrganismTaxon	patients	9606
1768	20648600	671	680	DiseaseOrPhenotypicFeature	infection	D007239
1769	20648600	718	721	OrganismTaxon	HBV	10407
1770	20648600	744	752	OrganismTaxon	patients	9606
1771	20648600	840	848	OrganismTaxon	patients	9606
1772	20648600	867	870	ChemicalEntity	LAM	D019259
1773	20648600	879	887	OrganismTaxon	patients	9606
1774	20648600	906	909	ChemicalEntity	LAM	D019259
1775	20648600	915	918	ChemicalEntity	TDF	D000068698
1776	20648600	946	949	ChemicalEntity	LAM	D019259
1777	20648600	954	957	ChemicalEntity	TDF	D000068698
1778	20648600	987	990	ChemicalEntity	LAM	D019259
1779	20648600	1019	1024	SequenceVariant	L180M	p|SUB|L|180|M
1780	20648600	1029	1034	SequenceVariant	M204V	p|SUB|M|204|V
1781	20648600	1072	1080	OrganismTaxon	patients	9606
1782	20648600	1086	1093	DiseaseOrPhenotypicFeature	viremia	D014766
1783	20648600	1130	1135	SequenceVariant	V173L	p|SUB|V|173|L
1784	20648600	1163	1171	OrganismTaxon	patients	9606
1785	20648600	1179	1187	OrganismTaxon	patients	9606
1786	20648600	1204	1214	GeneOrGeneProduct	polymerase	944565
1787	20648600	1239	1244	SequenceVariant	V173L	p|SUB|V|173|L
1788	20648600	1249	1254	SequenceVariant	L180M	p|SUB|L|180|M
1789	20648600	1259	1264	SequenceVariant	M204V	p|SUB|M|204|V
1790	20648600	1296	1304	GeneOrGeneProduct	envelope	944569
1791	20648600	1312	1317	SequenceVariant	E164D	p|SUB|E|164|D
1792	20648600	1321	1326	SequenceVariant	I195M	p|SUB|I|195|M
1793	20648600	1358	1364	SequenceVariant	A1762T	g|SUB|A|1762|T
1794	20648600	1366	1372	SequenceVariant	G1764A	g|SUB|G|1764|A
1795	20648600	1385	1392	GeneOrGeneProduct	precore	944568
1796	20648600	1401	1407	SequenceVariant	G1896A	g|SUB|G|1896|A
1797	20648600	1409	1415	SequenceVariant	G1899A	g|SUB|G|1899|A
1798	20648600	1446	1449	ChemicalEntity	TDF	D000068698
1799	20648600	1520	1523	ChemicalEntity	LAM	D019259
1800	20648600	1590	1593	OrganismTaxon	HBV	10407
1801	20648600	1682	1685	ChemicalEntity	TDF	D000068698
1802	20648600	1740	1743	ChemicalEntity	TDF	D000068698
1803	20683499	18	51	ChemicalEntity	constituents of Crocus sativus L.	D010936
1804	20683499	53	59	ChemicalEntity	crocin	C029036
1805	20683499	63	75	ChemicalEntity	streptozocin	D013311
1806	20683499	102	121	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
1807	20683499	130	134	OrganismTaxon	rats	10116
1808	20683499	181	192	ChemicalEntity	carotenoids	D002338
1809	20683499	194	201	ChemicalEntity	crocins	C029036
1810	20683499	240	265	ChemicalEntity	Crocus sativus L. extract	D010936
1811	20683499	354	361	ChemicalEntity	crocins	C029036
1812	20683499	374	393	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
1813	20683499	435	447	ChemicalEntity	streptozocin	D013311
1814	20683499	449	452	ChemicalEntity	STZ	D013311
1815	20683499	462	466	OrganismTaxon	rats	10116
1816	20683499	512	516	OrganismTaxon	rats	10116
1817	20683499	579	586	ChemicalEntity	crocins	C029036
1818	20683499	609	612	ChemicalEntity	STZ	D013311
1819	20683499	623	626	ChemicalEntity	STZ	D013311
1820	20683499	629	636	ChemicalEntity	crocins	C029036
1821	20683499	666	685	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
1822	20683499	694	698	OrganismTaxon	rats	10116
1823	20683499	718	721	ChemicalEntity	STZ	D013311
1824	20683499	789	792	ChemicalEntity	STZ	D013311
1825	20683499	826	829	ChemicalEntity	STZ	D013311
1826	20683499	832	838	ChemicalEntity	crocin	C029036
1827	20683499	854	860	ChemicalEntity	crocin	C029036
1828	20683499	975	981	ChemicalEntity	crocin	C029036
1829	20683499	1210	1216	ChemicalEntity	crocin	C029036
1830	20683499	1236	1239	ChemicalEntity	STZ	D013311
1831	20683499	1249	1253	OrganismTaxon	rats	10116
1832	20683499	1330	1333	ChemicalEntity	STZ	D013311
1833	20683499	1343	1347	OrganismTaxon	rats	10116
1834	20683499	1362	1368	ChemicalEntity	crocin	C029036
1835	20683499	1422	1452	DiseaseOrPhenotypicFeature	learning and memory impairment	D007859,D008569
1836	20683499	1464	1467	ChemicalEntity	STZ	D013311
1837	20683499	1580	1586	ChemicalEntity	crocin	C029036
1838	20683499	1618	1636	DiseaseOrPhenotypicFeature	cognitive deficits	D003072
1839	20683499	1647	1650	ChemicalEntity	STZ	D013311
1840	20683499	1658	1662	OrganismTaxon	rats	10116
1841	20683499	1701	1727	DiseaseOrPhenotypicFeature	neurodegenerative diseases	D019636
1842	20683499	1736	1755	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
1843	20806042	20	24	GeneOrGeneProduct	GJA8	2703
1844	20806042	44	73	DiseaseOrPhenotypicFeature	cataract-microcornea syndrome	C538287
1845	20806042	133	147	DiseaseOrPhenotypicFeature	genetic defect	D030342
1846	20806042	229	258	DiseaseOrPhenotypicFeature	cataract-microcornea syndrome	C538287
1847	20806042	260	264	DiseaseOrPhenotypicFeature	CCMC	C538287
1848	20806042	647	657	SequenceVariant	c.592C-->T	c|SUB|C|592|T
1849	20806042	675	704	GeneOrGeneProduct	gap junction protein, alpha 8	2703
1850	20806042	706	710	GeneOrGeneProduct	GJA8	2703
1851	20806042	821	856	SequenceVariant	arginine to tryptophan at codon 198	p|SUB|R|198|W
1852	20806042	858	865	SequenceVariant	p.R198W	p|SUB|R|198|W
1853	20806042	1071	1078	SequenceVariant	p.R198W	p|SUB|R|198|W
1854	20806042	1091	1095	GeneOrGeneProduct	GJA8	2703
1855	20806042	1101	1105	DiseaseOrPhenotypicFeature	CCMC	C538287
1856	20806042	1151	1155	GeneOrGeneProduct	GJA8	2703
1857	20806042	1186	1194	DiseaseOrPhenotypicFeature	cataract	D002386
1858	20806042	1199	1210	DiseaseOrPhenotypicFeature	microcornea	D005124
1859	21496008	56	83	GeneOrGeneProduct	Aristaless-related homeobox	170302
1860	21496008	85	88	GeneOrGeneProduct	ARX	170302
1861	21496008	96	99	GeneOrGeneProduct	ARX	170302
1862	21496008	138	143	OrganismTaxon	human	9606
1863	21496008	175	206	DiseaseOrPhenotypicFeature	brain and genital malformations	D000013
1864	21496008	224	247	DiseaseOrPhenotypicFeature	intellectual disability	D008607
1865	21496008	249	251	DiseaseOrPhenotypicFeature	ID	D008607
1866	21496008	254	257	GeneOrGeneProduct	ARX	170302
1867	21496008	324	335	ChemicalEntity	polyalanine	C019529
1868	21496008	337	339	ChemicalEntity	pA	C019529
1869	21496008	474	476	DiseaseOrPhenotypicFeature	ID	D008607
1870	21496008	509	512	GeneOrGeneProduct	ARX	170302
1871	21496008	524	540	SequenceVariant	c.304ins(GCG)(7)	c|INS|304|GCG(7)
1872	21496008	563	575	SequenceVariant	c.429_452dup	c|DUP|429_452||
1873	21496008	577	584	SequenceVariant	dup24bp	c|DUP||24|
1874	21496008	660	663	GeneOrGeneProduct	ARX	170302
1875	21496008	847	850	GeneOrGeneProduct	ARX	170302
1876	21496008	971	978	SequenceVariant	dup24bp	c|DUP||24|
1877	21496008	1016	1023	SequenceVariant	dup24bp	c|DUP||24|
1878	21496008	1045	1052	SequenceVariant	dup27bp	c|DUP||27|
1879	21496008	1054	1061	SequenceVariant	dup33bp	c|DUP||33|
1880	21496008	1147	1156	SequenceVariant	c.1074G>T	c|SUB|G|1074|T
1881	21496008	1197	1200	GeneOrGeneProduct	ARX	170302
1882	21496008	1250	1258	OrganismTaxon	patients	9606
1883	21496008	1375	1378	GeneOrGeneProduct	ARX	170302
1884	21699520	0	5	GeneOrGeneProduct	PTCH1	5727
1885	21699520	110	115	OrganismTaxon	human	9606
1886	21699520	116	137	DiseaseOrPhenotypicFeature	basal cell carcinomas	D002280
1887	21699520	151	172	DiseaseOrPhenotypicFeature	Basal cell carcinomas	D002280
1888	21699520	174	178	DiseaseOrPhenotypicFeature	BCCs	D002280
1889	21699520	202	207	OrganismTaxon	human	9606
1890	21699520	208	214	DiseaseOrPhenotypicFeature	cancer	D009369
1891	21699520	291	306	DiseaseOrPhenotypicFeature	Gorlin syndrome	D001478
1892	21699520	317	353	DiseaseOrPhenotypicFeature	inherited autosomal dominant disease	D030342
1893	21699520	385	389	DiseaseOrPhenotypicFeature	BCCs	D002280
1894	21699520	400	413	DiseaseOrPhenotypicFeature	birth defects	D000013
1895	21699520	443	447	DiseaseOrPhenotypicFeature	BCCs	D002280
1896	21699520	485	490	DiseaseOrPhenotypicFeature	tumor	D009369
1897	21699520	507	512	GeneOrGeneProduct	PTCH1	5727
1898	21699520	572	577	GeneOrGeneProduct	PTCH2	8643
1899	21699520	665	669	DiseaseOrPhenotypicFeature	BCCs	D002280
1900	21699520	713	718	DiseaseOrPhenotypicFeature	tumor	D009369
1901	21699520	792	797	GeneOrGeneProduct	PTCH1	5727
1902	21699520	802	807	GeneOrGeneProduct	PTCH2	8643
1903	21699520	987	991	DiseaseOrPhenotypicFeature	BCCs	D002280
1904	21699520	1039	1042	DiseaseOrPhenotypicFeature	BCC	D002280
1905	21699520	1066	1075	SequenceVariant	g.2885G>C	g|SUB|G|2885|C
1906	21699520	1090	1095	GeneOrGeneProduct	PTCH1	5727
1907	21699520	1129	1136	SequenceVariant	p.R962T	p|SUB|R|962|T
1908	21699520	1207	1212	DiseaseOrPhenotypicFeature	tumor	D009369
1909	21699520	1226	1233	OrganismTaxon	patient	9606
1910	21699520	1239	1254	DiseaseOrPhenotypicFeature	Gorlin syndrome	D001478
1911	21699520	1275	1284	SequenceVariant	g.2839T>G	g|SUB|T|2839|G
1912	21699520	1329	1339	SequenceVariant	p.E947stop	p|SUB|E|947|X
1913	21699520	1379	1384	DiseaseOrPhenotypicFeature	tumor	D009369
1914	21699520	1403	1414	SequenceVariant	IVS9 + 217T	c|Allele|T|IVS9+217
1915	21699520	1430	1435	GeneOrGeneProduct	PTCH1	5727
1916	21699520	1472	1477	GeneOrGeneProduct	PTCH1	5727
1917	21699520	1575	1579	DiseaseOrPhenotypicFeature	BCCs	D002280
1918	21799811	22	29	SequenceVariant	677 C>T	rs1801133
1919	21799811	50	55	GeneOrGeneProduct	MTHFR	4524
1920	21799811	66	82	DiseaseOrPhenotypicFeature	male infertility	D007248
1921	21799811	149	184	GeneOrGeneProduct	Methylenetetrahydrofolate reductase	4524
1922	21799811	186	191	GeneOrGeneProduct	MTHFR	4524
1923	21799811	219	225	ChemicalEntity	folate	D005492
1924	21799811	230	240	ChemicalEntity	methionine	D008715
1925	21799811	349	354	GeneOrGeneProduct	MTHFR	4524
1926	21799811	360	366	SequenceVariant	677C>T	rs1801133
1927	21799811	938	944	SequenceVariant	677C>T	rs1801133
1928	21799811	961	977	DiseaseOrPhenotypicFeature	male infertility	D007248
1929	21799811	1639	1645	SequenceVariant	677C>T	rs1801133
1930	21799811	1664	1680	DiseaseOrPhenotypicFeature	male infertility	D007248
1931	21799811	1708	1714	SequenceVariant	677C>T	rs1801133
1932	21799811	1753	1769	DiseaseOrPhenotypicFeature	male infertility	D007248
1933	21799811	1869	1885	DiseaseOrPhenotypicFeature	male infertility	D007248
1934	21810259	0	5	OrganismTaxon	HIV-1	11676
1935	21810259	6	9	GeneOrGeneProduct	Tat	155871
1936	21810259	20	47	GeneOrGeneProduct	indoleamine 2,3 dioxygenase	15930
1937	21810259	51	57	OrganismTaxon	murine	10090
1938	21810259	102	138	GeneOrGeneProduct	p38 mitogen-activated protein kinase	26416
1939	21810259	212	222	ChemicalEntity	tryptophan	D014364
1940	21810259	240	267	GeneOrGeneProduct	indoleamine 2,3 dioxygenase	15930
1941	21810259	269	272	GeneOrGeneProduct	IDO	15930
1942	21810259	337	347	DiseaseOrPhenotypicFeature	depressive	D000275
1943	21810259	371	406	OrganismTaxon	human immunodeficiency virus type 1	11676
1944	21810259	408	413	OrganismTaxon	HIV-1	11676
1945	21810259	415	418	GeneOrGeneProduct	Tat	155871
1946	21810259	434	444	DiseaseOrPhenotypicFeature	depressive	D000275
1947	21810259	462	466	OrganismTaxon	mice	10090
1948	21810259	508	511	GeneOrGeneProduct	IDO	15930
1949	21810259	584	591	CellLine	C57BL/6	10090
1950	21810259	592	596	OrganismTaxon	mice	10090
1951	21810259	607	617	DiseaseOrPhenotypicFeature	Depressive	D000275
1952	21810259	635	643	CellLine	C57BL/6J	10090
1953	21810259	644	648	OrganismTaxon	mice	10090
1954	21810259	715	718	GeneOrGeneProduct	IDO	15930
1955	21810259	848	856	GeneOrGeneProduct	p38 MAPK	26416
1956	21810259	963	966	GeneOrGeneProduct	Tat	155871
1957	21810259	983	993	DiseaseOrPhenotypicFeature	depressive	D000275
1958	21810259	1048	1051	GeneOrGeneProduct	Tat	155871
1959	21810259	1097	1100	GeneOrGeneProduct	IDO	15930
1960	21810259	1188	1192	GeneOrGeneProduct	IFNg	15978
1961	21810259	1194	1197	GeneOrGeneProduct	Tat	155871
1962	21810259	1240	1244	GeneOrGeneProduct	TNFa	21926
1963	21810259	1249	1253	GeneOrGeneProduct	IL-6	16193
1964	21810259	1327	1369	GeneOrGeneProduct	inducible isoform of nitric oxide synthase	18126
1965	21810259	1371	1375	GeneOrGeneProduct	iNOS	18126
1966	21810259	1385	1406	GeneOrGeneProduct	serotonin transporter	15567
1967	21810259	1408	1412	GeneOrGeneProduct	SERT	15567
1968	21810259	1415	1418	GeneOrGeneProduct	Tat	155871
1969	21810259	1460	1464	GeneOrGeneProduct	IFNg	15978
1970	21810259	1495	1498	GeneOrGeneProduct	Tat	155871
1971	21810259	1507	1510	GeneOrGeneProduct	IDO	15930
1972	21810259	1555	1591	GeneOrGeneProduct	p38 mitogen-activated protein kinase	26416
1973	21810259	1593	1597	GeneOrGeneProduct	MAPK	26416
1974	21810259	1609	1618	ChemicalEntity	SB 202190	C090942
1975	21810259	1637	1640	GeneOrGeneProduct	Tat	155871
1976	21810259	1652	1661	ChemicalEntity	SB 202190	C090942
1977	21810259	1686	1689	GeneOrGeneProduct	IDO	15930
1978	21810259	1712	1715	GeneOrGeneProduct	Tat	155871
1979	21810259	1767	1770	GeneOrGeneProduct	Tat	155871
1980	21810259	1793	1797	GeneOrGeneProduct	TNFa	21926
1981	21810259	1799	1803	GeneOrGeneProduct	IL-6	16193
1982	21810259	1805	1809	GeneOrGeneProduct	iNOS	18126
1983	21810259	1814	1818	GeneOrGeneProduct	SERT	15567
1984	21810259	1858	1861	GeneOrGeneProduct	Tat	155871
1985	21810259	1870	1873	GeneOrGeneProduct	IDO	15930
1986	21810259	1892	1896	GeneOrGeneProduct	IFNg	15978
1987	21810259	1951	1959	GeneOrGeneProduct	p38 MAPK	26416
1988	21810259	1971	1974	GeneOrGeneProduct	IDO	3620
1989	21810259	1989	1997	GeneOrGeneProduct	p38 MAPK	26416
1990	21810259	2059	2079	DiseaseOrPhenotypicFeature	depressive disorders	D000275
1991	21810259	2083	2097	DiseaseOrPhenotypicFeature	HIV-1-infected	D015658
1992	21810259	2098	2106	OrganismTaxon	patients	9606
1993	21911891	0	38	GeneOrGeneProduct	Plasminogen activator inhibitor type 1	5054
1994	21911891	92	97	DiseaseOrPhenotypicFeature	obese	D009765
1995	21911891	107	115	OrganismTaxon	patients	9606
1996	21911891	121	154	DiseaseOrPhenotypicFeature	non-alcoholic fatty liver disease	D065626
1997	21911891	172	210	GeneOrGeneProduct	plasminogen activator inhibitor type-1	5054
1998	21911891	212	217	GeneOrGeneProduct	PAI-1	5054
1999	21911891	413	418	GeneOrGeneProduct	PAI-1	5054
2000	21911891	435	440	GeneOrGeneProduct	PAI-1	5054
2001	21911891	468	488	DiseaseOrPhenotypicFeature	hepatic fibrogenesis	D008107
2002	21911891	524	529	GeneOrGeneProduct	PAI-1	5054
2003	21911891	581	595	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
2004	21911891	610	643	DiseaseOrPhenotypicFeature	non-alcoholic fatty liver disease	D065626
2005	21911891	645	650	DiseaseOrPhenotypicFeature	NAFLD	D065626
2006	21911891	664	669	DiseaseOrPhenotypicFeature	obese	D009765
2007	21911891	670	678	OrganismTaxon	patients	9606
2008	21911891	727	732	DiseaseOrPhenotypicFeature	obese	D009765
2009	21911891	733	741	OrganismTaxon	patients	9606
2010	21911891	782	787	DiseaseOrPhenotypicFeature	obese	D009765
2011	21911891	891	896	GeneOrGeneProduct	PAI-1	5054
2012	21911891	1009	1022	ChemicalEntity	triglycerides	D014280
2013	21911891	1033	1045	DiseaseOrPhenotypicFeature	hypertension	D006973
2014	21911891	1050	1058	DiseaseOrPhenotypicFeature	diabetes	D003920
2015	21911891	1088	1093	DiseaseOrPhenotypicFeature	obese	D009765
2016	21911891	1094	1102	OrganismTaxon	patients	9606
2017	21911891	1133	1138	GeneOrGeneProduct	PAI-1	5054
2018	21911891	1164	1169	DiseaseOrPhenotypicFeature	obese	D009765
2019	21911891	1170	1178	OrganismTaxon	patients	9606
2020	21911891	1298	1303	GeneOrGeneProduct	PAI-1	5054
2021	21911891	1385	1390	GeneOrGeneProduct	PAI-1	5054
2022	21911891	1411	1416	DiseaseOrPhenotypicFeature	obese	D009765
2023	21911891	1417	1425	OrganismTaxon	patients	9606
2024	21911891	1431	1445	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
2025	21911891	1471	1479	OrganismTaxon	patients	9606
2026	21911891	1488	1502	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
2027	21911891	1527	1532	GeneOrGeneProduct	PAI-1	5054
2028	21911891	1586	1594	OrganismTaxon	patients	9606
2029	21911891	1611	1625	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
2030	21911891	1640	1644	DiseaseOrPhenotypicFeature	NASH	D065626
2031	21911891	1678	1683	DiseaseOrPhenotypicFeature	obese	D009765
2032	21911891	1684	1692	OrganismTaxon	patients	9606
2033	21911891	1717	1722	GeneOrGeneProduct	PAI-1	5054
2034	21911891	1749	1754	GeneOrGeneProduct	PAI-1	5054
2035	21911891	1799	1804	DiseaseOrPhenotypicFeature	obese	D009765
2036	21911891	1970	1975	GeneOrGeneProduct	PAI-1	5054
2037	21911891	2012	2026	DiseaseOrPhenotypicFeature	liver fibrosis	D008103
2038	21911891	2030	2035	DiseaseOrPhenotypicFeature	obese	D009765
2039	21911891	2036	2044	OrganismTaxon	patients	9606
2040	22048266	56	60	GeneOrGeneProduct	ETS2	2114
2041	22048266	65	69	GeneOrGeneProduct	SIM2	6493
2042	22048266	79	92	DiseaseOrPhenotypicFeature	Down syndrome	D004314
2043	22048266	182	195	DiseaseOrPhenotypicFeature	Down syndrome	D004314
2044	22048266	197	199	DiseaseOrPhenotypicFeature	DS	D004314
2045	22048266	341	343	DiseaseOrPhenotypicFeature	DS	D004314
2046	22048266	414	429	GeneOrGeneProduct	Single minded 2	6493
2047	22048266	431	435	GeneOrGeneProduct	SIM2	6493
2048	22048266	441	491	GeneOrGeneProduct	V-ets erythroblastosis virus E26 oncogene homolog2	2114
2049	22048266	493	497	GeneOrGeneProduct	ETS2	2114
2050	22048266	576	578	DiseaseOrPhenotypicFeature	DS	D004314
2051	22048266	624	626	DiseaseOrPhenotypicFeature	DS	D004314
2052	22048266	799	803	GeneOrGeneProduct	ETS2	2114
2053	22048266	804	812	SequenceVariant	rs461155	rs461155
2054	22048266	843	845	DiseaseOrPhenotypicFeature	DS	D004314
2055	22048266	880	884	GeneOrGeneProduct	SIM2	6493
2056	22048266	900	909	SequenceVariant	rs2073601	rs2073601
2057	22048266	910	919	SequenceVariant	rs2073416	rs2073416
2058	22048266	953	955	DiseaseOrPhenotypicFeature	DS	D004314
2059	22048266	1135	1137	DiseaseOrPhenotypicFeature	DS	D004314
2060	22048266	1215	1224	SequenceVariant	rs2073601	rs2073601
2061	22048266	1283	1304	SequenceVariant	leucine to methionine	rs2073601
2062	22048266	1328	1330	DiseaseOrPhenotypicFeature	DS	D004314
2063	22180037	28	56	GeneOrGeneProduct	glutathione-S-transferase P1	2950
2064	22180037	63	68	GeneOrGeneProduct	GSTP1	2950
2065	22180037	92	107	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2066	22180037	136	164	GeneOrGeneProduct	Glutathione-S-transferase P1	2950
2067	22180037	166	171	GeneOrGeneProduct	GSTP1	2950
2068	22180037	280	285	GeneOrGeneProduct	GSTP1	2950
2069	22180037	289	312	SequenceVariant	A > G at nucleotide 313	rs1695
2070	22180037	359	368	SequenceVariant	Ile105Val	rs1695
2071	22180037	403	408	GeneOrGeneProduct	GSTP1	2950
2072	22180037	443	448	GeneOrGeneProduct	GSTP1	2950
2073	22180037	469	474	GeneOrGeneProduct	GSTP1	2950
2074	22180037	475	484	SequenceVariant	Ile105Val	rs1695
2075	22180037	507	522	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2076	22180037	603	618	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2077	22180037	632	659	DiseaseOrPhenotypicFeature	benign prostate hyperplasia	D011470
2078	22180037	683	688	GeneOrGeneProduct	GSTP1	2950
2079	22180037	689	698	SequenceVariant	Ile105Val	rs1695
2080	22180037	865	870	GeneOrGeneProduct	GSTP1	2950
2081	22180037	871	880	SequenceVariant	Ile105Val	rs1695
2082	22180037	984	999	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2083	22180037	1032	1059	DiseaseOrPhenotypicFeature	benign prostate hyperplasia	D011470
2084	22180037	1177	1182	GeneOrGeneProduct	GSTP1	2950
2085	22180037	1183	1190	SequenceVariant	Ile/Val	rs1695
2086	22180037	1261	1266	GeneOrGeneProduct	GSTP1	2950
2087	22180037	1267	1274	SequenceVariant	Ile/Val	rs1695
2088	22180037	1315	1330	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2089	22369755	22	25	ChemicalEntity	NNK	C016583
2090	22369755	30	37	GeneOrGeneProduct	SLURP-1	57152
2091	22369755	116	149	GeneOrGeneProduct	nicotinic acetylcholine receptors	1136
2092	22369755	215	222	OrganismTaxon	tobacco	4097
2093	22369755	223	234	ChemicalEntity	nitrosamine	D009602
2094	22369755	236	282	ChemicalEntity	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone	C016583
2095	22369755	285	288	ChemicalEntity	NNK	C016583
2096	22369755	301	313	DiseaseOrPhenotypicFeature	carcinogenic	D009369
2097	22369755	350	353	ChemicalEntity	NNK	C016583
2098	22369755	435	498	GeneOrGeneProduct	Ly-6/urokinase plasminogen activator receptor related protein-1	57152
2099	22369755	500	507	GeneOrGeneProduct	SLURP-1	57152
2100	22369755	533	536	ChemicalEntity	NNK	C016583
2101	22369755	556	563	GeneOrGeneProduct	SLURP-1	57152
2102	22369755	602	615	DiseaseOrPhenotypicFeature	tumorigenesis	D009369
2103	22369755	619	624	OrganismTaxon	human	9606
2104	22369755	679	684	CellLine	BEP2D	9606
2105	22369755	689	695	CellLine	Het-1A	9606
2106	22369755	725	728	ChemicalEntity	NNK	C016583
2107	22369755	781	784	GeneOrGeneProduct	MYB	4602
2108	22369755	789	795	GeneOrGeneProduct	PIK3CA	5290
2109	22369755	799	804	CellLine	BEP2D	9606
2110	22369755	806	810	GeneOrGeneProduct	ETS1	2113
2111	22369755	812	816	GeneOrGeneProduct	NRAS	4893
2112	22369755	821	824	GeneOrGeneProduct	SRC	6714
2113	22369755	828	834	CellLine	Het-1A	9606
2114	22369755	840	844	GeneOrGeneProduct	AKT1	207
2115	22369755	846	849	GeneOrGeneProduct	KIT	3815
2116	22369755	854	857	GeneOrGeneProduct	RB1	5925
2117	22369755	922	930	GeneOrGeneProduct	rSLURP-1	57152
2118	22369755	938	944	DiseaseOrPhenotypicFeature	cancer	D009369
2119	22369755	981	984	ChemicalEntity	NNK	C016583
2120	22369755	1004	1012	GeneOrGeneProduct	rSLURP-1	57152
2121	22369755	1037	1040	GeneOrGeneProduct	EGF	1950
2122	22369755	1044	1049	CellLine	BEP2D	9606
2123	22369755	1060	1063	GeneOrGeneProduct	HGF	3082
2124	22369755	1067	1073	CellLine	Het-1A	9606
2125	22369755	1111	1117	GeneOrGeneProduct	CDKN2A	1029
2126	22369755	1122	1127	GeneOrGeneProduct	STAT3	6774
2127	22369755	1129	1135	CellLine	Het-1A	9606
2128	22369755	1143	1146	ChemicalEntity	NNK	C016583
2129	22369755	1183	1187	GeneOrGeneProduct	BCL2	596
2130	22369755	1189	1195	CellLine	Het-1A	9606
2131	22369755	1233	1236	GeneOrGeneProduct	TNF	7124
2132	22369755	1238	1244	CellLine	Het-1A	9606
2133	22369755	1247	1250	GeneOrGeneProduct	BAX	581
2134	22369755	1255	1260	GeneOrGeneProduct	CASP8	841
2135	22369755	1262	1267	CellLine	BEP2D	9606
2136	22369755	1315	1323	GeneOrGeneProduct	rSLURP-1	57152
2137	22369755	1325	1328	ChemicalEntity	NNK	C016583
2138	22369755	1357	1363	GeneOrGeneProduct	CTNNB1	1499
2139	22369755	1414	1426	GeneOrGeneProduct	beta-catenin	1499
2140	22369755	1428	1433	CellLine	BEP2D	9606
2141	22369755	1447	1452	DiseaseOrPhenotypicFeature	tumor	D009369
2142	22369755	1465	1470	GeneOrGeneProduct	CDKN3	1033
2143	22369755	1475	1480	GeneOrGeneProduct	FOXD3	27022
2144	22369755	1484	1489	CellLine	BEP2D	9606
2145	22369755	1500	1508	GeneOrGeneProduct	SERPINB5	5268
2146	22369755	1512	1518	CellLine	Het-1A	9606
2147	22369755	1557	1560	ChemicalEntity	NNK	C016583
2148	22369755	1579	1587	GeneOrGeneProduct	rSLURP-1	57152
2149	22369755	1610	1615	GeneOrGeneProduct	RUNX3	864
2150	22369755	1685	1688	ChemicalEntity	NNK	C016583
2151	22369755	1693	1700	GeneOrGeneProduct	SLURP-1	57152
2152	22369755	1774	1785	DiseaseOrPhenotypicFeature	tumorigenic	D009369
2153	22729903	16	21	GeneOrGeneProduct	STAT4	6775
2154	22729903	61	89	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
2155	22729903	120	125	GeneOrGeneProduct	STAT4	6775
2156	22729903	188	216	DiseaseOrPhenotypicFeature	systemic lupus erythematosus	D008180
2157	22729903	218	221	DiseaseOrPhenotypicFeature	SLE	D008180
2158	22729903	333	336	DiseaseOrPhenotypicFeature	SLE	D008180
2159	22729903	386	391	GeneOrGeneProduct	STAT4	6775
2160	22729903	392	397	SequenceVariant	G > C	rs7582694
2161	22729903	399	408	SequenceVariant	rs7582694	rs7582694
2162	22729903	426	434	OrganismTaxon	patients	9606
2163	22729903	440	443	DiseaseOrPhenotypicFeature	SLE	D008180
2164	22729903	529	537	OrganismTaxon	patients	9606
2165	22729903	547	552	GeneOrGeneProduct	STAT4	6775
2166	22729903	615	618	DiseaseOrPhenotypicFeature	SLE	D008180
2167	22729903	776	781	GeneOrGeneProduct	STAT4	6775
2168	22729903	839	842	DiseaseOrPhenotypicFeature	SLE	D008180
2169	22729903	923	928	GeneOrGeneProduct	STAT4	6775
2170	22729903	954	957	DiseaseOrPhenotypicFeature	SLE	D008180
2171	22729903	958	966	OrganismTaxon	patients	9606
2172	22729903	972	986	DiseaseOrPhenotypicFeature	renal symptoms	D007674
2173	22729903	1052	1055	DiseaseOrPhenotypicFeature	SLE	D008180
2174	22729903	1056	1064	OrganismTaxon	patients	9606
2175	22729903	1192	1197	GeneOrGeneProduct	STAT4	6775
2176	22729903	1248	1253	GeneOrGeneProduct	snRNP	57819
2177	22729903	1344	1350	GeneOrGeneProduct	Scl-70	7150
2178	22729903	1457	1462	GeneOrGeneProduct	STAT4	6775
2179	22729903	1466	1475	SequenceVariant	rs7582694	rs7582694
2180	22729903	1509	1512	DiseaseOrPhenotypicFeature	SLE	D008180
2181	23872883	23	49	ChemicalEntity	Solidago virgaurea extract	D010936
2182	23872883	66	80	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2183	23872883	82	105	DiseaseOrPhenotypicFeature	Cardiovascular diseases	D002318
2184	23872883	107	111	DiseaseOrPhenotypicFeature	CVDs	D002318
2185	23872883	277	303	ChemicalEntity	Solidago virgaurea extract	D010936
2186	23872883	307	320	ChemicalEntity	isoproterenol	D007545
2187	23872883	329	343	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2188	23872883	347	351	OrganismTaxon	rats	10116
2189	23872883	383	396	ChemicalEntity	isoproterenol	D007545
2190	23872883	413	417	OrganismTaxon	rats	10116
2191	23872883	513	534	GeneOrGeneProduct	lactate dehydrogenase	24533
2192	23872883	536	558	GeneOrGeneProduct	creatine phosphokinase	24264
2193	23872883	560	580	GeneOrGeneProduct	alanine transaminase	81670
2194	23872883	582	604	GeneOrGeneProduct	aspartate transaminase	25721
2195	23872883	610	639	GeneOrGeneProduct	angiotensin-converting enzyme	24310
2196	23872883	658	669	ChemicalEntity	cholesterol	D002784
2197	23872883	671	684	ChemicalEntity	triglycerides	D014280
2198	23872883	697	707	ChemicalEntity	fatty acid	D005227
2199	23872883	724	739	ChemicalEntity	malondialdehyde	D008315
2200	23872883	741	744	ChemicalEntity	MDA	D008315
2201	23872883	751	763	ChemicalEntity	nitric oxide	D009569
2202	23872883	811	822	ChemicalEntity	glutathione	D005978
2203	23872883	827	847	GeneOrGeneProduct	superoxide dismutase	24786
2204	23872883	936	956	ChemicalEntity	S. virgaurea extract	D010936
2205	23872883	1004	1017	ChemicalEntity	isoproterenol	D007545
2206	23872883	1078	1087	ChemicalEntity	Captopril	D002216
2207	23872883	1134	1163	GeneOrGeneProduct	angiotensin-converting enzyme	24310
2208	23872883	1183	1204	ChemicalEntity	cardioprotective drug	D002316
2209	23872883	1295	1315	ChemicalEntity	S. virgaurea extract	D010936
2210	23872883	1359	1362	ChemicalEntity	MDA	D008315
2211	23872883	1410	1423	ChemicalEntity	isoproterenol	D007545
2212	23872883	1432	1436	OrganismTaxon	rats	10116
2213	23872883	1484	1504	ChemicalEntity	S. virgaurea extract	D010936
2214	23872883	1510	1532	ChemicalEntity	cardioprotective agent	D002316
2215	24114426	0	10	DiseaseOrPhenotypicFeature	Depression	D003866
2216	24114426	12	25	DiseaseOrPhenotypicFeature	impulsiveness	D010554
2217	24114426	83	116	ChemicalEntity	3,4-methylenedioxymethamphetamine	D018817
2218	24114426	118	122	ChemicalEntity	MDMA	D018817
2219	24114426	124	131	ChemicalEntity	ecstasy	D018817
2220	24114426	145	152	ChemicalEntity	Ecstasy	D018817
2221	24114426	154	187	ChemicalEntity	3,4-methylenedioxymethamphetamine	D018817
2222	24114426	189	193	ChemicalEntity	MDMA	D018817
2223	24114426	270	275	OrganismTaxon	human	9606
2224	24114426	430	433	ChemicalEntity	5HT	D012701
2225	24114426	482	489	ChemicalEntity	ecstasy	D018817
2226	24114426	731	738	ChemicalEntity	alcohol	D000431
2227	24114426	739	747	ChemicalEntity	nicotine	D009538
2228	24114426	749	751	ChemicalEntity	AN	D000431,D009538
2229	24114426	754	762	ChemicalEntity	cannabis	D002188
2230	24114426	763	770	ChemicalEntity	alcohol	D000431
2231	24114426	771	779	ChemicalEntity	nicotine	D009538
2232	24114426	781	784	ChemicalEntity	CAN	D000431,D002188,D009538
2233	24114426	791	798	ChemicalEntity	ecstasy	D018817
2234	24114426	823	830	ChemicalEntity	ecstasy	D018817
2235	24114426	857	861	ChemicalEntity	MDMA	D018817
2236	24114426	882	886	ChemicalEntity	MDMA	D018817
2237	24114426	1135	1138	ChemicalEntity	CAN	D000431,D002188,D009538
2238	24114426	1219	1223	ChemicalEntity	MDMA	D018817
2239	24114426	1231	1235	ChemicalEntity	MDMA	D018817
2240	24114426	1415	1422	ChemicalEntity	ecstasy	D018817
2241	24114426	1481	1488	ChemicalEntity	ecstasy	D018817
2242	24114426	1656	1671	DiseaseOrPhenotypicFeature	impaired memory	D008569
2243	24114426	1709	1719	DiseaseOrPhenotypicFeature	depression	D003866
2244	24114426	1721	1734	DiseaseOrPhenotypicFeature	impulsiveness	D010554
2245	24114426	1740	1757	DiseaseOrPhenotypicFeature	sleep disturbance	D020920
2246	24114426	1803	1810	ChemicalEntity	ecstasy	D018817
2247	24126708	42	48	GeneOrGeneProduct	HOMER1	9456
2248	24126708	59	67	ChemicalEntity	levodopa	D007980
2249	24126708	87	106	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
2250	24126708	107	115	OrganismTaxon	patients	9606
2251	24126708	117	125	ChemicalEntity	Levodopa	D007980
2252	24126708	172	191	DiseaseOrPhenotypicFeature	Parkinson's disease	D010300
2253	24126708	281	291	DiseaseOrPhenotypicFeature	dyskinesia	D004409
2254	24126708	296	317	DiseaseOrPhenotypicFeature	visual hallucinations	D006212
2255	24126708	319	325	GeneOrGeneProduct	HOMER1	9456
2256	24126708	364	373	ChemicalEntity	glutamate	D018698
2257	24126708	508	514	GeneOrGeneProduct	HOMER1	9456
2258	24126708	603	611	ChemicalEntity	levodopa	D007980
2259	24126708	636	644	OrganismTaxon	patients	9606
2260	24126708	650	680	DiseaseOrPhenotypicFeature	idiopathic Parkinson's disease	D010300
2261	24126708	700	708	OrganismTaxon	Patients	9606
2262	24126708	728	737	SequenceVariant	rs4704559	rs4704559
2263	24126708	739	749	SequenceVariant	rs10942891	rs10942891
2264	24126708	754	763	SequenceVariant	rs4704560	rs4704560
2265	24126708	814	823	SequenceVariant	rs4704559	rs4704559
2266	24126708	875	885	DiseaseOrPhenotypicFeature	dyskinesia	D004409
2267	24126708	971	992	DiseaseOrPhenotypicFeature	visual hallucinations	D006212
2268	24126708	1056	1062	GeneOrGeneProduct	HOMER1	9456
2269	24126708	1063	1072	SequenceVariant	rs4704559	rs4704559
2270	24126708	1127	1135	ChemicalEntity	levodopa	D007980
2271	24132704	0	6	ChemicalEntity	Crocin	C029036
2272	24132704	16	21	ChemicalEntity	lipid	D008055
2273	24132704	48	56	ChemicalEntity	diazinon	D003976
2274	24132704	74	80	GeneOrGeneProduct	ERK1/2	116590,50689
2275	24132704	92	95	OrganismTaxon	rat	10116
2276	24132704	117	125	ChemicalEntity	Diazinon	D003976
2277	24132704	159	175	ChemicalEntity	organophosphorus	D010755
2278	24132704	240	248	ChemicalEntity	diazinon	D003976
2279	24132704	268	273	ChemicalEntity	lipid	D008055
2280	24132704	324	330	ChemicalEntity	crocin	C029036
2281	24132704	396	433	GeneOrGeneProduct	Extracellular signal-regulated kinase	116590,50689
2282	24132704	435	438	GeneOrGeneProduct	ERK	116590,50689
2283	24132704	452	484	GeneOrGeneProduct	low-density lipoprotein receptor	300438
2284	24132704	486	490	GeneOrGeneProduct	LDLr	300438
2285	24132704	571	576	ChemicalEntity	lipid	D008055
2286	24132704	589	592	GeneOrGeneProduct	ERK	116590,50689
2287	24132704	597	601	GeneOrGeneProduct	LDLr	300438
2288	24132704	629	633	OrganismTaxon	rats	10116
2289	24132704	654	662	ChemicalEntity	diazinon	D003976
2290	24132704	699	705	ChemicalEntity	crocin	C029036
2291	24132704	709	717	ChemicalEntity	diazinon	D003976
2292	24132704	736	747	ChemicalEntity	cholesterol	D002784
2293	24132704	785	789	OrganismTaxon	Rats	10116
2294	24132704	864	872	ChemicalEntity	Corn oil	D003314
2295	24132704	884	892	ChemicalEntity	diazinon	D003976
2296	24132704	923	929	ChemicalEntity	crocin	C029036
2297	24132704	996	1004	ChemicalEntity	diazinon	D003976
2298	24132704	1031	1042	ChemicalEntity	cholesterol	D002784
2299	24132704	1044	1056	ChemicalEntity	triglyceride	D014280
2300	24132704	1061	1064	ChemicalEntity	LDL	D008077
2301	24132704	1077	1081	OrganismTaxon	rats	10116
2302	24132704	1121	1125	GeneOrGeneProduct	LDLr	300438
2303	24132704	1130	1136	GeneOrGeneProduct	ERK1/2	116590,50689
2304	24132704	1195	1201	GeneOrGeneProduct	ERK1/2	116590,50689
2305	24132704	1205	1208	OrganismTaxon	rat	10116
2306	24132704	1364	1372	ChemicalEntity	diazinon	D003976
2307	24132704	1415	1426	ChemicalEntity	cholesterol	D002784
2308	24132704	1428	1440	ChemicalEntity	triglyceride	D014280
2309	24132704	1445	1448	ChemicalEntity	LDL	D008077
2310	24132704	1459	1467	ChemicalEntity	diazinon	D003976
2311	24132704	1478	1484	GeneOrGeneProduct	ERK1/2	116590,50689
2312	24132704	1513	1517	GeneOrGeneProduct	LDLr	300438
2313	24132704	1530	1536	ChemicalEntity	Crocin	C029036
2314	24132704	1559	1562	GeneOrGeneProduct	ERK	116590,50689
2315	24132704	1578	1586	ChemicalEntity	diazinon	D003976
2316	24132704	1595	1607	DiseaseOrPhenotypicFeature	hyperlipemia	D006949
2317	24132704	1632	1636	GeneOrGeneProduct	LDLr	300438
2318	24132704	1662	1668	ChemicalEntity	Crocin	C029036
2319	24132704	1718	1726	ChemicalEntity	diazinon	D003976
2320	24132704	1735	1747	DiseaseOrPhenotypicFeature	hyperlipemia	D006949
2321	24132704	1770	1773	GeneOrGeneProduct	ERK	116590,50689
2322	24132704	1798	1802	GeneOrGeneProduct	LDLr	300438
2323	24535067	14	23	ChemicalEntity	etomidate	D005045
2324	24535067	32	41	DiseaseOrPhenotypicFeature	myoclonus	D009207
2325	24535067	62	70	ChemicalEntity	Fentanyl	D005283
2326	24535067	72	81	ChemicalEntity	midazolam	D008874
2327	24535067	230	238	ChemicalEntity	fentanyl	D005283
2328	24535067	240	249	ChemicalEntity	midazolam	D008874
2329	24535067	272	280	ChemicalEntity	fentanyl	D005283
2330	24535067	285	294	ChemicalEntity	midazolam	D008874
2331	24535067	306	315	ChemicalEntity	etomidate	D005045
2332	24535067	324	333	DiseaseOrPhenotypicFeature	myoclonus	D009207
2333	24535067	494	503	ChemicalEntity	etomidate	D005045
2334	24535067	576	584	ChemicalEntity	fentanyl	D005283
2335	24535067	606	615	ChemicalEntity	midazolam	D008874
2336	24535067	644	653	ChemicalEntity	midazolam	D008874
2337	24535067	670	678	ChemicalEntity	fentanyl	D005283
2338	24535067	875	884	ChemicalEntity	etomidate	D005045
2339	24535067	940	959	DiseaseOrPhenotypicFeature	Myoclonic movements	D009069
2340	24535067	1064	1073	ChemicalEntity	etomidate	D005045
2341	24535067	1101	1105	DiseaseOrPhenotypicFeature	pain	D010146
2342	24535067	1113	1122	ChemicalEntity	etomidate	D005045
2343	24535067	1246	1255	DiseaseOrPhenotypicFeature	myoclonus	D009207
2344	24535067	1454	1462	ChemicalEntity	fentanyl	D005283
2345	24535067	1481	1489	ChemicalEntity	fentanyl	D005283
2346	24535067	1494	1503	ChemicalEntity	midazolam	D008874
2347	24535067	1532	1541	ChemicalEntity	etomidate	D005045
2348	24535067	1550	1559	DiseaseOrPhenotypicFeature	myoclonus	D009207
2349	24739405	11	33	ChemicalEntity	dehydroepiandrosterone	D003687
2350	24739405	37	48	ChemicalEntity	amphetamine	D000661
2351	24739405	57	70	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2352	24739405	81	85	OrganismTaxon	mice	10090
2353	24739405	124	146	ChemicalEntity	dehydroepiandrosterone	D003687
2354	24739405	148	152	ChemicalEntity	DHEA	D003687
2355	24739405	174	187	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2356	24739405	226	230	OrganismTaxon	mice	10090
2357	24739405	269	280	ChemicalEntity	amphetamine	D000661
2358	24739405	297	308	ChemicalEntity	amphetamine	D000661
2359	24739405	328	332	ChemicalEntity	DHEA	D003687
2360	24739405	338	342	ChemicalEntity	DHEA	D003687
2361	24739405	395	406	ChemicalEntity	Amphetamine	D000661
2362	24739405	428	444	DiseaseOrPhenotypicFeature	hyper locomotion	D006948
2363	24739405	446	457	ChemicalEntity	apomorphine	D001058
2364	24739405	512	523	ChemicalEntity	haloperidol	D006220
2365	24739405	547	556	DiseaseOrPhenotypicFeature	catalepsy	D002375
2366	24739405	593	606	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2367	24739405	860	876	DiseaseOrPhenotypicFeature	hyper locomotion	D006948
2368	24739405	913	922	DiseaseOrPhenotypicFeature	catalepsy	D002375
2369	24739405	946	957	ChemicalEntity	amphetamine	D000661
2370	24739405	1051	1062	ChemicalEntity	amphetamine	D000661
2371	24739405	1080	1084	ChemicalEntity	DHEA	D003687
2372	24739405	1183	1194	ChemicalEntity	amphetamine	D000661
2373	24739405	1278	1289	ChemicalEntity	haloperidol	D006220
2374	24739405	1298	1307	DiseaseOrPhenotypicFeature	catalepsy	D002375
2375	24739405	1413	1424	ChemicalEntity	apomorphine	D001058
2376	24739405	1486	1490	ChemicalEntity	DHEA	D003687
2377	24739405	1532	1541	DiseaseOrPhenotypicFeature	catalepsy	D002375
2378	24739405	1618	1622	ChemicalEntity	DHEA	D003687
2379	24739405	1702	1715	DiseaseOrPhenotypicFeature	schizophrenia	D012559
2380	24768818	52	69	GeneOrGeneProduct	collagen receptor	4921,780
2381	24768818	70	74	GeneOrGeneProduct	DDR1	780
2382	24768818	138	164	GeneOrGeneProduct	discoidin domain receptors	4921,780
2383	24768818	166	170	GeneOrGeneProduct	DDRs	4921,780
2384	24768818	173	177	GeneOrGeneProduct	DDR1	780
2385	24768818	182	186	GeneOrGeneProduct	DDR2	4921
2386	24768818	215	240	GeneOrGeneProduct	receptor tyrosine kinases	4921,780
2387	24768818	293	301	GeneOrGeneProduct	collagen	1277
2388	24768818	326	330	GeneOrGeneProduct	DDR1	780
2389	24768818	335	339	GeneOrGeneProduct	DDR2	4921
2390	24768818	386	391	OrganismTaxon	human	9606
2391	24768818	412	420	DiseaseOrPhenotypicFeature	fibrosis	D005355
2392	24768818	422	437	DiseaseOrPhenotypicFeature	atherosclerosis	D050197
2393	24768818	442	448	DiseaseOrPhenotypicFeature	cancer	D009369
2394	24768818	492	517	GeneOrGeneProduct	receptor tyrosine kinases	4921,780
2395	24768818	540	546	DiseaseOrPhenotypicFeature	cancer	D009369
2396	24768818	553	561	ChemicalEntity	imatinib	D000068877
2397	24768818	566	575	ChemicalEntity	ponatinib	C545373
2398	24768818	620	629	ChemicalEntity	DDR1-IN-1	-
2399	24768818	631	640	ChemicalEntity	Ponatinib	C545373
2400	24768818	699	703	GeneOrGeneProduct	DDR1	780
2401	24768818	708	712	GeneOrGeneProduct	DDR2	4921
2402	24768818	759	764	OrganismTaxon	human	9606
2403	24768818	765	769	GeneOrGeneProduct	DDR1	780
2404	24768818	779	782	ChemicalEntity	DFG	C553185
2405	24768818	801	804	ChemicalEntity	DFG	C553185
2406	24768818	806	817	ChemicalEntity	Asp-Phe-Gly	C553185
2407	24768818	942	956	GeneOrGeneProduct	Abelson kinase	25
2408	24768818	958	961	GeneOrGeneProduct	ABL	25
2409	24768818	983	987	GeneOrGeneProduct	DDR1	780
2410	24768818	1050	1053	GeneOrGeneProduct	ABL	25
2411	24768818	1074	1078	GeneOrGeneProduct	DDR1	780
2412	24768818	1110	1113	GeneOrGeneProduct	ABL	25
2413	24768818	1153	1156	ChemicalEntity	ATP	D000255
2414	24768818	1173	1181	ChemicalEntity	imatinib	D000068877
2415	24768818	1186	1195	ChemicalEntity	ponatinib	C545373
2416	24768818	1222	1225	GeneOrGeneProduct	DDR	4921,780
2417	24768818	1230	1233	GeneOrGeneProduct	ABL	25
2418	24768818	1279	1282	GeneOrGeneProduct	ABL	25
2419	24768818	1317	1326	ChemicalEntity	DDR1-IN-1	-
2420	24768818	1365	1369	GeneOrGeneProduct	DDR1	780
2421	24768818	1448	1452	GeneOrGeneProduct	DDR1	780
2422	24768818	1457	1461	GeneOrGeneProduct	DDR2	4921
2423	24768818	1500	1511	DiseaseOrPhenotypicFeature	lung cancer	D008175
2424	24853300	16	30	GeneOrGeneProduct	calbindin-D28k	12307
2425	24853300	54	73	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
2426	24853300	74	79	OrganismTaxon	mouse	10090
2427	24853300	87	101	GeneOrGeneProduct	Calbindin-D28k	12307
2428	24853300	103	105	GeneOrGeneProduct	CB	12307
2429	24853300	125	132	ChemicalEntity	calcium	D002118
2430	24853300	201	215	DiseaseOrPhenotypicFeature	neuronal death	D009410
2431	24853300	239	246	ChemicalEntity	calcium	D002118
2432	24853300	290	292	GeneOrGeneProduct	CB	12307,793
2433	24853300	340	344	OrganismTaxon	mice	10090
2434	24853300	349	355	OrganismTaxon	humans	9606
2435	24853300	361	378	DiseaseOrPhenotypicFeature	Alzheimer disease	D000544
2436	24853300	380	382	DiseaseOrPhenotypicFeature	AD	D000544
2437	24853300	435	437	DiseaseOrPhenotypicFeature	AD	D000544
2438	24853300	501	503	GeneOrGeneProduct	CB	12307
2439	24853300	518	520	DiseaseOrPhenotypicFeature	AD	D000544
2440	24853300	551	553	DiseaseOrPhenotypicFeature	AD	D000544
2441	24853300	568	570	DiseaseOrPhenotypicFeature	AD	D000544
2442	24853300	576	580	OrganismTaxon	mice	10090
2443	24853300	586	588	GeneOrGeneProduct	CB	12307
2444	24853300	600	602	GeneOrGeneProduct	CB	12307
2445	24853300	606	610	OrganismTaxon	mice	10090
2446	24853300	638	640	GeneOrGeneProduct	CB	12307
2447	24853300	646	648	DiseaseOrPhenotypicFeature	AD	D000544
2448	24853300	650	652	GeneOrGeneProduct	CB	12307
2449	24853300	658	662	OrganismTaxon	mice	10090
2450	24853300	776	778	GeneOrGeneProduct	CB	12307
2451	24853300	785	789	OrganismTaxon	mice	10090
2452	24853300	872	874	GeneOrGeneProduct	CB	12307
2453	24853300	879	883	OrganismTaxon	mice	10090
2454	24853300	900	913	DiseaseOrPhenotypicFeature	neuronal loss	D009410
2455	24853300	979	996	GeneOrGeneProduct	amyloid b-peptide	11820
2456	24853300	998	1000	GeneOrGeneProduct	Ab	11820
2457	24853300	1069	1094	DiseaseOrPhenotypicFeature	mitochondrial dysfunction	D028361
2458	24853300	1112	1116	OrganismTaxon	mice	10090
2459	24853300	1128	1130	GeneOrGeneProduct	CB	12307
2460	24853300	1135	1139	OrganismTaxon	mice	10090
2461	24853300	1173	1205	GeneOrGeneProduct	mitogen-activated protein kinase	26413,26417
2462	24853300	1207	1249	GeneOrGeneProduct	extracellular signal-regulated kinase) 1/2	26413,26417
2463	24853300	1254	1291	GeneOrGeneProduct	cAMP response element-binding protein	12912
2464	24853300	1295	1302	SequenceVariant	Ser-133	p|Allele|S|133
2465	24853300	1334	1365	GeneOrGeneProduct	N-methyl-D-aspartate receptor 1	14810
2466	24853300	1367	1382	GeneOrGeneProduct	NMDA receptor 1	14810
2467	24853300	1385	1401	GeneOrGeneProduct	NMDA receptor 2A	14811
2468	24853300	1403	1409	GeneOrGeneProduct	PSD-95	13385
2469	24853300	1414	1427	GeneOrGeneProduct	synaptophysin	20977
2470	24853300	1462	1466	OrganismTaxon	mice	10090
2471	24853300	1537	1539	GeneOrGeneProduct	CB	12307
2472	24853300	1545	1570	GeneOrGeneProduct	amyloid precursor protein	11820
2473	24853300	1571	1581	GeneOrGeneProduct	presenilin	19164
2474	24853300	1593	1597	OrganismTaxon	mice	10090
2475	24853300	1609	1611	DiseaseOrPhenotypicFeature	AD	D000544
2476	24853300	1642	1644	GeneOrGeneProduct	CB	12307
2477	24853300	1668	1670	DiseaseOrPhenotypicFeature	AD	D000544
2478	25080425	14	64	GeneOrGeneProduct	signal transducer and activator of transcription 3	25125
2479	25080425	91	98	ChemicalEntity	betaine	D001622
2480	25080425	110	123	ChemicalEntity	isoproterenol	D007545
2481	25080425	138	155	DiseaseOrPhenotypicFeature	myocardial injury	D009202
2482	25080425	159	163	OrganismTaxon	rats	10116
2483	25080425	243	250	ChemicalEntity	betaine	D001622
2484	25080425	260	279	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
2485	25080425	306	310	OrganismTaxon	rats	10116
2486	25080425	337	387	GeneOrGeneProduct	signal transducer and activator of transcription 3	25125
2487	25080425	389	394	GeneOrGeneProduct	STAT3	25125
2488	25080425	494	498	OrganismTaxon	rats	10116
2489	25080425	517	524	ChemicalEntity	betaine	D001622
2490	25080425	577	603	DiseaseOrPhenotypicFeature	myocardial ischemic injury	D017202
2491	25080425	619	623	OrganismTaxon	rats	10116
2492	25080425	653	666	ChemicalEntity	isoproterenol	D007545
2493	25080425	833	840	ChemicalEntity	betaine	D001622
2494	25080425	950	972	DiseaseOrPhenotypicFeature	ventricular remodeling	D020257
2495	25080425	1008	1021	ChemicalEntity	isoproterenol	D007545
2496	25080425	1049	1054	GeneOrGeneProduct	STAT3	25125
2497	25080425	1093	1100	ChemicalEntity	betaine	D001622
2498	25080425	1139	1146	ChemicalEntity	betaine	D001622
2499	25080425	1217	1222	GeneOrGeneProduct	Bcl-2	24224
2500	25080425	1248	1251	GeneOrGeneProduct	Bax	24887
2501	25080425	1310	1315	GeneOrGeneProduct	Bcl-2	24224
2502	25080425	1316	1319	GeneOrGeneProduct	Bax	24887
2503	25080425	1344	1351	ChemicalEntity	betaine	D001622
2504	25080425	1355	1372	DiseaseOrPhenotypicFeature	myocardial damage	D009202
2505	25080425	1465	1472	ChemicalEntity	betaine	D001622
2506	25080425	1497	1510	ChemicalEntity	isoproterenol	D007545
2507	25080425	1525	1544	DiseaseOrPhenotypicFeature	myocardial ischemia	D017202
2508	25080425	1567	1572	GeneOrGeneProduct	STAT3	25125
2509	25305591	0	5	GeneOrGeneProduct	VPAC2	22355
2510	25305591	7	52	GeneOrGeneProduct	vasoactive intestinal peptide receptor type 2	22355
2511	25305591	73	77	OrganismTaxon	mice	10090
2512	25305591	98	139	DiseaseOrPhenotypicFeature	experimental autoimmune encephalomyelitis	D004681
2513	25305591	196	225	GeneOrGeneProduct	Vasoactive intestinal peptide	22353
2514	25305591	227	230	GeneOrGeneProduct	VIP	22353
2515	25305591	236	285	GeneOrGeneProduct	pituitary adenylyl cyclase-activating polypeptide	11516
2516	25305591	287	292	GeneOrGeneProduct	PACAP	11516
2517	25305591	483	495	DiseaseOrPhenotypicFeature	inflammatory	D007249
2518	25305591	542	562	DiseaseOrPhenotypicFeature	inflammatory disease	D007249
2519	25305591	564	568	OrganismTaxon	mice	10090
2520	25305591	582	585	GeneOrGeneProduct	VIP	22353
2521	25305591	590	595	GeneOrGeneProduct	PACAP	11516
2522	25305591	707	748	DiseaseOrPhenotypicFeature	experimental autoimmune encephalomyelitis	D004681
2523	25305591	750	753	DiseaseOrPhenotypicFeature	EAE	D004681
2524	25305591	867	872	GeneOrGeneProduct	VPAC1	22354
2525	25305591	874	879	GeneOrGeneProduct	VPAC2	22355
2526	25305591	885	889	GeneOrGeneProduct	PAC1	11517
2527	25305591	933	937	OrganismTaxon	mice	10090
2528	25305591	965	970	GeneOrGeneProduct	VIPR2	22355
2529	25305591	985	999	GeneOrGeneProduct	VPAC2 receptor	22355
2530	25305591	1024	1032	GeneOrGeneProduct	MOG35-55	4340
2531	25305591	1042	1045	DiseaseOrPhenotypicFeature	EAE	D004681
2532	25305591	1068	1072	OrganismTaxon	mice	10090
2533	25305591	1151	1176	GeneOrGeneProduct	proinflammatory cytokines	15978,16171,16193,21926
2534	25305591	1178	1187	GeneOrGeneProduct	TNF-alpha	21926
2535	25305591	1189	1193	GeneOrGeneProduct	IL-6	16193
2536	25305591	1195	1204	GeneOrGeneProduct	IFN-gamma	15978
2537	25305591	1216	1221	GeneOrGeneProduct	IL-17	16171
2538	25305591	1242	1269	GeneOrGeneProduct	anti-inflammatory cytokines	16153,16189,21803
2539	25305591	1271	1276	GeneOrGeneProduct	IL-10	16153
2540	25305591	1278	1285	GeneOrGeneProduct	TGFbeta	21803
2541	25305591	1291	1295	GeneOrGeneProduct	IL-4	16189
2542	25305591	1409	1412	GeneOrGeneProduct	CD4	12504
2543	25305591	1415	1419	GeneOrGeneProduct	CD25	16184
2544	25305591	1422	1427	GeneOrGeneProduct	FoxP3	20371
2545	25305591	1464	1469	GeneOrGeneProduct	VPAC2	22355
2546	25305591	1480	1484	OrganismTaxon	mice	10090
2547	25305591	1490	1493	DiseaseOrPhenotypicFeature	EAE	D004681
2548	25305591	1575	1580	GeneOrGeneProduct	VPAC2	22355
2549	25305591	1591	1595	OrganismTaxon	mice	10090
2550	25305591	1673	1678	GeneOrGeneProduct	PACAP	11516
2551	25305591	1687	1701	GeneOrGeneProduct	VPAC2 receptor	22355
2552	25983002	14	18	GeneOrGeneProduct	LDHA	3939
2553	25983002	30	35	DiseaseOrPhenotypicFeature	tumor	D009369
2554	25983002	51	66	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2555	25983002	86	92	DiseaseOrPhenotypicFeature	cancer	D009369
2556	25983002	153	176	GeneOrGeneProduct	Lactate dehydrogenase A	3939
2557	25983002	178	182	GeneOrGeneProduct	LDHA	3939
2558	25983002	274	279	DiseaseOrPhenotypicFeature	tumor	D009369
2559	25983002	318	322	GeneOrGeneProduct	LDHA	3939
2560	25983002	326	341	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2561	25983002	412	416	GeneOrGeneProduct	LDHA	3939
2562	25983002	433	448	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2563	25983002	471	498	DiseaseOrPhenotypicFeature	benign prostate hyperplasia	D011470
2564	25983002	592	596	GeneOrGeneProduct	LDHA	3939
2565	25983002	623	627	GeneOrGeneProduct	LDHA	3939
2566	25983002	642	646	ChemicalEntity	FX11	C547455
2567	25983002	729	733	CellLine	PC-3	9606
2568	25983002	738	743	CellLine	DU145	9606
2569	25983002	820	827	ChemicalEntity	glucose	D005947
2570	25983002	844	851	ChemicalEntity	lactate	D019344
2571	25983002	888	893	GeneOrGeneProduct	MMP-9	4318
2572	25983002	895	899	GeneOrGeneProduct	PLAU	5328
2573	25983002	905	916	GeneOrGeneProduct	cathepsin B	1508
2574	25983002	934	938	GeneOrGeneProduct	LDHA	3939
2575	25983002	952	956	ChemicalEntity	FX11	C547455
2576	25983002	970	974	CellLine	PC-3	9606
2577	25983002	979	984	CellLine	DU145	9606
2578	25983002	1049	1053	GeneOrGeneProduct	LDHA	3939
2579	25983002	1057	1072	DiseaseOrPhenotypicFeature	prostate cancer	D011471
2580	25983002	1092	1096	GeneOrGeneProduct	LDHA	3939
2581	25986755	36	40	GeneOrGeneProduct	AT2R	24182
2582	25986755	78	96	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2583	25986755	136	144	ChemicalEntity	caffeine	D002110
2584	25986755	214	222	ChemicalEntity	caffeine	D002110
2585	25986755	251	282	DiseaseOrPhenotypicFeature	intrauterine growth retardation	D005317
2586	25986755	284	288	DiseaseOrPhenotypicFeature	IUGR	D005317
2587	25986755	335	339	DiseaseOrPhenotypicFeature	IUGR	D005317
2588	25986755	361	379	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2589	25986755	415	433	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2590	25986755	529	547	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2591	25986755	621	624	OrganismTaxon	rat	10116
2592	25986755	634	638	DiseaseOrPhenotypicFeature	IUGR	D005317
2593	25986755	826	844	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2594	25986755	856	877	DiseaseOrPhenotypicFeature	interstitial fibrosis	D005355
2595	25986755	919	929	ChemicalEntity	creatinine	D003404
2596	25986755	955	985	GeneOrGeneProduct	angiotensin II receptor type 2	24182
2597	25986755	987	991	GeneOrGeneProduct	AT2R	24182
2598	25986755	1066	1097	GeneOrGeneProduct	angiotensin II receptor type 1a	24180
2599	25986755	1099	1104	GeneOrGeneProduct	AT1aR	24180
2600	25986755	1106	1110	GeneOrGeneProduct	AT2R	24182
2601	25986755	1479	1486	GeneOrGeneProduct	nephrin	64563
2602	25986755	1491	1498	GeneOrGeneProduct	podocin	170672
2603	25986755	1538	1542	GeneOrGeneProduct	AT2R	24182
2604	25986755	1669	1712	GeneOrGeneProduct	glial-cell-line-derived neurotrophic factor	25453
2605	25986755	1714	1718	GeneOrGeneProduct	GDNF	25453
2606	25986755	1720	1744	GeneOrGeneProduct	tyrosine kinase receptor	24716
2607	25986755	1746	1751	GeneOrGeneProduct	c-Ret	24716
2608	25986755	1821	1847	DiseaseOrPhenotypicFeature	dysplasia of fetal kidneys	D007674
2609	25986755	1859	1877	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2610	25986755	1942	1946	GeneOrGeneProduct	AT2R	24182
2611	25986755	1995	2013	DiseaseOrPhenotypicFeature	glomerulosclerosis	D005921
2612	26027517	4	13	GeneOrGeneProduct	autotaxin	84050
2613	26027517	14	18	GeneOrGeneProduct	LPA2	498609,53978
2614	26027517	19	23	GeneOrGeneProduct	GPCR	295589
2615	26027517	144	160	DiseaseOrPhenotypicFeature	radiation injury	D011832
2616	26027517	199	208	GeneOrGeneProduct	autotaxin	84050
2617	26027517	210	213	GeneOrGeneProduct	ATX	84050
2618	26027517	215	219	GeneOrGeneProduct	LPA2	498609
2619	26027517	220	224	GeneOrGeneProduct	GPCR	295589
2620	26027517	234	239	CellLine	IEC-6	10116
2621	26027517	344	348	GeneOrGeneProduct	lpa2	498609
2622	26027517	420	429	GeneOrGeneProduct	NF-kappaB	81736
2623	26027517	442	446	GeneOrGeneProduct	lpa2	498609
2624	26027517	476	491	GeneOrGeneProduct	ATM/ATR kinases	300711,685055
2625	26027517	497	504	ChemicalEntity	CGK-733	C512273
2626	26027517	522	526	GeneOrGeneProduct	lpa2	498609
2627	26027517	572	575	GeneOrGeneProduct	ATM	300711
2628	26027517	580	589	GeneOrGeneProduct	NF-kappaB	81736
2629	26027517	640	650	GeneOrGeneProduct	gamma-H2AX	500987
2630	26027517	654	657	GeneOrGeneProduct	LPA	53978
2631	26027517	666	671	CellLine	IEC-6	10116
2632	26027517	782	786	GeneOrGeneProduct	LPA2	498609
2633	26027517	813	823	GeneOrGeneProduct	gamma-H2AX	500987
2634	26027517	828	832	GeneOrGeneProduct	LPA2	53978
2635	26027517	847	850	CellLine	MEF	10090
2636	26027517	865	875	GeneOrGeneProduct	LPA1    '3	14745,65086
2637	26027517	890	900	GeneOrGeneProduct	gamma-H2AX	15270
2638	26027517	938	941	CellLine	MEF	10090
2639	26027517	990	1000	GeneOrGeneProduct	ERK1    '2	26413,26417
2640	26027517	1004	1008	GeneOrGeneProduct	PI3K	18708
2641	26027517	1009	1012	GeneOrGeneProduct	AKT	11651
2642	26027517	1054	1059	SequenceVariant	C311A	p|SUB|C|311|A
2643	26027517	1060	1065	SequenceVariant	C314A	p|SUB|C|314|A
2644	26027517	1066	1071	SequenceVariant	L351A	p|SUB|L|351|A
2645	26027517	1102	1106	GeneOrGeneProduct	LPA2	53978
2646	26027517	1131	1134	GeneOrGeneProduct	LPA	53978
2647	26027517	1150	1154	GeneOrGeneProduct	LPA2	53978
2648	26027517	1170	1173	GeneOrGeneProduct	Lin	83557
2649	26027517	1176	1181	GeneOrGeneProduct	Sca-1	110454
2650	26027517	1184	1189	GeneOrGeneProduct	c-Kit	16590
2651	26027517	1365	1375	GeneOrGeneProduct	gamma-H2AX	15270
2652	26027517	1441	1445	GeneOrGeneProduct	LPA2	53978
2653	26027517	1449	1453	OrganismTaxon	mice	10090
2654	26027517	1469	1473	OrganismTaxon	mice	10090
2655	26027517	1524	1527	GeneOrGeneProduct	ATX	84050
2656	26027517	1541	1544	GeneOrGeneProduct	LPA	53978
2657	26027517	1635	1643	GeneOrGeneProduct	TNFalpha	21926
2658	26027517	1669	1672	GeneOrGeneProduct	ATX	18606,84050
2659	26027517	1677	1681	GeneOrGeneProduct	LPA2	498609,53978
2660	26110643	8	12	GeneOrGeneProduct	Trap	436725
2661	26110643	68	77	OrganismTaxon	Zebrafish	7955
2662	26110643	108	121	GeneOrGeneProduct	Neuregulin 2a	100006951
2663	26110643	128	132	GeneOrGeneProduct	ErbB	386635,386966
2664	26110643	198	212	DiseaseOrPhenotypicFeature	Skin disorders	D012871
2665	26110643	419	428	OrganismTaxon	Zebrafish	7955
2666	26110643	555	566	OrganismTaxon	Danio rerio	7955
2667	26110643	568	577	OrganismTaxon	zebrafish	7955
2668	26110643	769	774	GeneOrGeneProduct	fras1	563428
2669	26110643	776	781	GeneOrGeneProduct	grip1	558006
2670	26110643	783	788	GeneOrGeneProduct	hmcn1	559150
2671	26110643	790	794	GeneOrGeneProduct	msxc	30526
2672	26110643	796	802	GeneOrGeneProduct	col4a4	554270
2673	26110643	804	809	GeneOrGeneProduct	ahnak	559276
2674	26110643	811	817	GeneOrGeneProduct	capn12	799247
2675	26110643	823	828	GeneOrGeneProduct	nrg2a	100006951
2676	26110643	903	912	GeneOrGeneProduct	arhgef25b	569561
2677	26110643	914	921	GeneOrGeneProduct	fkbp10b	324381
2678	26110643	927	933	GeneOrGeneProduct	megf6a	565108
2679	26110643	1009	1022	GeneOrGeneProduct	neuregulin 2a	100006951
2680	26110643	1024	1029	GeneOrGeneProduct	nrg2a	100006951
2681	26110643	1066	1079	GeneOrGeneProduct	Neuregulin 2a	100006951
2682	26110643	1081	1086	GeneOrGeneProduct	Nrg2a	100006951
2683	26110643	1088	1095	GeneOrGeneProduct	ErbB2/3	386635,386966
2684	26110643	1096	1099	GeneOrGeneProduct	AKT	101910198
2685	26110643	1234	1239	GeneOrGeneProduct	nrg2a	100006951
2686	26110643	1343	1346	GeneOrGeneProduct	AKT	101910198
2687	26110643	1595	1600	GeneOrGeneProduct	Nrg2a	100006951
2688	26110643	1621	1650	GeneOrGeneProduct	ErbB receptor tyrosine kinase	386635,386966
2689	26110643	1721	1726	DiseaseOrPhenotypicFeature	tumor	D009369
2690	26110643	1738	1742	GeneOrGeneProduct	lgl2	795670
2691	26110643	1759	1764	GeneOrGeneProduct	nrg2a	100006951
2692	26110643	1795	1799	GeneOrGeneProduct	Lgl2	795670
2693	26110643	1820	1825	GeneOrGeneProduct	Nrg2a	100006951
2694	26110643	1826	1830	GeneOrGeneProduct	ErbB	386635,386966
2695	26110643	1883	1887	GeneOrGeneProduct	Lgl2	795670
2696	26516699	46	63	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
2697	26516699	120	124	GeneOrGeneProduct	Kras	3845
2698	26516699	124	128	SequenceVariant	G12D	p|SUB|G|12|D
2699	26516699	129	133	GeneOrGeneProduct	Pdx1	18609
2700	26516699	138	143	OrganismTaxon	mouse	10090
2701	26516699	235	242	DiseaseOrPhenotypicFeature	cancers	D009369
2702	26516699	254	271	DiseaseOrPhenotypicFeature	pancreatic cancer	D010190
2703	26516699	273	275	DiseaseOrPhenotypicFeature	PC	D010190
2704	26516699	333	335	DiseaseOrPhenotypicFeature	PC	D010190
2705	26516699	384	386	DiseaseOrPhenotypicFeature	PC	D010190
2706	26516699	539	541	DiseaseOrPhenotypicFeature	PC	D010190
2707	26516699	564	568	GeneOrGeneProduct	Kras	3845
2708	26516699	568	572	SequenceVariant	G12D	p|SUB|G|12|D
2709	26516699	573	577	GeneOrGeneProduct	Pdx1	18609
2710	26516699	587	592	OrganismTaxon	mouse	10090
2711	26516699	682	689	GeneOrGeneProduct	miR-150	387168
2712	26516699	691	698	GeneOrGeneProduct	miR-494	723878
2713	26516699	700	707	GeneOrGeneProduct	miR-138	387156,723956
2714	26516699	709	717	GeneOrGeneProduct	miR-148a	387166
2715	26516699	719	727	GeneOrGeneProduct	miR-216a	387212
2716	26516699	733	740	GeneOrGeneProduct	miR-217	387213
2717	26516699	761	769	GeneOrGeneProduct	miR-146b	751550
2718	26516699	771	778	GeneOrGeneProduct	miR-205	387201
2719	26516699	780	786	GeneOrGeneProduct	miR-31	723895
2720	26516699	788	795	GeneOrGeneProduct	miR-192	387187
2721	26516699	801	807	GeneOrGeneProduct	miR-21	387140
2722	26516699	814	818	OrganismTaxon	mice	10090
2723	26516699	903	908	GeneOrGeneProduct	Dicer	192119
2724	26516699	910	920	GeneOrGeneProduct	Exportin-5	72322
2725	26516699	922	927	GeneOrGeneProduct	TRKRA	18211
2726	26516699	933	939	GeneOrGeneProduct	TARBP2	21357
2727	26516699	966	971	GeneOrGeneProduct	DGCR8	94223
2728	26516699	976	980	GeneOrGeneProduct	Ago2	239528
2729	26516699	1004	1008	OrganismTaxon	mice	10090
2730	26516699	1102	1106	OrganismTaxon	mice	10090
2731	26516699	1134	1141	GeneOrGeneProduct	miR-216	387212
2732	26516699	1143	1150	GeneOrGeneProduct	miR-217	387213
2733	26516699	1152	1159	GeneOrGeneProduct	miR-100	723892
2734	26516699	1161	1168	GeneOrGeneProduct	miR-345	723946
2735	26516699	1170	1177	GeneOrGeneProduct	miR-141	387159
2736	26516699	1179	1189	GeneOrGeneProduct	miR-483-3p	723874
2737	26516699	1191	1198	GeneOrGeneProduct	miR-26b	387219
2738	26516699	1200	1207	GeneOrGeneProduct	miR-150	387168
2739	26516699	1209	1216	GeneOrGeneProduct	miR-195	387190
2740	26516699	1218	1224	GeneOrGeneProduct	Let-7b	387245
2741	26516699	1229	1235	GeneOrGeneProduct	Let-96	-
2742	26516699	1256	1262	GeneOrGeneProduct	miR-21	387140
2743	26516699	1264	1271	GeneOrGeneProduct	miR-205	387201
2744	26516699	1273	1281	GeneOrGeneProduct	miR-146b	751550
2745	26516699	1283	1290	GeneOrGeneProduct	miR-34c	723932
2746	26516699	1292	1300	GeneOrGeneProduct	miR-1273	100422821
2747	26516699	1302	1309	GeneOrGeneProduct	miR-223	723814
2748	26516699	1314	1321	GeneOrGeneProduct	miR-195	387190
2749	26516699	1342	1346	OrganismTaxon	mice	10090
2750	26516699	1403	1407	OrganismTaxon	mice	10090
2751	26516699	1455	1460	OrganismTaxon	human	9606
2752	26516699	1461	1463	DiseaseOrPhenotypicFeature	PC	D010190
2753	26516699	1517	1523	GeneOrGeneProduct	Let-7b	406884
2754	26516699	1527	1536	CellLine	CD18/HPAF	9606
2755	26516699	1541	1547	CellLine	Capan1	9606
2756	26516699	1588	1592	GeneOrGeneProduct	KRAS	3845
2757	26516699	1597	1602	GeneOrGeneProduct	MSST1	-
2758	26516699	1700	1702	DiseaseOrPhenotypicFeature	PC	D010190
2759	26731607	25	32	GeneOrGeneProduct	GADD45A	13197
2760	26731607	293	340	GeneOrGeneProduct	Growth arrest and DNA-damage-inducible 45 alpha	13197
2761	26731607	342	349	GeneOrGeneProduct	GADD45A	13197
2762	26731607	391	398	GeneOrGeneProduct	GADD45A	13197
2763	26731607	514	521	GeneOrGeneProduct	GADD45A	13197
2764	26731607	704	711	GeneOrGeneProduct	GADD45A	13197
2765	26731607	779	785	OrganismTaxon	murine	10090
2766	26731607	837	844	GeneOrGeneProduct	GADD45A	13197
2767	26731607	911	918	GeneOrGeneProduct	GADD45A	13197
2768	26731607	1054	1061	GeneOrGeneProduct	GADD45A	13197
2769	26731607	1236	1243	GeneOrGeneProduct	GADD45A	13197
2770	26731607	1322	1329	GeneOrGeneProduct	GADD45A	13197
2771	26731607	1545	1552	GeneOrGeneProduct	GADD45A	13197
2772	26731607	1587	1594	GeneOrGeneProduct	GADD45A	13197
2773	26731607	1625	1661	GeneOrGeneProduct	p38 Mitogen-activated protein kinase	26416
2774	26731607	1663	1667	GeneOrGeneProduct	MAPK	26416
2775	26731607	1817	1824	GeneOrGeneProduct	GADD45A	13197
2776	27134166	96	100	GeneOrGeneProduct	mTOR	56717
2777	27134166	137	142	DiseaseOrPhenotypicFeature	tumor	D009369
2778	27134166	161	165	GeneOrGeneProduct	VEGF	22339,7422
2779	27134166	237	242	OrganismTaxon	human	9606
2780	27134166	243	249	DiseaseOrPhenotypicFeature	tumors	D009369
2781	27134166	254	259	OrganismTaxon	mouse	10090
2782	27134166	270	276	DiseaseOrPhenotypicFeature	cancer	D009369
2783	27134166	354	359	OrganismTaxon	mouse	10090
2784	27134166	437	443	DiseaseOrPhenotypicFeature	cancer	D009369
2785	27134166	519	524	GeneOrGeneProduct	GLUT1	20525
2786	27134166	529	533	GeneOrGeneProduct	MCT4	80879
2787	27134166	556	563	DiseaseOrPhenotypicFeature	hypoxic	D000860
2788	27134166	575	580	GeneOrGeneProduct	HIF1a	15251
2789	27134166	626	631	DiseaseOrPhenotypicFeature	Tumor	D009369
2790	27134166	704	708	GeneOrGeneProduct	MCT1	20501
2791	27134166	714	718	GeneOrGeneProduct	p-S6	72508
2792	27134166	742	746	GeneOrGeneProduct	mTOR	56717
2793	27134166	758	773	DiseaseOrPhenotypicFeature	Normoxic cancer	D009369
2794	27134166	802	809	ChemicalEntity	lactate	D019344
2795	27134166	840	844	GeneOrGeneProduct	mTOR	56717
2796	27134166	859	868	ChemicalEntity	glutamine	D005973
2797	27134166	892	899	ChemicalEntity	lactate	D019344
2798	27134166	1009	1015	DiseaseOrPhenotypicFeature	cancer	D009369
2799	27134166	1029	1036	ChemicalEntity	glucose	D005947
2800	27134166	1048	1055	ChemicalEntity	lactate	D019344
2801	27134166	1100	1107	ChemicalEntity	lactate	D019344
2802	27134166	1109	1113	GeneOrGeneProduct	mTOR	56717
2803	27134166	1226	1231	GeneOrGeneProduct	GLUT2	20526
2804	27248656	0	9	GeneOrGeneProduct	Hsp90beta	301252
2805	27248656	49	53	ChemicalEntity	salt	D012492
2806	27248656	67	78	DiseaseOrPhenotypicFeature	nephropathy	D007674
2807	27248656	136	140	ChemicalEntity	salt	D012492
2808	27248656	192	205	DiseaseOrPhenotypicFeature	renal hypoxia	D007674
2809	27248656	332	344	DiseaseOrPhenotypicFeature	hypertensive	D006973
2810	27248656	355	359	OrganismTaxon	rats	10116
2811	27248656	371	375	ChemicalEntity	salt	D012492
2812	27248656	398	409	DiseaseOrPhenotypicFeature	proteinuria	D011507
2813	27248656	437	455	DiseaseOrPhenotypicFeature	renal inflammation	D007674
2814	27248656	457	465	DiseaseOrPhenotypicFeature	fibrosis	D005355
2815	27248656	557	566	GeneOrGeneProduct	Hsp90beta	301252
2816	27248656	568	577	GeneOrGeneProduct	TGF-beta,	59086
2817	27248656	578	588	GeneOrGeneProduct	HIF-1alpha	29560
2818	27248656	590	599	GeneOrGeneProduct	TNF-alpha	24835
2819	27248656	601	605	GeneOrGeneProduct	IL-6	24498
2820	27248656	610	615	GeneOrGeneProduct	MCP-1	24770
2821	27248656	665	669	ChemicalEntity	salt	D012492
2822	27248656	699	708	GeneOrGeneProduct	Hsp90beta	301252
2823	27248656	768	772	ChemicalEntity	salt	D012492
2824	27248656	843	852	GeneOrGeneProduct	NF-kappaB	81736
2825	27248656	854	857	GeneOrGeneProduct	p38	81649
2826	27248656	873	878	GeneOrGeneProduct	Bcl-2	24224
2827	27248656	893	902	GeneOrGeneProduct	Hsp90beta	301252
2828	27248656	1069	1120	ChemicalEntity	17-dimethylaminoethylamino-17-demethoxygeldanamycin	C448659
2829	27248656	1122	1129	ChemicalEntity	17-DMAG	C448659
2830	27248656	1134	1143	GeneOrGeneProduct	Hsp90beta	301252
2831	27248656	1187	1191	ChemicalEntity	salt	D012492
2832	27248656	1205	1216	DiseaseOrPhenotypicFeature	proteinuria	D011507
2833	27248656	1221	1233	DiseaseOrPhenotypicFeature	renal damage	D007674
2834	27248656	1313	1322	GeneOrGeneProduct	NF-kappaB	81736
2835	27248656	1324	1328	GeneOrGeneProduct	mTOR	56718
2836	27248656	1333	1336	GeneOrGeneProduct	p38	81649
2837	27248656	1401	1410	GeneOrGeneProduct	Hsp90beta	301252
2838	27248656	1445	1449	GeneOrGeneProduct	TAK1	313121
2839	27248656	1451	1460	GeneOrGeneProduct	AMPKalpha	65248
2840	27248656	1462	1475	GeneOrGeneProduct	IKKalpha/beta	309361,84351
2841	27248656	1477	1487	GeneOrGeneProduct	HIF-1alpha	29560
2842	27248656	1492	1498	GeneOrGeneProduct	Raptor	287871
2843	27248656	1508	1517	GeneOrGeneProduct	Hsp90beta	301252
2844	27248656	1566	1575	GeneOrGeneProduct	Hsp90beta	301252
2845	27248656	1688	1692	ChemicalEntity	salt	D012492
2846	27248656	1750	1761	DiseaseOrPhenotypicFeature	proteinuria	D011507
2847	27248656	1766	1783	DiseaseOrPhenotypicFeature	renal dysfunction	D051437
2848	27248656	1795	1799	OrganismTaxon	rats	10116
2849	27248656	1801	1810	GeneOrGeneProduct	Hsp90beta	301252
2850	27248656	1950	1961	DiseaseOrPhenotypicFeature	nephropathy	D007674
2851	27248656	1971	1984	DiseaseOrPhenotypicFeature	renal hypoxia	D007674
2852	27384305	5	13	GeneOrGeneProduct	11b-HSD1	15483
2853	27384305	23	27	OrganismTaxon	Mice	10090
2854	27384305	32	42	ChemicalEntity	Trans-Fats	D044242
2855	27384305	47	55	ChemicalEntity	Fructose	D005632
2856	27384305	79	97	DiseaseOrPhenotypicFeature	Metabolic Syndrome	D008659
2857	27384305	101	133	DiseaseOrPhenotypicFeature	Nonalcoholic Fatty Liver Disease	D065626
2858	27384305	135	167	DiseaseOrPhenotypicFeature	Nonalcoholic fatty liver disease	D065626
2859	27384305	169	174	DiseaseOrPhenotypicFeature	NAFLD	D065626
2860	27384305	221	230	DiseaseOrPhenotypicFeature	steatosis	D005234
2861	27384305	234	262	DiseaseOrPhenotypicFeature	nonalcoholic steatohepatitis	D065626
2862	27384305	264	268	DiseaseOrPhenotypicFeature	NASH	D065626
2863	27384305	274	283	DiseaseOrPhenotypicFeature	cirrhosis	D005355
2864	27384305	336	354	DiseaseOrPhenotypicFeature	metabolic syndrome	D008659
2865	27384305	356	371	ChemicalEntity	Glucocorticoids	D005938
2866	27384305	384	393	DiseaseOrPhenotypicFeature	steatosis	D005234
2867	27384305	442	457	ChemicalEntity	free fatty acid	D005230
2868	27384305	509	524	ChemicalEntity	Glucocorticoids	D005938
2869	27384305	561	600	GeneOrGeneProduct	11b-hydroxysteroid dehydrogenase type 1	15483
2870	27384305	602	610	GeneOrGeneProduct	11b-HSD1	15483
2871	27384305	643	651	GeneOrGeneProduct	11b-HSD1	15483
2872	27384305	700	705	DiseaseOrPhenotypicFeature	NAFLD	D065626
2873	27384305	726	730	OrganismTaxon	mice	10090
2874	27384305	744	752	GeneOrGeneProduct	11b-HSD1	15483
2875	27384305	793	801	GeneOrGeneProduct	11b-HSD1	15483
2876	27384305	928	933	DiseaseOrPhenotypicFeature	NAFLD	D065626
2877	27384305	1045	1052	ChemicalEntity	glucose	D005947
2878	27384305	1077	1085	GeneOrGeneProduct	11b-HSD1	15483
2879	27384305	1096	1100	OrganismTaxon	mice	10090
2880	27384305	1134	1151	DiseaseOrPhenotypicFeature	metabolic disease	D008659
2881	27384305	1186	1198	ChemicalEntity	triglyceride	D014280
2882	27384305	1220	1225	DiseaseOrPhenotypicFeature	NAFLD	D065626
2883	27384305	1277	1286	DiseaseOrPhenotypicFeature	steatosis	D005234
2884	27384305	1308	1316	GeneOrGeneProduct	11b-HSD1	15483
2885	27384305	1337	1341	OrganismTaxon	mice	10090
2886	27384305	1455	1463	GeneOrGeneProduct	11b-HSD1	15483
2887	27384305	1489	1493	OrganismTaxon	mice	10090
2888	27384305	1525	1529	DiseaseOrPhenotypicFeature	NASH	D065626
2889	27384305	1603	1615	DiseaseOrPhenotypicFeature	inflammatory	D007249
2890	27384305	1650	1658	GeneOrGeneProduct	11b-HSD1	15483
2891	27384305	1669	1673	OrganismTaxon	mice	10090
2892	27384305	1697	1714	DiseaseOrPhenotypicFeature	metabolic disease	D008659
2893	27384305	1718	1733	DiseaseOrPhenotypicFeature	hepatosteatosis	D005234
2894	27384305	1751	1756	DiseaseOrPhenotypicFeature	NAFLD	D065626
2895	27384305	1802	1810	GeneOrGeneProduct	11b-HSD1	15483
2896	27384305	1835	1855	DiseaseOrPhenotypicFeature	hepatic inflammation	D008107
2897	27384305	1889	1897	GeneOrGeneProduct	11b-HSD1	15483
2898	27384305	1931	1935	DiseaseOrPhenotypicFeature	NASH	D065626
2899	27640183	0	14	GeneOrGeneProduct	Erythropoietin	2056
2900	27640183	33	56	GeneOrGeneProduct	erythropoietin receptor	2057
2901	27640183	92	97	OrganismTaxon	human	9606
2902	27640183	153	167	GeneOrGeneProduct	Erythropoietin	13856
2903	27640183	169	172	GeneOrGeneProduct	Epo	13856
2904	27640183	229	233	OrganismTaxon	mice	10090
2905	27640183	284	290	OrganismTaxon	humans	9606
2906	27640183	291	294	GeneOrGeneProduct	Epo	2056
2907	27640183	349	354	ChemicalEntity	lipid	D008055
2908	27640183	385	388	GeneOrGeneProduct	Epo	2056
2909	27640183	392	397	OrganismTaxon	human	9606
2910	27640183	489	492	GeneOrGeneProduct	Epo	2056
2911	27640183	505	510	OrganismTaxon	human	9606
2912	27640183	586	589	GeneOrGeneProduct	Epo	2056
2913	27640183	689	721	ChemicalEntity	erythropoiesis-stimulating agent	D006397
2914	27640183	723	726	ChemicalEntity	ESA	D006397
2915	27640183	728	746	ChemicalEntity	Darbepoietin-alpha	-
2916	27640183	782	794	GeneOrGeneProduct	Epo receptor	2057
2917	27640183	796	801	GeneOrGeneProduct	Epo-R	2057
2918	27640183	894	899	GeneOrGeneProduct	Epo-R	2057
2919	27640183	940	945	GeneOrGeneProduct	Epo-R	2057
2920	27640183	966	969	GeneOrGeneProduct	Akt	207
2921	27640183	971	976	GeneOrGeneProduct	STAT5	6776
2922	27640183	978	984	GeneOrGeneProduct	p70s6k	6198
2923	27640183	986	989	GeneOrGeneProduct	LYN	4067
2924	27640183	995	1002	GeneOrGeneProduct	p38MAPK	1432
2925	27640183	1039	1043	GeneOrGeneProduct	ATGL	57104
2926	27640183	1045	1048	GeneOrGeneProduct	HSL	3991
2927	27640183	1050	1056	GeneOrGeneProduct	CGI-58	51099
2928	27640183	1058	1062	GeneOrGeneProduct	G0S2	50486
2929	27640183	1064	1073	GeneOrGeneProduct	Perilipin	5346
2930	27640183	1075	1080	GeneOrGeneProduct	Cidea	1149
2931	27640183	1082	1087	GeneOrGeneProduct	Cidec	63924
2932	27640183	1089	1093	GeneOrGeneProduct	AMPK	5562
2933	27640183	1099	1102	GeneOrGeneProduct	ACC	31
2934	27640183	1135	1139	GeneOrGeneProduct	VDAC	7416
2935	27640183	1141	1146	GeneOrGeneProduct	HSP90	3320
2936	27640183	1148	1151	GeneOrGeneProduct	PDH	54704
2937	27640183	1157	1161	GeneOrGeneProduct	SDHA	6389
2938	27640183	1214	1219	GeneOrGeneProduct	Epo-R	2057
2939	27640183	1276	1281	GeneOrGeneProduct	Epo-R	2057
2940	27640183	1342	1345	GeneOrGeneProduct	Epo	2056
2941	27640183	1397	1403	OrganismTaxon	humans	9606
2942	27825100	5	12	ChemicalEntity	glucose	D005947
2943	27825100	24	29	OrganismTaxon	human	9606
2944	27825100	84	104	DiseaseOrPhenotypicFeature	diabetic nephropathy	D003928
2945	27825100	135	155	DiseaseOrPhenotypicFeature	diabetic nephropathy	D003928
2946	27825100	224	229	OrganismTaxon	human	9606
2947	27825100	279	284	OrganismTaxon	human	9606
2948	27825100	420	427	ChemicalEntity	glucose	D005947
2949	27825100	448	455	ChemicalEntity	glucose	D005947
2950	27825100	576	635	GeneOrGeneProduct	peroxisome proliferator-activated receptor-g coactivator 1a	10891
2951	27825100	637	643	GeneOrGeneProduct	PGC-1a	10891
2952	27825100	819	826	ChemicalEntity	glucose	D005947
2953	27825100	946	961	DiseaseOrPhenotypicFeature	lactic acidosis	D000140
2954	27825100	981	1059	GeneOrGeneProduct	master regulators of oxidative metabolism transcription factor A mitochondrial	10891
2955	27825100	1061	1067	GeneOrGeneProduct	PGC-1a	10891
2956	27825100	1069	1073	GeneOrGeneProduct	AMPK	5562
2957	27825100	1079	1111	GeneOrGeneProduct	serine-threonine liver kinase B1	6794
2958	27825100	1132	1139	ChemicalEntity	glucose	D005947
2959	27825100	1227	1262	GeneOrGeneProduct	myocyte-specific enhancer factor 2C	4208
2960	27825100	1264	1269	GeneOrGeneProduct	MEF2C	4208
2961	27825100	1275	1292	GeneOrGeneProduct	myogenic factor 5	4617
2962	27825100	1294	1298	GeneOrGeneProduct	MYF5	4617
2963	27825100	1333	1340	ChemicalEntity	glucose	D005947
2964	27825100	1520	1527	ChemicalEntity	glucose	D005947
2965	27825100	1577	1582	GeneOrGeneProduct	MEF2C	4208
2966	27825100	1584	1588	GeneOrGeneProduct	MYF5	4617
2967	27825100	1594	1600	GeneOrGeneProduct	PGC-1a	10891
2968	27825100	1661	1669	OrganismTaxon	patients	9606
2969	27825100	1675	1695	DiseaseOrPhenotypicFeature	diabetic nephropathy	D003928
2970	27825100	1724	1729	OrganismTaxon	human	9606
2971	27825100	1755	1760	GeneOrGeneProduct	MEF2C	4208
2972	27825100	1761	1765	GeneOrGeneProduct	MYF5	4617
2973	27825100	1859	1866	ChemicalEntity	glucose	D005947
2974	27825100	2044	2051	ChemicalEntity	glucose	D005947
2975	27825100	2063	2068	OrganismTaxon	human	9606
2976	27825100	2123	2143	DiseaseOrPhenotypicFeature	diabetic nephropathy	D003928
2977	28098423	0	33	GeneOrGeneProduct	Brain-derived neurotrophic factor	24225
2978	28098423	45	56	ChemicalEntity	doxorubicin	D004317
2979	28098423	65	84	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
2980	28098423	104	107	GeneOrGeneProduct	Akt	24185
2981	28098423	122	126	OrganismTaxon	rats	10116
2982	28098423	156	167	ChemicalEntity	doxorubicin	D004317
2983	28098423	169	172	ChemicalEntity	Dox	D004317
2984	28098423	210	224	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2985	28098423	289	322	GeneOrGeneProduct	brain-derived neurotrophic factor	24225
2986	28098423	324	328	GeneOrGeneProduct	BDNF	24225
2987	28098423	351	355	GeneOrGeneProduct	BDNF	24225
2988	28098423	378	381	ChemicalEntity	Dox	D004317
2989	28098423	390	404	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
2990	28098423	421	425	OrganismTaxon	rats	10116
2991	28098423	445	448	ChemicalEntity	Dox	D004317
2992	28098423	524	528	GeneOrGeneProduct	BDNF	24225
2993	28098423	560	564	CellLine	H9c2	10116
2994	28098423	589	592	ChemicalEntity	Dox	D004317
2995	28098423	607	611	GeneOrGeneProduct	BDNF	24225
2996	28098423	656	660	GeneOrGeneProduct	BDNF	24225
2997	28098423	669	672	ChemicalEntity	Dox	D004317
2998	28098423	681	695	DiseaseOrPhenotypicFeature	cardiac injury	D006331
2999	28098423	754	758	GeneOrGeneProduct	BDNF	24225
3000	28098423	774	777	ChemicalEntity	Dox	D004317
3001	28098423	786	789	OrganismTaxon	rat	10116
3002	28098423	810	814	GeneOrGeneProduct	BDNF	24225
3003	28098423	832	860	GeneOrGeneProduct	tropomyosin-related kinase B	25054
3004	28098423	862	866	GeneOrGeneProduct	TrkB	25054
3005	28098423	901	905	GeneOrGeneProduct	BDNF	24225
3006	28098423	922	955	GeneOrGeneProduct	Brain-derived neurotrophic factor	24225
3007	28098423	980	983	ChemicalEntity	Dox	D004317
3008	28098423	1038	1057	DiseaseOrPhenotypicFeature	cardiac dysfunction	D006331
3009	28098423	1061	1065	OrganismTaxon	rats	10116
3010	28098423	1078	1082	GeneOrGeneProduct	BDNF	24225
3011	28098423	1147	1150	ChemicalEntity	Dox	D004317
3012	28098423	1159	1163	CellLine	H9c2	10116
3013	28098423	1229	1233	GeneOrGeneProduct	BDNF	24225
3014	28098423	1244	1247	GeneOrGeneProduct	Akt	24185
3015	28098423	1281	1310	GeneOrGeneProduct	mammalian target of rapamycin	56718
3016	28098423	1315	1318	GeneOrGeneProduct	Bad	64639
3017	28098423	1337	1373	GeneOrGeneProduct	p38 mitogen-activated protein kinase	81649
3018	28098423	1378	1416	GeneOrGeneProduct	extracellular regulated protein kinase	116590
3019	28098423	1465	1469	GeneOrGeneProduct	BDNF	24225
3020	28098423	1487	1491	GeneOrGeneProduct	BDNF	24225
3021	28098423	1502	1506	GeneOrGeneProduct	TrkB	25054
3022	28098423	1513	1516	GeneOrGeneProduct	Akt	24185
3023	28098423	1591	1595	GeneOrGeneProduct	BDNF	24225
3024	28098423	1604	1607	ChemicalEntity	Dox	D004317
3025	28098423	1616	1630	DiseaseOrPhenotypicFeature	cardiotoxicity	D066126
3026	28098423	1645	1648	GeneOrGeneProduct	Akt	24185
3027	28098423	1698	1701	ChemicalEntity	Dox	D004317
3028	28098423	1705	1711	DiseaseOrPhenotypicFeature	cancer	D009369
3029	28279980	0	5	GeneOrGeneProduct	GLUT4	20528
3030	28279980	44	51	ChemicalEntity	Glucose	D005947
3031	28279980	85	90	OrganismTaxon	Mouse	10090
3032	28279980	108	113	GeneOrGeneProduct	GLUT4	20528
3033	28279980	137	144	GeneOrGeneProduct	insulin	3630
3034	28279980	186	193	ChemicalEntity	glucose	D005947
3035	28279980	260	267	ChemicalEntity	glucose	D005947
3036	28279980	321	326	GeneOrGeneProduct	GLUT4	20528
3037	28279980	360	367	ChemicalEntity	glucose	D005947
3038	28279980	400	405	OrganismTaxon	mouse	10090
3039	28279980	498	522	ChemicalEntity	[(3)H]-2-deoxy-d-glucose	D003847
3040	28279980	569	576	ChemicalEntity	glucose	D005947
3041	28279980	645	650	GeneOrGeneProduct	GLUT4	20528
3042	28279980	660	664	OrganismTaxon	mice	10090
3043	28279980	685	690	GeneOrGeneProduct	GLUT4	20528
3044	28279980	783	790	ChemicalEntity	glucose	D005947
3045	28279980	847	851	GeneOrGeneProduct	GLUT	170441,20525,20526,20527,20528,227659,353169,56017,56485
3046	28279980	862	876	ChemicalEntity	cytochalasin B	D003571
3047	28279980	890	896	ChemicalEntity	sodium	D012964
3048	28279980	907	914	ChemicalEntity	glucose	D005947
3049	28279980	937	947	ChemicalEntity	phloridzin	D010695
3050	28279980	1002	1007	GeneOrGeneProduct	GLUTs	170441,20525,20526,20527,20528,227659,353169,56017,56485
3051	28279980	1045	1049	GeneOrGeneProduct	GLUT	170441,20525,20526,20527,20528,227659,353169,56017,56485
3052	28279980	1051	1057	ChemicalEntity	hexose	D006601
3053	28279980	1115	1139	ChemicalEntity	[(3)H]-2-deoxy-d-glucose	D003847
3054	28279980	1168	1178	ChemicalEntity	d-fructose	D005632
3055	28279980	1225	1230	GeneOrGeneProduct	GLUT2	20526
3056	28279980	1232	1237	GeneOrGeneProduct	GLUT5	56485
3057	28279980	1239	1244	GeneOrGeneProduct	GLUT8	56017
3058	28279980	1250	1256	GeneOrGeneProduct	GLUT12	353169
3059	28279980	1306	1311	GeneOrGeneProduct	GLUTs	170441,20525,20526,20527,20528,227659,353169,56017,56485
3060	28279980	1360	1365	GeneOrGeneProduct	GLUT1	20525
3061	28279980	1367	1372	GeneOrGeneProduct	GLUT3	20527
3062	28279980	1374	1379	GeneOrGeneProduct	GLUT6	227659
3063	28279980	1385	1391	GeneOrGeneProduct	GLUT10	170441
3064	28279980	1473	1478	GeneOrGeneProduct	GLUT4	20528
3065	28279980	1524	1531	ChemicalEntity	glucose	D005947
3066	28279980	1579	1584	GeneOrGeneProduct	GLUT1	20525
3067	28279980	1586	1591	GeneOrGeneProduct	GLUT3	20527
3068	28279980	1593	1598	GeneOrGeneProduct	GLUT6	227659
3069	28279980	1607	1613	GeneOrGeneProduct	GLUT10	170441
3070	28279980	1639	1646	ChemicalEntity	glucose	D005947
3071	28348168	0	5	GeneOrGeneProduct	FGFR2	14183
3072	28348168	287	293	DiseaseOrPhenotypicFeature	cancer	D009369
3073	28348168	297	317	DiseaseOrPhenotypicFeature	degenerative disease	D019636
3074	28348168	398	412	GeneOrGeneProduct	FGF receptor 2	14183
3075	28348168	414	419	GeneOrGeneProduct	FGFR2	14183
3076	28348168	430	435	OrganismTaxon	mouse	10090
3077	28348168	524	529	GeneOrGeneProduct	FGFR2	14183
3078	28348168	662	666	GeneOrGeneProduct	SOX2	20674
3079	28348168	731	755	GeneOrGeneProduct	receptor tyrosine kinase	14183
3080	28348168	863	869	DiseaseOrPhenotypicFeature	cancer	D009369
3081	28481876	32	66	GeneOrGeneProduct	miniature chromosome maintenance 8	84515
3082	28481876	70	75	OrganismTaxon	human	9606
3083	28481876	76	88	DiseaseOrPhenotypicFeature	malignancies	D009369
3084	28481876	90	122	GeneOrGeneProduct	Miniature chromosome maintenance	84515
3085	28481876	124	127	GeneOrGeneProduct	MCM	84515
3086	28481876	215	219	GeneOrGeneProduct	MCM8	84515
3087	28481876	232	235	GeneOrGeneProduct	MCM	84515
3088	28481876	384	389	OrganismTaxon	human	9606
3089	28481876	390	402	DiseaseOrPhenotypicFeature	malignancies	D009369
3090	28481876	416	420	GeneOrGeneProduct	MCM8	84515
3091	28481876	480	485	OrganismTaxon	human	9606
3092	28481876	486	493	DiseaseOrPhenotypicFeature	cancers	D009369
3093	28481876	519	523	GeneOrGeneProduct	MCM8	84515
3094	28481876	527	542	DiseaseOrPhenotypicFeature	prostate cancer	D011471
3095	28481876	562	568	DiseaseOrPhenotypicFeature	cancer	D009369
3096	28481876	602	606	GeneOrGeneProduct	MCM8	84515
3097	28481876	610	615	CellLine	RWPE1	9606
3098	28481876	758	762	GeneOrGeneProduct	MCM8	84515
3099	28481876	766	769	CellLine	PC3	9606
3100	28481876	771	776	CellLine	DU145	9606
3101	28481876	781	786	CellLine	LNCaP	9606
3102	28481876	835	841	DiseaseOrPhenotypicFeature	tumour	D009369
3103	28481876	883	899	DiseaseOrPhenotypicFeature	immunodeficiency	D007153
3104	28481876	900	904	OrganismTaxon	mice	10090
3105	28481876	922	925	CellLine	PC3	9606
3106	28481876	930	935	CellLine	DU145	9606
3107	28481876	943	947	GeneOrGeneProduct	MCM8	84515
3108	28481876	954	963	GeneOrGeneProduct	cyclin D1	595
3109	28481876	978	980	GeneOrGeneProduct	Rb	5925
3110	28481876	1008	1033	GeneOrGeneProduct	cyclin-dependent kinase 4	1019
3111	28481876	1060	1069	GeneOrGeneProduct	cyclin D1	595
3112	28481876	1070	1074	GeneOrGeneProduct	MCM8	84515
3113	28481876	1103	1105	GeneOrGeneProduct	Rb	5925
3114	28481876	1143	1149	DiseaseOrPhenotypicFeature	cancer	D009369
3115	28481876	1235	1239	GeneOrGeneProduct	MCM8	84515
3116	28481876	1267	1272	OrganismTaxon	human	9606
3117	28481876	1273	1279	DiseaseOrPhenotypicFeature	cancer	D009369
3118	28687665	16	25	GeneOrGeneProduct	a-tubulin	22142
3119	28687665	26	32	GeneOrGeneProduct	Tuba1a	22142
3120	28687665	253	264	GeneOrGeneProduct	a/b-tubulin	22142,22152,53857
3121	28687665	295	304	GeneOrGeneProduct	a-tubulin	22142
3122	28687665	313	319	GeneOrGeneProduct	TUBA1A	7846
3123	28687665	339	361	DiseaseOrPhenotypicFeature	cortical malformations	D054220
3124	28687665	365	371	OrganismTaxon	humans	9606
3125	28687665	441	447	GeneOrGeneProduct	Tuba1a	22142
3126	28687665	460	464	OrganismTaxon	mice	10090
3127	28687665	476	482	GeneOrGeneProduct	Tuba1a	22142
3128	28687665	502	507	SequenceVariant	S140G	p|SUB|S|140|G
3129	28687665	642	648	GeneOrGeneProduct	Tuba1a	22142
3130	28687665	822	828	GeneOrGeneProduct	Tuba1a	22142
3131	28687665	962	973	GeneOrGeneProduct	a/b-tubulin	22142,22152,53857
3132	28687665	1000	1005	GeneOrGeneProduct	Tuba8	53857
3133	28687665	1015	1024	GeneOrGeneProduct	a-tubulin	22142
3134	28687665	1060	1082	DiseaseOrPhenotypicFeature	cortical malformations	D054220
3135	28687665	1119	1125	GeneOrGeneProduct	Tuba1a	22142
3136	28687665	1147	1153	GeneOrGeneProduct	Tuba1a	22142
3137	29045486	0	19	DiseaseOrPhenotypicFeature	Thiamine deficiency	D013832
3138	29045486	30	57	GeneOrGeneProduct	hypoxia inducible factor-1a	15251
3139	29045486	99	104	OrganismTaxon	mouse	10090
3140	29045486	125	133	ChemicalEntity	Thiamine	D013831
3141	29045486	295	314	DiseaseOrPhenotypicFeature	thiamine deficiency	D013832
3142	29045486	316	318	DiseaseOrPhenotypicFeature	TD	D013832
3143	29045486	363	370	ChemicalEntity	alcohol	D000438
3144	29045486	394	425	DiseaseOrPhenotypicFeature	impaired mitochondrial function	D028361
3145	29045486	445	457	DiseaseOrPhenotypicFeature	inflammation	D007249
3146	29045486	462	476	DiseaseOrPhenotypicFeature	excitotoxicity	D064420
3147	29045486	603	611	OrganismTaxon	patients	9606
3148	29045486	617	624	DiseaseOrPhenotypicFeature	hypoxia	D000860
3149	29045486	625	633	DiseaseOrPhenotypicFeature	ischemia	D007511
3150	29045486	638	640	DiseaseOrPhenotypicFeature	TD	D013832
3151	29045486	790	797	DiseaseOrPhenotypicFeature	hypoxia	D000860
3152	29045486	798	806	DiseaseOrPhenotypicFeature	ischemia	D007511
3153	29045486	808	810	DiseaseOrPhenotypicFeature	TD	D013832
3154	29045486	836	863	GeneOrGeneProduct	Hypoxia Inducible Factor-1a	15251
3155	29045486	865	871	GeneOrGeneProduct	HIF-1a	15251
3156	29045486	893	899	ChemicalEntity	oxygen	D010100
3157	29045486	929	931	DiseaseOrPhenotypicFeature	TD	D013832
3158	29045486	940	946	GeneOrGeneProduct	HIF-1a	15251
3159	29045486	950	969	DiseaseOrPhenotypicFeature	neurological injury	D009422
3160	29045486	1058	1060	DiseaseOrPhenotypicFeature	TD	D013832
3161	29045486	1069	1075	GeneOrGeneProduct	HIF-1a	15251
3162	29045486	1111	1116	OrganismTaxon	mouse	10090
3163	29045486	1227	1239	DiseaseOrPhenotypicFeature	inflammatory	D007249
3164	29045486	1240	1246	GeneOrGeneProduct	HIF-1a	15251
3165	29045486	1260	1264	GeneOrGeneProduct	MCP1	20296
3166	29045486	1266	1271	GeneOrGeneProduct	BNIP3	12176
3167	29045486	1273	1276	GeneOrGeneProduct	Nix	12177
3168	29045486	1281	1285	GeneOrGeneProduct	Noxa	58801
3169	29045486	1293	1295	DiseaseOrPhenotypicFeature	TD	D013832
3170	29045486	1338	1340	DiseaseOrPhenotypicFeature	TD	D013832
3171	29045486	1363	1372	GeneOrGeneProduct	Annexin V	11747
3172	29045486	1448	1454	GeneOrGeneProduct	HIF-1a	15251
3173	29045486	1470	1473	GeneOrGeneProduct	YC1	56878
3174	29045486	1478	1486	ChemicalEntity	thiamine	D013831
3175	29045486	1538	1544	GeneOrGeneProduct	HIF-1a	15251
3176	29045486	1586	1588	DiseaseOrPhenotypicFeature	TD	D013832
3177	29045486	1634	1640	GeneOrGeneProduct	HIF-1a	15251
3178	29045486	1697	1709	DiseaseOrPhenotypicFeature	inflammatory	D007249
3179	29045486	1763	1782	DiseaseOrPhenotypicFeature	thiamine deficiency	D013832
3180	30442153	0	4	ChemicalEntity	Ca2+	D002118
3181	30442153	61	73	DiseaseOrPhenotypicFeature	astrogliosis	D005911
3182	30442153	99	105	GeneOrGeneProduct	KCa3.1	16534,3783
3183	30442153	124	127	GeneOrGeneProduct	AKT	11651,207
3184	30442153	128	132	GeneOrGeneProduct	mTOR	2475,56717
3185	30442153	160	210	GeneOrGeneProduct	intermediate-conductance Ca2+-activated K+ channel	16534,3783
3186	30442153	211	217	GeneOrGeneProduct	KCa3.1	16534
3187	30442153	272	293	DiseaseOrPhenotypicFeature	reactive astrogliosis	D005911
3188	30442153	295	297	DiseaseOrPhenotypicFeature	RA	D005911
3189	30442153	302	321	DiseaseOrPhenotypicFeature	Alzheimer's disease	D000544
3190	30442153	323	325	DiseaseOrPhenotypicFeature	AD	D000544
3191	30442153	337	343	GeneOrGeneProduct	KCa3.1	16534,3783
3192	30442153	403	405	DiseaseOrPhenotypicFeature	AD	D000544
3193	30442153	406	414	OrganismTaxon	patients	9606
3194	30442153	419	422	GeneOrGeneProduct	APP	11820,351
3195	30442153	423	426	GeneOrGeneProduct	PS1	5663
3196	30442153	427	431	OrganismTaxon	mice	10090
3197	30442153	490	493	GeneOrGeneProduct	APP	11820,351
3198	30442153	494	497	GeneOrGeneProduct	PS1	5663
3199	30442153	498	502	OrganismTaxon	mice	10090
3200	30442153	507	513	GeneOrGeneProduct	KCa3.1	16534
3201	30442153	517	520	GeneOrGeneProduct	APP	11820,351
3202	30442153	521	524	GeneOrGeneProduct	PS1	5663
3203	30442153	525	529	OrganismTaxon	mice	10090
3204	30442153	595	610	DiseaseOrPhenotypicFeature	memory deficits	D008569
3205	30442153	632	643	DiseaseOrPhenotypicFeature	neuron loss	D009422
3206	30442153	676	684	ChemicalEntity	Fluo-4AM	C409648
3207	30442153	715	719	ChemicalEntity	Ca2+	D000069285
3208	30442153	729	741	GeneOrGeneProduct	beta-amyloid	351
3209	30442153	743	748	GeneOrGeneProduct	Abeta	351
3210	30442153	797	803	GeneOrGeneProduct	KCa3.1	16534,3783
3211	30442153	922	927	GeneOrGeneProduct	Abeta	11820,351
3212	30442153	979	981	DiseaseOrPhenotypicFeature	AD	D000544
3213	30442153	982	990	OrganismTaxon	patients	9606
3214	30442153	995	998	GeneOrGeneProduct	APP	11820,351
3215	30442153	999	1002	GeneOrGeneProduct	PS1	5663
3216	30442153	1003	1005	DiseaseOrPhenotypicFeature	AD	D000544
3217	30442153	1006	1010	OrganismTaxon	mice	10090
3218	30442153	1016	1022	GeneOrGeneProduct	KCa3.1	16534
3219	30442153	1068	1072	ChemicalEntity	Ca2+	D000069285
3220	30442153	1118	1122	ChemicalEntity	Ca2+	D002118
3221	30442153	1131	1136	GeneOrGeneProduct	Orai1	109305
3222	30442153	1205	1211	GeneOrGeneProduct	KCa3.1	16534
3223	30442153	1243	1247	ChemicalEntity	Ca2+	D000069285
3224	30442153	1279	1295	GeneOrGeneProduct	protein kinase B	11651
3225	30442153	1297	1300	GeneOrGeneProduct	AKT	11651
3226	30442153	1377	1383	GeneOrGeneProduct	KCa3.1	16534
3227	30442153	1393	1396	GeneOrGeneProduct	AKT	11651
3228	30442153	1397	1428	GeneOrGeneProduct	mechanistic target of rapamycin	56717
3229	30442153	1546	1578	GeneOrGeneProduct	78-kDa glucose-regulated protein	14828
3230	30442153	1583	1632	GeneOrGeneProduct	CCAAT/enhancer-binding protein homologous protein	13198
3231	30442153	1657	1659	DiseaseOrPhenotypicFeature	RA	D005911
3232	30442153	1667	1698	GeneOrGeneProduct	glial fibrillary acidic protein	14580
3233	30442153	1717	1720	GeneOrGeneProduct	APP	11820,351
3234	30442153	1721	1724	GeneOrGeneProduct	PS1	5663
3235	30442153	1725	1727	DiseaseOrPhenotypicFeature	AD	D000544
3236	30442153	1728	1733	OrganismTaxon	mouse	10090
3237	30442153	1756	1762	GeneOrGeneProduct	KCa3.1	16534
3238	30442153	1766	1772	GeneOrGeneProduct	KCa3.1	16534
3239	30442153	1776	1779	GeneOrGeneProduct	APP	11820,351
3240	30442153	1780	1783	GeneOrGeneProduct	PS1	5663
3241	30442153	1784	1788	OrganismTaxon	mice	10090
3242	30442153	1856	1873	DiseaseOrPhenotypicFeature	neuroinflammation	D007249
3243	30442153	1911	1917	GeneOrGeneProduct	KCa3.1	16534
3244	30442153	1921	1924	GeneOrGeneProduct	APP	11820,351
3245	30442153	1925	1928	GeneOrGeneProduct	PS1	5663
3246	30442153	1929	1933	OrganismTaxon	mice	10090
3247	30442153	1952	1955	GeneOrGeneProduct	APP	11820,351
3248	30442153	1956	1959	GeneOrGeneProduct	PS1	5663
3249	30442153	1960	1964	OrganismTaxon	mice	10090
3250	30442153	1979	1994	DiseaseOrPhenotypicFeature	memory deficits	D008569
3251	30442153	1999	2012	DiseaseOrPhenotypicFeature	neuronal loss	D009422
3252	30442153	2016	2019	GeneOrGeneProduct	APP	11820,351
3253	30442153	2020	2023	GeneOrGeneProduct	PS1	5663
3254	30442153	2024	2028	OrganismTaxon	mice	10090
3255	30442153	2046	2052	GeneOrGeneProduct	KCa3.1	16534
3256	30442153	2056	2059	GeneOrGeneProduct	APP	11820,351
3257	30442153	2060	2063	GeneOrGeneProduct	PS1	5663
3258	30442153	2064	2068	OrganismTaxon	mice	10090
3259	30442153	2119	2125	GeneOrGeneProduct	KCa3.1	16534,3783
3260	30442153	2159	2163	ChemicalEntity	Ca2+	D000069285
3261	30442153	2253	2268	DiseaseOrPhenotypicFeature	memory deficits	D008569
3262	30442153	2273	2286	DiseaseOrPhenotypicFeature	neuronal loss	D009422
